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ABSTRACT 
The threat of antimicrobial resistance particularly in the intensive care unit has become 
a global issue. This study aimed to evaluate the effectiveness of antimicrobial 
stewardship in limiting the spread of antimicrobial resistance in the hospital’s ICU.  The 
study further determined the deficiencies of the ASP and recommended strategies to 
remedy the identified deficiencies. 
A quasi-experimental descriptive quantitative design was used in this study. The study 
was conducted at the intensive care unit of an academic hospital. A structured 
questionnaire was used to extract information from patients’ medical records. This 
evaluation showed that the antimicrobial stewardship program had a sufficient impact 
on the appropriate use of antimicrobials in the hospital’s ICU. While there were a small 
(19.05 %) number of patients inappropriately prescribed antimicrobials, a moderate 
(35.59%) number of patients developed hospital acquired infections during the study 
period. In addition, the results revealed a lack of the facility’s leadership commitment to 
antimicrobial stewardship, which is crucial for ensuring the availability of human, 
financial and information technology resources.. 
Through the evaluation of the program the deficiency in the program’s performance can 
be identified and optimised. For the studied facility, the performance of the program 
could be improved by gaining the support of the facility leadership. The present study 
endorses the evaluation of health promotion initiatives to improve patients’ safety and 
outcome in healthcare institutions. 
Keywords  
Antimicrobial stewardship program; antimicrobial resistance; impact evaluation; 
leadership commitment; intensive care unit; spread; deficiencies. 
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CHAPTER 1 
 
ORIENTATION TO THE RESEARCH STUDY 
1.1 Introduction 
Healthcare-associated infections (HAIs) are a cause of significant morbidity and 
mortality in patients receiving health care (Brink, Feldman, Duse, Gopalan, Grolman, 
Mer, Naiker, Paget, Perovik & Richards 2006: 153). Majority of these infections are 
caused by antibiotic-resistant bacteria which can easily spread (Gould 2011:16). 
Furthermore, they are difficult to treat and do not respond to standard treatment, 
leading to prolonged illness, high treatment costs, extended hospitalisation and 
adverse complications (Cosgrove & Carmeli 2003:1435; Singh, Arora, Thangaraju, 
Singh & Natt 2013: 95). The increasing challenges to the emergence and spread of 
resistant bacteria are a global concern and affects both clinical and financial 
therapeutic outcomes (Essack 2006: 51).  
 
Although the evidence is not of high quality, it has been established that antibiotics 
are key contributors to the development and spread of antimicrobial resistance 
(AMR) (Tacconelli 2009: 355: 357).  In addition,  the driving force of this threat were 
identified as 1) The misuse of antibiotics by both patients healthcare providers 
(Tacconelli 2009: 356), (2) a lack of compliance with appropriate antibiotic therapy by 
patients, such as missing doses or ceasing a course of antibiotics before cure, self-
medicating (Pinder, Sallis, Berry & Chadborn 2015:17), (3) Host-susceptibility, which 
is demonstrated in the very old, the very young, those undergoing invasive 
procedures, severely ill, immune-compromised patient and those patients staying 
longer in hospitals (Weinstein 1998:417). 
Healthcare settings are associated with the highest emergence and spread of 
antimicrobial resistance (Pinder et al, 2015: 9). The highest rates are observed in 
intensive care units (ICU); adult and paediatric ICUs (Weinstein 1998: 147). In South 
African ICUs, antibiotic prescription habits are far from acceptable and are 
associated with poor fiscal outcomes, increased mortality and limitations of 
therapeutic options (Paruk, Richards, Scribante, Bhagwanjee, Mer & Perrie 2012: 
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615). Therefore, an urgent intervention to curb the emergence and spread of 
antimicrobial resistant pathogens is imperative in this country.  
 
To counter the emergence and spread of multi-drug resistant pathogens, Duse 
(2005: 37) recommended the implementation of an effective and integrated 
programme that involves antimicrobial surveillance, a rational antimicrobial use 
programme, and infection control. This was corroborated by Bamford, Bonorchis, 
Ryan, Simpson, Elliott, Hoffmann, Naicker, Ismail, Mbelle, Nchabeleng, Nana, 
Sriruttan, Seetharam & Wadula (2011: 243) advocating regular surveillance of local 
antimicrobial susceptibility patterns to provide information on new, or changing, 
patterns of resistance, and informing clinician on prescribing and selection of empiric 
therapy.  
 
Despite the recommendations and guidelines from governmental and professional 
groups, South African infection control programmes are generally poor, ranging from 
non-existent to excellent (Duse 2005: 39). Good and standardised surveillance 
systems for HAIs are currently not in place in most healthcare institutions (Brink, et 
al. 2006:153). Additionally, the monitoring of antimicrobial resistance has been 
largely neglected (Duse 2005:39).  
According to Antimicrobial Resistance Background report, all public hospitals in 
South Africa have implemented an antimicrobial stewardship programme involving a 
restricted formulary approach and perform a pharmacy-led ward rounds (NDoH 2015: 
11).  However, constant impact evaluation of the programme is important to assist in 
making decision to scaling-up.  Although, numerous studies have evaluated the 
impact of ASPs in health care institutions and provided evidence on the effectiveness 
of ASPs, there is no evidence of any comprehensive impact assessment on the 
ASPs implemented in South African hospitals.  
 
This study was therefore aimed at assessing the sustainable effectiveness of the 
implemented antimicrobial stewardship programme, to identify constraints in its 
performance to optimise the quality of antimicrobial prescribing and improve patients’ 
outcome. 
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1.2 BACKGROUND TO THE RESEARCH PROBLEM 
South African hospitals are battling with the growing emergence of key antimicrobial 
resistant pathogens particularly regarding carbapenems (Bamford, Brink, Govender, 
Lewis, Perovic, Botha, Harris, Keddy, Gelband, & Duse 2011: 250).  
 
In 2001, Global Antibiotic Resistant Partnership published a situational analysis of 
antibiotic use and resistance in South Africa, suggesting that antibiotic resistance is 
driven by many factors, many of which are associated with inappropriate antibiotic 
management and consumption (Gelband & Duse 2001: 552). Further, the authors 
identified the poor living conditions, shortages of antibiotics to the public sector, the 
use of previously prescribed antibiotics, and self-diagnosing and over the counter 
access to antibiotics, as well as clinicians as contributing factors (Gelband & Duse 
2011: 552).  
 
Another author pointed out that the poverty-driven practices of medication sharing 
and self-treatment, resulting in inappropriate choice of medication for the specific 
organism, and the inappropriate dose or duration of therapy, involving the use of 
poor-quality and foreign-made drugs, may exacerbate the emergence and spread of 
multidrug-resistant organisms (Planta 2007: 534- 535). Omulo, Thumbi, Njenga and 
Call (2015: 1) states that the increased demand for antimicrobial therapies in south 
Africa, is exacerbated by the occurrence and increase of conditions such as acute 
respiratory infections, diarrheal diseases, HIV/AIDs, tuberculosis, malaria and 
helminthic infections .  
 
Resistance to antimicrobial drugs is escalating worldwide including South Africa 
(Truter 2015: 52). A 2015 study analyzing prevalence of infection and  patterns of 
resistance in critically injured polytrauma patients admitted to a level1 trauma ICU, at 
a Charlotte Maxeke Johannesburg Academic hospital, indicated  Gram-negative 
organisms as predominant, along with the most common organism  as Pseudomonas 
(30.1%), followed by Klebsiella (25.7%),  Acinetobacter (16.4%) as well as 
Staphylococcus aureus infection (5.8%)  (Pillai, Yazicioglu, Moeng, Rangaka, 
Monareng, Jayakrishnan, Veller & Pinkus 2015: 740) 
 
 
 
4 
 
In a review conducted to gather scientific evidence of the extent and patterns of 
antimicrobial resistance in selected hospital-acquired pathogens, eight manuscripts 
published between 2000 and 2011 were reviewed and included susceptibility data 
from four of the nine provinces of South Africa. An overall occurrence of resistance to 
antimicrobials used was observed and escalating rates of antimicrobial resistance to 
several conventional antimicrobials, such as the high rates of ESBL and MRSA was 
detected in these urban academic centres and private institutions (Nyasulu, Murray, 
Perovic & Koornhof 2012: 9-12)  
 
A study undertaken in a large tertiary hospital in Durban, KwaZulu Natal 
demonstrated a high overall prevalence of antimicrobial resistant bacteria isolated in 
adult medical and surgical ICUs, medical and surgical neurosurgery ICU, trauma ICU 
(TICU), Cardiothoracic ICU (CTC ICU) and the burns unit, indicating MRSA with an 
average of 64.2%, and ESBL + K pneumoniae (63%), MDR Acinebacter species 
(62.6%) and MDR Pseudomonas auruginosa (10.4%) (Swe Swe-Han & Coovadia 
2010: 2). 
 
The increasing rate of antimicrobial resistant pathogens is critically compromising the 
management of common and lethal bacterial infections (GARP-India working group 
2011: 282).  Consequently, the Infectious Diseases Society of America in 2007 
published guidelines promoting the development of an institutional programme in all 
hospitals to enhance antimicrobial stewardship (Dellit, Owens, McGowan, Jr., 
Gerding, Weinstein, Burke, Huskins, Paterson, Fishman, Carpenter, Brennan, Billeter 
& Hooton 2007:159).  
 
In response to the current status of AMR a number of initiatives including  Global 
Antibiotic Resistance Partnership (GARP) in South Africa (Duse 2011: 551), South 
African Antibiotic Stewardship Programme (SAASP) (Mendelson, Whitelaw, Nicol & 
Brink 2012: 307), were introduced to address the scourge of AMR. Although, 
laboratory-based antimicrobial resistance surveillance has been implemented for 
many years  by South African Society for Clinical Microbiology (SASCM) formerly 
known as  National Antibiotic Surveillance Forum (NASF) (Bamford et al. 2011: 243), 
and  Group for Enteric, Respiratory and Meningeal Surveillance  (GERMS)-SA 
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(GERMS-SA 2007: 4), there are still gaps in knowledge about the extent of AMR in 
South Africa. 
 
Nevertheless, such efforts are flooded with a multitude of limitations which may 
impede the AMS activities in healthcare facilities. According to the Antimicrobial 
Resistance Background Report some of the  deficiencies include the prescribers’ 
inability to send appropriate clinical samples for culture and sensitivity testing prior to 
prescribing antimicrobials, a lack of linkage of pharmacy, clinical and laboratory data 
systems in institutions resulting in poor and incomplete reporting of antimicrobial use 
as well as a shortage in trained personnel such as microbiologists, AMS practitioners 
and infectious diseases specialist (NDoH 2015: 15).  
 
Thus, despite the advocacy and initiatives embarked on, South Africa is at the 
forefront in the prevalence of gram-negative microorganisms that are resistant to 
beta-lactam antibiotics (extended-spectrum beta lactamases) (Van den Bergh 
2009:1). Without a further assessment of the on-going support and relevance of the 
activities of the ASP, the programme's aim of improving the quality of healthcare and 
patients care will not be achieved. Even so, there is a scarcity of evidence of the 
impact of ASP in South Africa, therefore, this situation must be corrected to elucidate 
and improve on the limitation of the ASP implemented in South African hospitals. 
 
1.3 RESEARCH PROBLEM 
Based on the growing evidence of the increasing rate of antimicrobial resistant 
pathogens in South Africa, the effectiveness of the ASPs implemented in healthcare 
institutions to promote appropriate antimicrobial use should be evaluated and 
optimised. Any unattended deficient in the performance of the ASP will render the 
efforts inadequate to limit the scourge of antimicrobial resistant and improve patients' 
health. 
 
A comprehensive evaluation of the impact of ASP implemented in hospitals in South 
Africa is imperative to elucidate any shortfall on its performance. Such evaluation will 
help in optimising ASP and improving on the quality of the antimicrobial prescription 
and safety of patients, subsequently limiting the emergence and spread of resistant 
bacteria.  
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1.4 RESEARCH QUESTION AND HYPOTHESES 
This study was set to answer the question “What is the effect of performing the ASP’s 
strategies on reducing the spread of antimicrobial resistant bacteria in patients 
admitted to the ICU of South African hospitals?” 
The null hypothesis states that promoting the quality of antimicrobial prescribing 
through ASP does not reduce the spread of antimicrobial resistant bacteria in the ICU 
of South African hospitals. 
 
1.5 AIMS OF THE STUDY 
 
1.5.1 PURPOSE OF THE STUDY 
This study provides a comprehensive evaluation of whether the effectiveness of 
antimicrobial stewardship programme implemented in Gauteng academic hospitals in 
South Africa,  achieved its objective of improving the quality of antimicrobial use, with 
the consequence of limiting the spread of resistant bacteria. The deficiencies in   
ASPs were identified and recommendations were made to achieve optimal 
performance. 
 
1.5.2 OBJECTIVES OF THE STUDY 
The objectives of this study were to: 
 Determine the capacity of the hospital to appropriately prescribe antimicrobials. 
 Determine the appropriateness of prescribing antimicrobials to patients 
suspected of having hospital-acquired infection after 48 -72h of admission. 
 Determine the incidence of the variety of bacteria and their antimicrobial 
susceptibility patterns in patients admitted in the ICU. 
 Assess the effectiveness of antimicrobial stewardship in improving the quality 
of antimicrobial prescribing in the ICU using the RE-AIM framework. 
 Develop and recommend strategies for the improvement of antimicrobial 
stewardship programmes in the ICU. 
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1.6 SIGNIFICANCE OF THE STUDY 
The significance of this study was informed by the ever-growing threat of 
antimicrobial resistance caused by use and misuse of antimicrobials in healthcare 
institutes. Promoting appropriate use of antibiotics through various interventions will 
help stop unnecessary prescribing and misuse of antibiotics. The findings of this 
research study will contribute substantially in strengthening infection control practices 
and preventing the emergence and spread of antimicrobial resistance in hospitals. 
 At a national level, the information provided in this study may inform policy 
decisions, such as antibiotic guideline development or revision, and help in 
prioritising public health action, such as education campaigns and/or regulatory 
measures. This information may also help address the problem of increasing rates of 
antimicrobial resistance in South Africa, which has dire consequences of prescribing 
expensive and /or more toxic antimicrobials as well as increasing the risk of patients 
developing resistant infections. Economically resistant infections not only cost more 
but can prolong the hospital stay increasing healthcare cost.  
 
1.7 DEFINITIONS OF TERMS  
1.7.1 Healthcare-associated infection 
Health care-associated infection refers to a localized or systemic condition resulting 
from an adverse reaction to the presence of an infectious agent(s) or its toxin(s) that 
occurs in a patient in a healthcare setting, was not found to be present or incubating 
at the time of admission unless the infection was related to a previous admission to 
the same setting (McKibben, Horan, Tokars, Fowler, Cardo, Pearson, Brennan, & the 
Healthcare Infection Control Practices Advisory Committee 2005: 225) 
 
1.7.2 Antimicrobial (AM) 
Antimicrobials are naturally occurring or synthetic chemical agents that kill or inhibit 
the growth of microorganisms (Premanandh, Samara & Mazen 2016:1).  
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1.7.3 Antimicrobial stewardship (AMS) 
Antimicrobial stewardship is defined as a multi-disciplinary, systematic approach to 
optimising the appropriate use of all antimicrobials to improve patient outcomes and 
limit the emergence of resistant pathogens whilst ensuring patient safety (Dellit et al. 
2007:159). 
 
1.7.4 Antimicrobial stewardship program (ASP)  
Antimicrobial stewardship program is defined as an ongoing effort by a health care 
institution to optimize antimicrobial use among hospitalized patients in order to 
improve patient outcomes, ensure cost-effective therapy, and reduce adverse effects 
of antimicrobial use (MacDougall & Polk 2005: 640). 
 
1.7.5 Antimicrobial resistance (AMR) 
Antimicrobial resistance is the ability of a microorganism to survive and reproduce in 
the presence of antibiotic doses that were previously thought effective against them 
(Singh, Arora, Thangaraju, Singh & Natt 2013: 95)  
 
1.7.6 Multi-drug resistance (MDR) 
Multiple drug resistance is defined as resistance to two or more drugs or drug classes 
(Singh et al. 2013: 95)  
 
1.7.7 Adverse effects 
An adverse event is an untoward medical experience in a patient who has been 
administered a medication, and that event does not necessarily have to have a 
casual relationship with the treatment. The administration of a particular drug may 
results in prolonged hospital stay, cause a permanent disability, or death (Martin, 
Micek, & Wood 2010:155). 
 
1.7.8 Prudent use  
It means an educated appropriate prescription, using antimicrobials only in cases in 
which their administration was fully justified on objective grounds (Baquero & Garau 
2010:487). 
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1.7.9 Surgical prophylaxis 
It is defined as any dose of an antimicrobial agent given within 24 hour period before 
8:00 am on the day of the survey (Sinatra, Carubia, Marchese, Aprea, Alessandro, 
Mammina & Toregrosa 2013: 201). 
 
1.8.0 Medical prophylaxis 
An antimicrobial therapy administered to prevent disease or its recurrence (Sinatra et 
al. 2013: 201). 
 
1.8 RESEARCH DESIGN  
A prospective, quasi-experimental descriptive survey was conducted to achieve the 
objectives of this study. 
 
1.9 METHODOLOGY 
Data collection occurred between July 2017 and September 2017 at large academic 
hospital in Gauteng, South Africa. The targeted participants were critically-ill elderly 
patients admitted in the intensive care unit. Data were extracted from patients’ 
medical records using a structured questionnaire.  
A detailed outline of research design and methodology will be given in chapter 3.   
 
1.10 SCOPE OF THE STUDY 
This study focused on the antimicrobial stewardship program, examining the 
program’s performance in promoting appropriate antimicrobial prescribing in 
intensive care units in academic Hospital in Gauteng province, South Africa. Further, 
this study examined the effectiveness of the program in reducing the emergence of 
antimicrobial resistance.  
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1.11 LIMITATIONS OF THE STUDY 
Since this was conducted in a natural setting involving critically ill patients it was 
difficult to select a control or treatment group, as such the limitations in this study 
included the lack of randomization for group assignments. Additionally, information 
was collected from adult patients only who were admitted to a general ICU, and as 
such, results were not generalizable to paediatric patients or other ICUs such as 
Burn unit.  
While public healthcare facilities can provide valuable information on the impact of 
ASP, the exclusion of private healthcare sector from the study restricted the study 
from obtaining a comprehensive picture of the impact of ASP in South African 
hospitals. 
 
1.12 STRUCTURE OF THE THESIS 
The thesis is composed of five chapters, each chapter deals with a different aspect of 
the study. 
 
Chapter one describes the aims and objectives of the thesis and also provides the 
rationale supporting the methodological approach to evaluating the impact of ASP. It 
gives both an overview and serves as an introduction to the study, establishing the 
background of the problem. Additionally, the chapter highlights the importance of 
evaluating the effectiveness of the program as well as defining basic terminology 
used in the thesis.  
 
Chapter two presents the results of a broad literature review conducted prior to the 
start of this study, which was also used to inform the direction of this study. It touches 
on the work done by other researchers on the topics on antimicrobial stewardship 
and the spread of resistance demonstrating the gaps that the proposed research will 
fill.  
 
Chapter three detail out the research methodology for the present study. It describes 
the pilot study, participants of the study, instrumentation done for the study, data 
collection and data analysis procedures of the study 
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Chapter four outlines the results of the study in relation to the research aims and 
objectives of the study. A detailed discussion on the significance of the results as well 
as the explanation for unexpected results is provided here.  
 
Chapter five summarizes the thesis, provides the literature, methodology, and 
discussion of the main findings. The most significant results are emphasized. 
 
Chapter six discusses the effectiveness of the ASP implemented in the hospital. It 
deals with the identified weakness of the program, to inform decisions on how to 
remedy the deficiencies identified. Additionally, this chapter discusses strategies 
proposed for the optimisation of the program. 
 
Chapter seven discusses the strength and limitations of the study, also suggestions 
for further research as well as recommendations are presented herein. 
 
1.13 CONCLUSION 
The inappropriate use of antimicrobials causes harm to human health by introducing 
adverse drug effects and promotion of the development of antimicrobial resistance. 
Therefore, the gradual increase in antimicrobial-resistant pathogens in South Africa is 
of a great concern. This study aims to assess the impact of antimicrobial stewardship 
program (ASP) in limiting the spread of antimicrobial resistance in South African 
hospital. Thus, elucidating the weakness of the program with the aim of improving the 
quality of antimicrobial use. Guided by the RE-AIM framework, comprehensive 
evaluation of the effectiveness of the ASP on the promotion of the appropriate use of 
antibiotics was performed, and the areas that needed improving were highlighted to 
optimise the appropriate use of antibiotics. 
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CHAPTER 2 
 
LITERATURE REVIEW 
2.1 INTRODUCTION 
This chapter provides an analysis of published literature that pertains to the 
effectiveness of antimicrobial stewardship on promoting the appropriate use of 
antimicrobials. It examines the causes and effects of antimicrobial resistance and the 
impact of ASP which aims to limit the spread of antimicrobial resistance. The main 
purpose of the literature review is to review previous studies on the implementation 
and impact of ASP as well as its effect on limiting adverse drug effects on hospital 
admitted patients. The theoretical basis of the main focus of the study is introduced 
and a detailed context of the literature review is provided. 
 
2.2. SEARCH STRATEGY 
The literature review was based on South African and international resources, with a 
focus on the scourge of antimicrobial resistance and the effects of antimicrobial 
stewardship. Various data search engines such as Google Scholar, Cochran 
database of systematic review and Pubmed, were utilised to obtain the materials for 
the literature review. The topic and the aims of the study were used as the basis for 
the subheadings of the literature review.  
 
Search terms used for the literature included, antimicrobial management, 
antimicrobial stewardship, antimicrobial resistance, appropriate antimicrobial use, 
judicial antimicrobial use, acquisition of antimicrobial resistance, factors promoting 
antimicrobial resistance, hospital-acquired infections, nosocomial infections. Manual 
search of local conferences, theses, and dissertations to identify relevant articles was 
also performed. Additional sources including South African National Department of 
Health (NDoH), South African Antimicrobial Stewardship Program (SAASP), Centre 
for Disease Prevention and Control (CDC) and World Health Organization (WHO) as 
well as reference list of relevant articles, book chapters and reviews were also 
searched. 
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The literature search was restricted to English language publications. The review 
included studies that considered the implementation and the effectiveness of 
antimicrobial stewardship interventions in hospitals.  
 
2.3 PATHOLOGY AND TREATMENT OF INFECTIONS  
Infectious diseases currently cause about one-third of all human deaths in the world 
(Alberta, Johnson, Lewis, Raff, Roberts & Walter, 2002: 1485). In order to 
understand how the bacteria spread and become a burden to human health, the 
knowledge of colonization and invasion of the host by bacteria will be discussed in 
subsequent sections.  
 
2.3.1 Bacterial mechanisms for invading the host 
Microbes are ubiquitous in nature and humans are constantly exposed to them, some 
are harmless but may cause infectious diseases leading to acute or chronic illness 
(Albiger, Dahlberg, Henriques-Normark & Normak 2007:511). Only a marginal 
bacterial species have the ability to cause disease in humans (Alberta et al 
2002:1490). Some bacteria have evolving mechanisms that aids them to successfully 
colonize and survive within the human body (Stones & Krachler, 2015: 2626).  But 
their localization in the human body is normally restricted to certain areas of the body 
including: the skin, respiratory and gastrointestinal tracts (Alberta et al. 2002: 1501; 
Ribert & Cossart 2015: 173). 
 
Opportunistic pathogens take advantage of injuries or breaches to penetrate the host 
barriers (Ribet & Cossart 2015: 173). Whereas, some bacteria produce proteases 
and directly target host mucins, which plays a role in limiting the microbial invasion of 
the microflora to reach the epithelial layer (Ribet & Cossart 2015: 174).  Since 
microbiota play an important role in aiding host barriers against invading pathogens 
by competing for nutrients and niches with pathogens, and enhancement of host 
defence mechanism (Kamada, Chen, Inohara & Nunez 2014: 686- 687), the 
pathogens may involve triggering mucosal inflammation to alter the composition of 
the microbiota, to escape the host barriers. Subsequently increasing mucosal 
antimicrobial peptides to which pathogens may be resistant to, compared to the 
resident bacteria (Ribet & Cossart 2015: 175). 
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 A variety of bacterial pathogens have acquired the ability to survive and replicate 
within macrophages after they have been taken up into a cell by phagocytes or 
receptor-mediated endocytosis (Alberta 2002: 1507; Chiang, Uzoma, Moore, Gilbert, 
Duplantier & Panchal 2018: 2). This mechanism protects the pathogen from the 
complement or adaptive immune system and helps the pathogen avoid competing 
with other resident microbes (Chiang et al 2018: 2). 
  
According to Stones and Krachler (2015:2626) different bacterial species display a 
wide array of specialized cell surface organelles or macromolecules (pili or fimbriae) 
which aid in mediating attachment to target host structures for the colonization and 
penetration of the host. They adhere to the host by either using adhesions or through 
a non-specific adherence mechanism such as electrostatic forces and lipophilic/ 
hydrophobic interaction (Adlerberth, Cerquetti, Poillane, Wold & Collignon 2000: 
225). These macromolecules help to overcome peristalsis in the gut and the flushing 
action of mucus, saliva, and urine, which remove non-adherent bacteria (Alberta et 
al. 1502- 1503). The pathogen that manages to survive the immune onslaught and 
penetrates host cells and the mucosal layer can exert their pathogenic effect and 
therefore replicate further. 
 
2.3.2 Antimicrobial treatment of bacterial infections 
According to Varley, Sule, and Absolom (2009: 184) throughout history, infectious 
diseases have been treated with a variety of herbal remedies; and the first true 
antimicrobial agent in the world was salvarsan, used for the treatment of syphilis and 
was discovered in 1909 by Paul Ehrlich (Varley et al. 2009:184; Saga & Yamaguchi 
2009:104). Saga and Yamguchi (2009: 104) state that the originally discovered drugs 
were synthetic compounds and had limitations in terms of safety and efficacy, and in 
1928, Fleming discovered a safe and efficient antibiotic, the penicillin.   
 
Subsequently, new classes of antimicrobial agents were developed leading to a 
surge of the discovery of antimicrobial therapy (Saga & Yamguchi 2009: 104). Since 
then, the development of antimicrobials has greatly reduced mortality and morbidity 
from infectious diseases (Song 2003: 1).  Because of antimicrobials development, 
millions of lives have been saved and important medical procedures including 
surgery and cancer chemotherapy enabled (WHO 2017:12). 
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2.4 THE DEVELOPMENT OF ANTIMICROBIAL RESISTANCE 
Since their conception antimicrobial agents have been used to treat infectious 
disease and have been successful in reducing illness and death from infectious 
microbial species (Baker, Thomson, Weill & Holt 2017: 733; Brinkac, Veerhies, 
Gomez & Nelson 2017: 1002;Premanandh, Samara & Mazen 2016: 1). Lately, the 
effectiveness of the agents has declined, whereas, the frequency of antimicrobial 
resistant pathogens have increased (Michael, Dominey-Howes, Labbate 2014:1; 
Palmer & Kishony 2013: 243). In addition, the development of novel antimicrobial 
agents has dramatically declined (Spellberg, Powers, Brass, Miller & Edwards, Jr. 
2004: 1279-1280). The situation is exacerbated by the rapid development of 
antimicrobial resistance, which renders the existing microbial agents obsolete 
(Perron, Inglis, Pennings & Cobey 2015: 211). Such occurrence puts a strain in the 
effective treatment of common nosocomial infection leading to a significant 
deterioration of clinical outcome (Dik, Poelman, Friedrich, Ronday, Lo-Ten-Foe, van 
Assen, van Gemert-Pijnen, Niesters, Hendrix & Sinha 2015: 93). 
 
Hospitals are an important breeding ground for the development and spread of 
antimicrobial resistant bacteria (Struelens 1998: 652). Infections acquired in the 
hospital (HAIs) are a cause of significant morbidity and mortality, worsened by the 
development of antimicrobial resistant infections in patients receiving health care 
(Brink, Feldmann, Duse, Gopolan, Grolman, Mer, Naicker, Paget, Perovic & Richards 
2006: 153; Struelens 1998: 652). The Centres for Disease Control and Prevention 
(CDC) define HAI as a localized or systemic condition resulting from an adverse 
reaction to the presence of an infectious agent(s) or its toxin(s) that develop during 
hospitalization, with no evidence that the infection was present or incubating at the 
time of admission to the acute care setting (Horan & Gaynes 2008: 309). WHO 
(2002: 1) emphasizes that a patient must be admitted for a reason other than the 
developed infection. 
 
Weinstein (1998: 417) points out that HAI typically affects patients, who are 
immunocompromised because of age, underlying diseases, or medical or surgical 
treatment.  As a consequence to the patients' frail conditions, exposure to heavy 
antimicrobial use, overcrowded and poor ventilated wards, surgical procedures, and 
daily invasive procedures, patients admitted to ICUs are the most susceptible to 
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nosocomial infections (Baker et al 2017: 735; Valles, Leon & Alvarez-Lerna 
1997:387). Furthermore, patients who are treated with inadequate antibiotic therapy 
are at risk of a poor outcome and are a high risk of spreading the resistant pathogen 
further (Acar, 1997: 17). Moreover, inadequate antibiotics therapy originate from 
inappropriate interpretation or use of microbiological test results; lack of 
microbiologically confirmed diagnosis; laboratory test errors; failure to submit 
appropriate specimen for culture; misuse of microbiology resources (Moreney-Patvin, 
Schwartz & Weinstein 2017: 382).  
 
The agents of utmost importance in HAI include Streptococcus spp., Acinetobacter 
spp., enterococci, Pseudomonas aeruginosa (P. aeruginosa), coagulase-negative 
staphylococci, Staphylococcus aureus (S. aureus), Enterobacteriaceae,  K. 
pneumonia (Klebsiella pneumonia), Escherichia coli (E. coli) (Babamahmoodi,  
Ahangarkani & Davoudi  2015: 153; WHO 2002: 2). A retrospective descriptive study 
from Kimberly hospital Burn Unit, showed Staphylococcus aureus, coagulase-
negative Staphylococcus (CNS) and methicillin-resistant S. aureus (MRSA) as the 
most common pathogens isolated (40.17%) on wound swabs, whereas in blood 
cultures S. aureus (32.08%), K. Pneumonia (20.75%) and P. aeruginosa (16.98%) 
were the most frequent pathogens found (Giaquinto-Cilliers,  Hoosen, Govender &  
van der Merwe  2014: 30).  
 
Owing to the increased incidence of HAI with antibiotic-resistant bacteria, antibiotic 
resistance has become a critical challenge for infective disease management. More 
than 70% of the bacteria that causes HAIs are resistant to at least one antibiotic 
(Krzowska-Firych, Kozlowska, Sukhadia & Al-Mosawi 2014: 784). Lately antimicrobial 
resistance (AMR) is recognized globally as one of the greatest threats to human 
health (Llor & Bjerrum 2014: 229), and further, microbes have developed resistance 
to the majority of available antimicrobials (Laxminarayan,  Duse, Wattal,  Zaidi, 
Wertheim, Sumpradit, Vlieghe, Hara, Gould, Goossens, Greko, So, Bigdeli,  Tomson, 
Woodhouse, Ombaka, Peralta,  Qamar, Mir, Kariuki,  Bhutta, Coates, Bergstrom, 
Wright, Brown & Cars  2013:1057), consequently complicating the management of 
infectious diseases.  
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In addition to antibiotic resistance impacting negatively on the ability to effectively 
manage infectious diseases, antimicrobial resistance results in increased morbidity, 
mortality and economic expenditure (Borg  2009: 7; Ozer, Tatman-Otkun, Memis & 
Otkun  2010: 203- 204). To improve on the impact of antimicrobials, the defence 
mechanisms of bacteria from antimicrobials’ assault should be understood.  
 
2.5 MECHANISMS   OF ANTIMICROBIAL RESISTANCE 
Antimicrobial agents exert their activities selectively on vital microbial functions with 
minimal effects on or without affecting host functions (Lakshmi, Nusrin, Ann & 
Sreelakshmi 2014: 37; Toma & Dyeno 2015: 29). The antimicrobials act by targeting 
specific sites of microbes to retard their proliferation through the inhibition of bacterial 
cell wall synthesis, protein synthesis, folic acid synthesis, and/or DNA replication 
(Liwa & Jaka 2015: 877; Toma et al. 2015:29).  
 
However, microbes have developed a variety of mechanisms to protect themselves 
against the effects of antimicrobials (Hawkey 1998: 657; Brinkac et al 2017: 1002). 
These mechanisms may be intrinsic or acquired by mutation or horizontal transfer of 
genes or DNA containing resistance determinants (Holmes, Moore, Sundsfjard, 
Steinbakk, Regmi, Korkey, Guerin & Piddock 2015:3; Kumar & Varela 2013: 523; 
Liwa & Jaka, 2015: 879-880). In intrinsic resistance, bacteria may comprise bacterial 
chromosomal DNA containing genes for antibiotic resistance.  Additionally, microbes 
may either lack target sites for the antimicrobials or have low permeability to those 
agents that require entry into the microbial cell in order to effect their action (Toma & 
Dyeno 2015: 30). A common example of intrinsic resistance is demonstrated in the 
bacteria-impermeable to antimicrobials which prevent antimicrobial's access to target 
sites. This is observed in enterococcus spp. and Pseudomonas aeroginosa (Kapil 
2005:84; van Hoek, Mevius, Guerra, Mullany, Roberts & Aarts 2011:1). 
 
Regarding acquired antimicrobial resistance, bacteria exposed to a specific 
evolutionary pressure e.g. antimicrobials may develop a defence mechanism against 
that antimicrobial or class of antimicrobials (Toma & Dyeno 2015: 30). Bacteria may 
contain genetic material that can spread from one bacterium to another through 
plasmids, bacteriophages, and transposons or integrons (Hawkey 1998: 659; Martin 
et al. 2010: 155; Perron, Inglis, Pennings & Cobey 2015: 214). Fundamentally, 
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antibiotic resistance can be acquired through sharing and transfer of genetic 
materials by 1) conjugation which involves cell-to-cell contact for the transfer of extra-
chromosomal, 2) transduction which involves the infection of bacteria by viruses, 
passing along genes from one infected organism to the next (bacteriophage), and 3) 
transformation whereby naked DNA is acquired from the environment having been 
released from another cell (Barbosa & Levy 2000:305). 
 
Bacteria can also adapt to antimicrobial assault using a wide variety of mechanisms 
(van Hoek et al. 2011: 1). The bacteria can protect themselves from antibiotics 
through active efflux that drives out antibacterial compounds from the bacterial cell 
thus reducing their intracellular concentrations to sub-or non-inhibitory levels (Kumar 
& Varela 2013:525). This mechanism is demonstrated in the efflux of the tetracycline 
antibiotics through an export protein from the major facilitator superfamily (MFS) 
(Byarugaba 2010: 21).  
 
In addition, bacteria can inactivate antibiotic agents through the production of 
enzymes that degrade or modify the drug itself through either hydrolysis group 
transfer and/or redox mechanisms (Dzidic, Suskovic & Kos 2008: 13; Hawkey 
1998:657- 658).  For example, inactivation of the drugs by aminoglycoside-modifying 
enzymes, using the enzymes, acetyltransferases (AAC), nucleotidyltransferases or 
adenyltransferases (ANT), phosphotransferase (APH) to render antimicrobials 
inactive (van Hoek et al. 2011:2). Additionally, the bacteria can protect themselves 
from antibiotic agents by modification of antibiotic targets whereby the target site is 
modified so that the antibiotic is unable to bind properly (Dzidic et al. 2008: 13). For 
example, methicillin-resistant S. aureus with altered penicillin-binding proteins (Kapil 
2005: 84). 
 
A study of van de Sande-Bruinsma, Grundmann, Verloo,  Tiemersma,  Monen,  
Goossens, Ferech, and the EARSS and ESACPG (2008:1727) found that an 
association between antimicrobial drug use and resistance exist and was specific 
and robust for 2 of the 3 compound combinations under study. The authors 
concluded that the data suggest that in Europe the variation of consumption 
coincides with the occurrence of resistance at country level (van de Sande-Bruinsma 
et al. 2008:1726). The authors further suggested that the mechanisms for acquiring 
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resistance against both substances involved successive alterations of chromosomally 
located genes by either homologous recombination or point mutations, resulting in a 
stepwise modification of the molecular targets (van de Sande-Bruinsma et al. 
2008:1727). This study demonstrates a relationship between antimicrobial use and 
the development of antimicrobial resistance.  
 
In light of the processes discussed above, acquisition of resistance may increase the 
survival rate and spread of bacteria under the assault of antibiotics. Consequentially 
the acquired resistance limits the choice of antibiotics that can be used for treatment. 
According to Barbosa and Levy (2000: 306), current major problems of antibiotic 
resistance are seen in methicillin-resistant S. aureus (MRSA), penicillin-resistant S. 
pneumoniae (PRSP), multidrug-resistant M. tuberculosis and vancomycin-resistant 
enterococci (VRE). Recently, a plasmid-borne colistin resistance gene,  mcr-1 in a 
cultured E.coli strain was found in a patient with a urinary tract infection (UTI) in the 
United States ( McGann, Snesrud, Maybank, Corey, Ong, Clifford, Hinkle, Whitman, 
Lesho & Schraecher 2016: 4420). 
 
Therapeutic options for several highly resistant gram-negative pathogens such as 
Acinetobacter species, multidrug-resistant (MDR) P. aeruginosa, and carbapenem-
resistant Klebsiella species and Escherichia coli, are so extremely limited that 
clinicians are forced to use older drugs that are associated with significant toxicity 
(Boucher, Talbot, Bradley, Edwards, Gilbert, Rice, Scheld,  Spellberg & Bartlett 2009: 
2). The number of antimicrobials in phase 2 or 3 of clinical development remains 
disappointing. In addition, the numbers of new antimicrobials that receive FDA 
approval has decreased (Boucher et al. 2009:7-8). Therefore, to devise an effective 
strategy for addressing the problem of antibiotic resistance requires an 
understanding of the basis of the factors contributing to inappropriate antimicrobial 
use and or prescribing (Oxford, Goossens, Schedler,  Sefton, Sessa  &  van der 
Velden 2013: 291). 
 
A review aimed at understanding and describing the current status of antimicrobial 
resistance in Africa in relation to common causes of infections and drugs 
recommended in WHO treatment guide found that Gram-negative pathogens 
reported were E coli (87/144: 60.4%), (Tadesse, Ashley, Ongarello, Havumaki, 
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Wjegoonewardena, Gonzalez & Dittrich 2017:619). In the gram- positive pathogens, 
Coagulase negative Staphylococcus species such as S aureus, Streptococcus 
pneumonia and group A streptococcus were the most commonly reported bacteria 
(Tadesse, et al 2017:619). The review identified a high level of resistance of 
Enterobacteriaceae to ampicillin and co-trimoxazole, as well as high resistance to co-
trimoxazole and tetracycline by S pnuemoniae were reported indicating a rising 
pattern in AMR in certain pathogens (Tadesse, et al 2017:632).  
In South Africa, an increase in antimicrobial resistance in all major types of 
pathogenic bacteria was observed, and that there are no antimicrobials in the 
pipeline or expected in the near future for the treatment of Gram-negative bacteria, 
the cause of common infections (NDoH 2015:9). In addition, an increase in the 
burden of antimicrobial resistance was observed from 2010, this included the 
realisation that one half of all hospital-acquired S aureus in public hospitals were 
resistant to methicillin; an outbreak of vancomycin-resistant enterococci; and the 
production of extended-spectrum beta-lactamase (ESBL) by common Gram-negative 
bacteria such as K pneumonia and E coli rendering them resistant to penicillins and 
cephalosporins (NDoH 2015: 9 -10).   
 
2.6 BARRIERS TO APPROPRIATE ANTIMICROBIAL PRESCRIBING 
To curb the growing burden of antimicrobial resistance, and optimize antimicrobial 
prescribing behaviours as well as promote quality improvement, policies and 
evidence-based interventions were drafted and implemented by the governments 
and healthcare institutions, (Charani, Castro-Sanchez, Sevdalis, Kyratsis, Drumright, 
Shah & Holmes  2013: 188). In an effort to curb antimicrobial resistance and promote 
quality improvement of antimicrobial prescriptions, South African Antimicrobial 
Stewardship Program (SAASP) was formed (NDoH 2015: 10). The SAASP promoted 
appropriate antimicrobial prescribing by availing an antimicrobial prescription chart on 
the SAASP website, as well as introducing the national guidance for the use of 
antimicrobials at different levels of institutions and district in the essential drug list 
(EDL) and standard treatment guidelines (STGs) (NDoH 2015: 10 – 12). 
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Although healthcare providers are aware of problems associated with inappropriate 
prescribing, they often prescribe antibiotics against their better judgment (Oxford et 
al.  2013: 291-292). A study by Adorka, Dikokole, Mitonga and Allen (2013: 349), 
found that healthcare providers are influenced by patients' requests and expectations 
in prescribing antibiotics, even if an infection has been ruled out, and/or the diagnosis 
is not clear. Whereas, a study by Chaves, Cheng, Runnegar, Kirschner, Lee & 
Buising (2014: 570), showed that consultants, residents, and interns are also 
influenced by senior doctors who are more knowledgeable in prescribing antibiotics.  
 
In addition, a number of factors that influence the ability of healthcare providers to 
prescribe antimicrobial were identified (Livorsi, Comer, Matthias, Perencevich & Bair 
2015: 1066).  These included: 1) uncertainty in diagnostic, which leads to healthcare 
providers prescribing broad-spectrum therapy in fear of missing and an undetected 
infection. 2) fear of lawsuits, wherein, healthcare providers will initiate antibiotics 
therapy even in patients without a definitive infection; 3) being more concerned with 
achieving a clinical cure for a suspected or proven infection than preventing potential 
adverse effects of antibiotics: 4) respect of hierarchy whereby, healthcare providers 
fear to critique each other even when antibiotics are prescribed unnecessarily (Livorsi  
et al. 2015:1068) 
 
There are considerable variations seen in adherence to antibiotic prescribing 
guidelines across healthcare providers. The study of Skodvin, Aase, Charani, 
Holmes and Smith (2016: 30), demonstrated that interns and inexperienced residents 
regard National guideline as a useful tool. While the more experienced residents use 
the guideline as a reference for checking dosages and treating uncommon infectious 
diseases (Skodvin et al. 2016: 29). Furthermore, the lack of adherence to the 
guideline among senior doctors could be explained by time consumption due to 
suboptimal IT-systems (Skodvin et al. 2016: 29). Whereas,  another study identified a 
gap in knowledge of antimicrobial prescribing, noncompliance to local and hospital 
guidelines, reliance on senior colleagues to make antimicrobial prescribing decisions 
were as barriers to appropriate antibiotic prescribing was also identified  (Chaves et 
al. 2014: 570, 572). 
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In addition to  misuse of antibiotics by both patients and healthcare providers 
(Barbosa & Levy, 2000: 304; Planta 2007:534; Sande-Bruinsma et al. 2008: 1727 ), 
antibiotic resistance risk factors are also associated with the change of preference of 
antimicrobial agents by the clinician   (Boonsong, Chongtrakool, Srisangkaew & 
Santanirand 2011: 244); fear of bad outcomes, lack of access to quality laboratory 
services, lack of healthcare providers’ knowledge regarding optimal diagnostic 
approaches as well as diagnostic uncertainty and habitual prescribing (Adorka , et al.  
2013. 344; Om, Daily, Vlieghe,  McLaughlin  &  McLaw 2006:64; Oxford et al. 2013: 
291- 292). Moreover, Adorka,  Allen,  Lubbe & Serfontein (2013: 134:137), noted that 
the severity of the infections encountered complicates and provides a challenge for 
the health providers to use their knowledge in the treatment of infections.  
 
Confirmation of the infection and the Identification of the responsible pathogen from 
biological samples obtained from the patients, is crucial before initiating the therapy 
to be able to select the appropriate treatment, and facilitate therapy de-escalation in 
response to susceptibility profiles (Luyt, Brechot, Trouillet & Chastre  2014: 481). 
Pulcini and Gyssens  (2013: 194) concur by suggesting that the empirical therapy 
should be decided upon at local level, guided by local antibiograms and patient 
outcome data. The lack of antibiograms and comprehensive antibiotic prescribing 
guidelines, compel the healthcare providers to take the responsibility of prescribing    
antibiotics based on their knowledge and experience (Adorka et al. 2013: 345).  
 
In Cambodia, antibiotic prescribing generally occurs in the absence of microbiological 
evidence of infection regardless of accessibility to microbiological services. 
Furthermore, the empirical treatment is changed to a broader spectrum antibiotic 
without microbiological evidence (Om et al. 2006: 61). The lack of availability of 
microbiological specimen and timeliness of the results has been shown to pose a 
major challenge in prescribing antibiotics (Skodvin et al. 2016: 26).  Whereas, in 
hospitals lacking microbiological laboratory, the prolonged broad-spectrum 
antimicrobial treatment is attributed to the delay of specimen transport and transfer of 
results into separate electronic systems (Skodvin et al. 2016: 26). 
 
As highlighted above, healthcare providers lack consistency in the capacity to 
prescribe and in the use of practical educational resources, they lack communication 
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skills, do not adhere to national and local guidelines. Therefore, informing and 
educating healthcare providers on appropriate prescribing may reduce the adverse 
effects due to antimicrobials.  
 
2.7THE BURDEN OF ANTIMICROBIAL RESISTANCE 
To capture the number of deaths attributable to the failure of antibiotic therapy due to 
antibiotic resistance, the term ‘burden of antibiotic resistance' is used and can be 
estimated by the frequency and clinical impact of failures of antibiotic therapy 
(Woolhouse, Wough, Perry & Nair 2016:1). The burden of antimicrobial resistance in 
the United States of America is estimated at 23 000 patients' death per year (CDC 
2013: 17). Whereas, in Europe, 25 000 fatalities were estimated for each year 
(ECDC 2011: 15). Reported data suggests that almost 19 000 patients die per year in 
Thailand (Lim, Takahashi, Hongsuwan, Wuthiekanun, Thamlikitkul, Hinjoy, Day,  
Peacock &  Limmathurotsakul 2016:18082). 
 
The unsuccessful surveillance programmes, insufficient data and a lack of research 
in the field makes the situation of antimicrobial resistance in sub-Saharan Africa 
unclear (Mendelson & Matsoso 2015:325). A systematic review of 8 studies 
published between 2000 and 2011 conducted in South Africa found that there was no 
national surveillance system that collates and collects data year on year to assess 
trends and resistance patterns for nosocomial pathogens (Nyasulu et al. 2012: 12). 
 
In an editorial section of GARP situational analysis part 2, Duse (2011: 551) 
acknowledged a major shortcoming of the AMR surveillance in the public healthcare 
sector. The authors point out that the approach used provides data collected only 
from large academic centres and does not profile AMR in the general population 
attending primary, secondary and non-academic tertiary health care facilities do not 
reflect the extent of AMR countrywide (Duse 2011: 551). 
 
Moreover, the burden of antibiotic resistance on health in South Africa is not 
unknown (Cosgrove & Carmelli 2003: 1433; Truter 2015: 52). Even so, antimicrobial 
resistance, HIV/AIDS, tuberculosis (TB) and malaria are major contributors to the 
high burden of infectious diseases (Crowther-Gibson, Govender, Lewis, Bamford, 
Brink, Gottenberg, Klugman, du Plessis, Fali, Harris, Keddy & Botha 2011:569).   A 
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growing evidence of escalating rates of antimicrobial resistance to several 
conventional antimicrobials was demonstrated in the studies reviewed by Nyasulu et 
al. (2012: 12). 
 
The worldwide estimates of the burden of antimicrobial resistance demonstrate that 
the emergence and spread of antimicrobial resistance have exacerbated the battle 
against infectious disease. In addition, this occurrence continues to contribute 
substantially to the death toll caused by AMR. Therefore, the reported estimates 
provide compelling evidence of the need for strategies to prevent and control this 
afflicts.  
 
Furthermore, it has been highlighted that  the limited access and delays in access to 
antibiotics plays an important role in the high death rate observed in people with 
infections compared to antimicrobial resistance, however access to antibiotics is still 
a challenge (Laxminarayan, Matsoso, Pant, Brower, Rettingen, Klugman & Davies 
2016: 169). Mendelson, Rettingen, Gopinathan, Hamer, Wertheim, Bosnyot, Butler, 
Tomson and Balasegaran (2016:188) points out that unrestricted access to 
antibiotics has the potential to substantially reduce morbidity and mortality in patients 
with infections, especially when unrestricted access is paired with appropriate use of 
antibiotics.  
 
2.8 ANTIMICROBIAL STRATEGIES IN GENERAL 
Various organizations and policy makers concur that inappropriate use of 
antimicrobials provide selective pressure for the development and spread of AMR 
(De Angelis, Restuccia, Cauda, Tacconelli 2011: 377; Levy 2001:124). The degree of 
the scourge of AMR prompted the World Health Organization calling for urgent 
intervention (WHO 2012: 2). Furthermore, Levy (2001:125) point out that a great 
impact on resistance can be achieved by changing the practice of inappropriate 
prescribing of antibiotics.   Accordingly, antimicrobial stewardship programs (ASPs) 
use a variety of strategies and techniques to optimize antimicrobial use in hospitals 
(Doron & Davidson 2011:1115). The primary objectives of an ASP are to ensure 
effective treatment of patients with infections while minimizing unintended 
consequences of antimicrobial use (Dellit et al. 2007: 159). These objectives can be 
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achieved through the formulation of policies, use of treatment guidelines, surveillance 
data, education resources, targeted interventions and audit (Dellit et al. 2007: 159).  
 
According to Njoku and Hermsen (2010: 51), antimicrobial stewardship is a patient 
safety measure that is multifaceted in nature and requires a collaborative, 
multidisciplinary approach to be successful. A collaboration of personnel with the 
appropriate qualifications such as pharmacists with infectious diseases training; 
infectious diseases physicians to help with antimicrobial stewardship; informatics 
personnel to maintain databases, as well as infection control (IC) and epidemiology 
departments are essential for the ASP to be a success (Dellit et al. 2007: 160; 
Kolman, Geertsema, van den Berg & Goff 2016: 25; Njoku  & Hermsen  2010: 55).  
 
Different interventions have been proposed by the Infectious Disease Society of 
America and Society for Healthcare Epidemiology of America, to offer a guide in 
appropriate and cost-effective use of antibiotics in hospitals (Dellit et al. 2007: 159). 
The interventions included core strategies that provide the foundation of an ASP: the 
prospective audit with intervention and feedback, and formulary restriction with 
preauthorization, which may be supplemented by either guidelines and clinical 
pathways, dose optimization, education, protocols and antimicrobial order forms, 
surveillance and clinical decision support databases, streamlining and de-escalation, 
and intravenous (IV) to oral (PO) conversion strategies (Dellit et al. 2007: 159).  
 
In the front-end or restrictive approach, the use of certain antibiotics based on the 
spectrum of activity, cost, or associated toxicities are restricted to ensure that use is 
reviewed with an antibiotic expert before therapy is initiated. Additionally, the front-
end approach has the advantage of targeting specific antimicrobials for specific 
indications based on local resistance patterns and the hospital formulary (Doron & 
Davidson 2011: 1115). 
 
Four distinct types of restrictive interventions have been identified (Davey, Brown, 
Charani, Fenelon, Goud, Holmes, Ramsay, Wiffen & Wilcox 2013: 7). These 
included: 1) Compulsory order form – which involves the completion of a form with 
clinical details to justify use of the restricted antibiotics; 2) Expert approval – whereby 
the prescription for a restricted antibiotic had to be approved by an Infection 
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specialist or by the Head of Department; 3) Restriction by removal – involves 
enforcing a restrictive policy in the target ward or unit, for example by removing 
restricted antibiotics from drug cupboards; 4) Review and make change – whereby 
the reviewer changes the prescription rather than giving health professionals either a 
verbal or written recommendation that they should change the prescription (Davey et 
al. 2013:7). 
 
Nevertheless Njoku and Hermsen (2010: 55-56) noted that the use of antimicrobial 
restriction as a means of controlling antimicrobial resistance has limitations in the ICU 
setting. It is often associated with an increase in the use of alternative agents, and 
perceived loss of prescriber autonomy in that prior approval of the use of the 
restricted antimicrobials is required, consequently causing delays in initiating 
antimicrobial treatment to critically ill patients (Johnson & Banks 2017: 112; Njoku & 
Hermsen 2010:56).   
 
Johnson and Banks (2017:112) recommend a ward-focused antimicrobial round, 
prospective audit and feedback strategy. In this strategy, current antibiotic 
prescriptions are reviewed and clinicians are provided with recommendations to 
continue, adjust, change, or discontinue the therapy based on the available 
microbiology results and clinical features of the case are provided (Doron & Davidson 
2011: 1115; Johnson & Banks 2017: 112). The impact of the prospective audit and 
feedback strategy was demonstrated in the study by Newland, Stach, De Lurgio, 
Hedican, Yu, Herigon, Prasad, Jackson, Myers and Zaoutis (2012: 179). This study 
revealed a significant decrease in the use of antibiotics from 37% at the beginning of 
the program to 13% at the end of the program (Newland et al. 2012: 182). The study 
of Nilholm, Holmstrand, Ahl, Mansson,Odenholt, Tham, Melander and Resman 
(2015: 1) showed a significant reduction in antibiotic use due to an Infectious Disease 
specialist- guided, audit based ASP   
 
The IDSA/SHEA guidelines (Dellit et al. 2007: 159) suggest that the ASM program 
should include one or both core strategies, and be complemented by either of the 
strategies mentioned above  (Delitt et al. 2007: 160). Chang, Chen, Lin, Tang, Hsu, 
Weng, Lee, Wang and Lo (2017: 356) caution that an ASP that proved successful in 
one institute may be confronted with difficulties in another because of cultural 
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differences. Therefore, institutions should adopt the strategies that are more likely to 
succeed and the measures that are most cost-effective (Chang et al. 2017: 356). 
Furthermore, some protocols such as antibiotic cycling are difficult to implement and 
to comply with, because the optimal duration for cycling are not entirely clear 
(Cadena, Taboada, Burgess, Ma, Lewis II, Freytes & Patterson 2007:153). 
 
In their study, Chang et al. 2017: 356) found a reduced consumption of total 
antibiotics and specific antimicrobial agents (imipenem, meropenem, and 
glycopeptides) within a short period using a focused educational program for primary 
prescribers. They also observed that antimicrobial prescribing can be optimized by 
the advancing their knowledge of general medicine, microbial virulence, 
immunological and genetic host factors, PK and PD properties of drugs, and basic 
knowledge of epidemiology (Chang et al., 2017: 356). The German Society for 
Infectious Diseases points out that education and training should be offered 
repeatedly as they are not sustainable as a one-off measure (de With, Allerberger, 
Amann, Apfalter, Brodt, Eckmanns, Fellhauer Geiss, Janata, Krause, Lemmen, 
Meyer, Mittermayer, Porsche, Presterl, Reuter,  Sinha, B,  Straub, Wechsler‑Fordos,  
Wenisch & Kern 2016: 400). 
 
The study of Baktygul, Marat, Ashirali, Harun-or-Rashid & Sakamoto (2011: 165), 
highlights the importance of the ASP and the adoption of international standard and 
local guidelines of antibiotic use in a hospital. The authors found a high level of 
inappropriate use of antibiotics in the hospital, and that parenteral administration of 
antibiotics (79.4%) was more common than oral (20.5%) (Baktygul et al. 2011: 165). 
The lack of clear guidelines in the hospital protocol for the choice of the route of 
treatment resulted in parenteral drugs not being switched to oral form (Baktygul et al. 
2011:165). Moreover, the study showed that 73.3% of patients were inappropriately 
prescribed antibiotic therapy due to the lack of antibiotic prophylaxis and the long-
term use of antimicrobials in the postoperative period (Baktygul et al. 2011: 165). 
 
Although there are some countries that lack behind in implementing antimicrobial 
stewardship, most countries have observed the call to implement ASP in hospitals. A 
global cross-sectional survey conducted to investigate the depth and penetration of 
AMS across the world, showed that European hospitals had the longest running AMS 
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programmes and that 52% of the countries had national AMS standards, while 4% 
planned to introduce them (Howard, Pulcini, Hara,  West, Gould,  Harbarth  &  
Nathwani  2015: 1246). 
 
2.9 AMS STRATEGIES IN SOUTH AFRICA 
In light of the current status of AMR in South Africa, a South African Antibiotic 
Stewardship Programme (SAASP) working group identified four priority interventions 
to effect change in the antibiotic prescribing practice (SAASP Working group 2012). 
These involved: 1) the appropriate use of microbiological diagnostic tests prior to 
initiation of antibiotics to allow de‐escalation and rationalization of therapy; 2) 
decreasing the overall consumption of antibiotics in South Africa, recognizing that all 
antibiotic prescribing predisposes to emergence of multi‐drug resistance (MDR); 3)   
decreasing the duration of antibiotic therapy, by setting clear evidence‐based 
guidelines or where good evidence is not available, use expert opinion from within 
the SAASP working group to define optimal duration. Develop pharmacy systems to 
identify and block prolonged antibiotic duration as well as 4) addressing inappropriate 
dosing of antibiotics, with specific relation to use of loading doses and weight‐based 
dosing where evidence exists, and directing the correct use of therapeutic drug 
monitoring (TDM) (SAASP Working group 2012). 
 
In 2015, South Africa developed the National AMR Strategic framework to combat 
increasing levels of resistance in bacteria other than tuberculosis, and limit further 
increases in resistant microbial infections, and improve patient outcomes (NDoH 
2015: 8). The framework defines the principles and short to medium term 
interventions needed to preserve the effectiveness of antimicrobials for future 
generations; to improve the appropriate use of antibiotics in human and animal 
health; to improve the effective management of antibiotic-resistant organisms and 
prevent their transmission further to create an enabling environment for the 
successful and sustainable implementation of the strategic objectives (NDoH 
2015:10). 
 
In 2017, guidelines on implementation of antimicrobial strategy in South Africa were 
published in accordance with the strategic framework and implementation plan 
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(NDoH, 2017: 8). The guide acts as an outline for the necessary steps to be taken by 
the South African healthcare providers to endorse AMS at national, provincial, district 
and health establishment levels (NDoH 2017: 8). In line with the recommendations of 
IDSA/SHEA guidelines, the practical guide recommends an AS team consisting of a 
prescriber, trained in antibiotic stewardship and a pharmacist who has either received 
stewardship training or to be trained as core members, supported by an IPC officer, 
microbiologist and/or intensivist and/or infectious diseases-trained specialist (NDoH 
2017: 22). 
A study by Boyles, Whitelaw,  Bamford, Moodley, Bonorchis, Morris, Rawoot,  
Naicker, LusakiewiczI, Black, Stead, Lesosky,  Raubenheimer, Dlamini  and 
Mendelson  (2013:4), endorsed the implementation of antibiotic prescription charts 
and the rollout of AS ward round activity in every healthcare institution, with the aim 
of reducing the volume of antibiotic use and slowing the evolution and spread of 
resistant bacterial strains. Antimicrobial stewardship ward rounds, a prospective audit 
and feedback intervention,  involves reviewing prescriptions at ward level, providing 
feedback to relevant personnel, collecting data on compliance and antimicrobial 
consumption (Chung, Wu, Yeo, Chan & Hsu 2013: 152). Resulting in the optimization 
of the use of appropriately prescribed antibiotics for patients with proven or 
suspected bacterial infection; ensuring patient safety by stopping or suggesting 
alterations in prescribing when sub-optimal, and/or where infection prevention is not 
being correctly applied; to transfer AS skills to senior and junior doctors, nurses, 
pharmacists and IPC officers (Chung et al. 2013: 152 -153). 
 
2.10 ASP IN THE ICU 
Antimicrobial stewardship programs (ASP) were developed to determine the best 
approach to antimicrobial prescribing, decreasing costs of healthcare, improving 
patient outcomes and preventing further creation of antimicrobial resistance (Shlaes, 
Gerding, John, Craig, Bornstein, Duncan, Eckman, Farrer, Greene, Lorain, Levy, 
McGowan, Paul, Ruskin, Tenover & Watanakunakorn 1997:275). Key components of 
antibiotic stewardship in ICUs include rapid identification of patients with bacterial 
infections, better empirical treatment selection, using pharmacokinetic-
pharmacodynamic (PK-PD) characteristics to optimize antibiotic dosing and 
administration modalities, de-escalation once culture results become available, 
 
 
30 
 
shortening therapy duration, and reducing the numbers of patients treated 
unnecessarily (Kollef, Sherman, Ward & Fraser, 1999: 472; Luyt, Brechot, Trouillet &  
Chastre  2014: 480). 
 
An observational study using the multicenter database OUTCOMEREA, which 
contains data from 12 ICUs in France, found that ICU-acquired bloodstream infection 
(BSI) was associated with a 3-fold increase in the risk of hospital death (Garrouste-
Orgeas, Timsit, Tafflet, Misset, Zahar, Soufir, Lazard, Jamali, Mourvillier, Cohen,  De 
Lassence,  Azoulay, Cheval, Descorps-Declere,  Adrie,  de Beauregard & Carlet 
2006: 1123). The higher incidence is partly attributable to the high proportion of BSI 
cases due to S. aureus (20%) or coagulase negative staphylococci (21.5%) and to 
the high proportion of primary BSI (32%) (Garrouste-Orgeas et al. 2006: 1124). The 
results further showed a 6-fold increase in the risk of mortality associated with gram-
negative bacilli, compared with the risk of mortality associated with gram-positive 
microorganisms (Garrouste-Orgeas et al. 2006:1124).  
 
Furthermore, the study demonstrated that an interval of more than a day before 
initiation of appropriate antimicrobial therapy was associated with a 2-fold increase in 
the risk of death (Garrouste-Orgeas et al. 2006:1124). This study highlights the 
impact of ICU-acquired BSI on mortality among the exposed patients, the 
consequence of delaying a treatment in the ICU. 
 
Generally in the ICU, an initial antibiotic therapy should be a broad-spectrum 
antibiotic therapy to avoid the detrimental consequences associated with 
inappropriate antibiotic therapy (Kollef et al.1999: 472: Luyt et al. 2014: 6). Although 
combination therapy is generally preferred in the empiric management of infection in 
critically ill patients, it has its disadvantages. Potential disadvantages of combination 
therapy include increased drug toxicity, the risk of infection with resistant pathogens 
and increased drug cost (Vincent, Bassetti, Francois, Karam, Chastre, Torres, 
Roberts, Taccone, Rello, Calandra, De Backer, Welte & Antonelli 2016:134). To 
avoid further development of resistant pathogens the antimicrobial regimen should 
subsequently be narrowed (de-escalated) or discontinued altogether based on the 
patient’s clinical course and culture results (Kollef et al. 1999:472; Vincent et al. 
2016: 135). 
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Joung, Lee, Moon, Cheong, Joo,  Ha,   Sohn, Chung, Suh, Chung, Song & Peck 
(2011:80) Define de-escalation as streamlined antibiotic treatment driven by 
microbiological documentation, clinical data and the severity-of-illness index 
achieved by decreasing the number and/or spectrum of antibiotics. In a retrospective, 
observational cohort study Joung et al. (2011: 85), found that the pneumonia-related 
mortality rate was not significantly different in the de-escalation group compared to 
the non-de-escalation group at day 14. The pneumonia-related mortality and overall 
mortality at day 30, however, was significantly lower in the de-escalation group. 
Furthermore, the study found that more than 40% of patients with negative cultures 
received de-escalation therapy, and all 12 patients survived at day 30 after the 
diagnosis of pneumonia but among all patients with negative cultures only two 
patients in the non-de-escalation group died (Joung et al. 2011: 85). 
 
According to Cha, Michienzi & Hsaiky (2012:5) pharmacokinetic/ pharmacodynamic 
profiling is an invaluable approach in the design and application of antimicrobial 
dosing strategies to optimize clinical outcomes. Even-though inter- and intra-patient 
pharmacokinetic variability may render the design of dosing regimens difficult when 
treating patients in the ICU (Cha et al. 2012: 8). Therefore, for appropriate 
antimicrobial therapy, pathophysiological changes associated with critical illness that 
may alter the pharmacokinetics (PK) for example, increased the volume of 
distribution (Vd) and augmented clearance (CL) should be considered (Vitrat, 
Hautefeuille, Janssen, Bougon  & Sirodot 2014:  264). In addition, strategies that may 
be considered for dose optimization include extended or continuous infusion of 
beta‐lactams; once‐daily dosing of aminoglycosides; appropriate dosing of 
antimicrobials (e.g. vancomycin, polymyxins, cefepime); weight‐based dosing of 
certain antimicrobials dose adjustments for patients with renal dysfunction (MOHM, 
2014: 23).  
 
2.11 BARRIER TO IMPLEMENTATION OF ASP  
Although ASPs have been shown to reduce inappropriate antimicrobial use with 
subsequent reductions in antimicrobial resistance, as discussed above,   they are 
also confronted by barriers in their implementation. For example, inadequate 
infectious diseases expertise and resources have been identified as the main barriers 
to implementation of antimicrobial stewardship programmes in almost all public and 
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private hospitals in South Africa (Brink, Messina, Feldman, Richards, Becker, Goff, 
Bauer, Nathwani & van den Bergh 2016: 1017). The study of Howard, Pulcini, Hara, 
West, Gould, Harbarth and Nathwani (2015: 1247) identified the common top three 
barriers to delivering a functional and effective AMS programme in hospitals across 
all continents except Africa as; a lack of funding or personnel and a lack of 
information technology or ability to get data, followed by prescriber opposition or 
other higher priorities. Whilst in Africa information technology is shown to be the main 
barrier to delivering optimal AMP  in hospitals (Howard et al. 2015: 1247). 
 
In addition to the lack of training programs for infectious disease (ID) pharmacists, a 
low number of ID physicians and the infantile introduction of clinical pharmacy 
practice are barriers for implementation of AMS in South Africa  (Messina,  van den 
Bergh &  Goff 2015: 10, 11). Allerberger, Gareis, Jindrak & Struelens (2009: 1181) 
pointed out that a lack of experts should not be viewed as an insurmountable barrier 
to implementation of an ASP since such deficit can be overcome by introducing 
training courses. A study conducted in 47 Netcare private hospitals in seven of the 
nine South African provinces demonstrated the effectiveness of the antimicrobial 
stewardship led by non-specialised pharmacists (Brink et al.  2016: 1017). This study 
showed a significant reduction in overall antibiotic consumption of 18.1% in 116 662 
patients in an infectious diseases resource-limited setting (Brink et al. 2016: 1023).  
 
Internationally pharmacists are accepted as equal antimicrobial stewardship partners 
in ensuring optimal use of antimicrobials (Schellack, Pretorius & Messina 2016: 973). 
While, in South Africa pharmacists usually provide advice on the rational use and 
dosing of antimicrobial agents, and write antimicrobial guidelines (Kolman et al. 2016: 
26). A recent prospective multicenter study conducted in 33 South African hospitals 
led by a non-infectious disease pharmacists, showed that non-infectious disease 
pharmacists can significantly improve the timely administration of antimicrobials to 
improve patient care and contribute to interdisciplinary engagement between doctors 
and nurses to strengthen the importance of early administration of antimicrobials to 
improve patient care (Messina, et al. 2015:12). This study found a significantly 
improved ‘‘hangtime of antibiotics’ compliance from 41.2% to 78.4% (Messina et al. 
2015: 9).  
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2.12 SUCCESSES OF ASP 
The effectiveness of ASP in reducing inappropriate antimicrobial use and the 
development and spread of antibiotic resistance has been evaluated in numerous 
published scientific papers. A Cochran review of 89 studies conducted in 19 
countries on five continent with the aim of identifying effective interventions in 
improving antimicrobial prescribing practices, showed that these interventions can 
reduce antimicrobial resistance or healthcare-associated infections (HAIs) and 
improve clinical outcomes (Davey et al. 2013: 21) Additionally,  the results showed 
that restrictive interventions work faster than persuasive intervention and that  
complex, multifaceted interventions were not necessarily more effective than simpler 
interventions (Davey et al. 2013: 25).   
 
 In a qualitative systematic review of 24 studies from 9 different countries including 
United States, Brazil, Austria, China, France, Tunisia, Hungary, Greece and 
Germany, a statistically significant reduction in the use of targeted antibiotics was 
observed in all studies of restriction and pre-approval policies. However, the 
approach of restricting the use of certain antibiotic classes is associated with a 
compensatory increase in unrestricted antibiotics (Kaki, Elligsen, Walker, Simor, 
Palmay & Daneman 2011: 1225, 1229). The study of Kaki et al. (2011: 1225) 
revealed that computer-assisted decision support, formal reassessment and the 
impact of an infectious diseases consultant caused a decrease in antibiotic use 
among several classes of antibiotics. In regard to averting the increase in antibiotic 
utilization and resistance among unrestricted alternative agents due to the passive 
restriction policies, the authors recommended more active and interactive 
stewardship interventions (Kaki et al. 2011: 1229).  
 
A quasi-experimental study of Guerri-Fernandez, Villar-García, Herrera-Fernández, 
Trenchs-Rodríguez, Fernandez-Morato, Moro, Sancho, Grande, Clara,  Grau  and 
Horcajada  2016: 119) demonstrated conflicting results. The study showed a 38% 
increase in audits with, and a 62% in audits without recommendations to change the 
prescribed antimicrobial regimen, also an inappropriate prescribing in 26.9% of 
treatments in the post-intervention period and 37.5% in the intervention were also 
observed (Guerri-Fernandez, et al. 2016:121).  The most frequent reasons for 
inappropriate treatment were: the deviation from the hospital’s antibiotic guidelines, 
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the wrong dosage as well as lack of antimicrobial coverage. A total of 12 patients 
died during the study period (Guerri-Fernandez, et al. 2016:121).  
 
Various interventions are multifaceted and while this may increase their 
effectiveness, the complexity makes it challenging to identify the successful 
components of the intervention. For example,  Filice, Drekonja, Greer, Butler, 
Wagner, MacDonald, Carlyle, Rutks and Wilt  (2013: 1209) in a systematic literature 
review focusing on the different components of ASP found improvements in 
antimicrobial prescribing patterns and reductions in antimicrobial resistance as well 
as costs due to ASPs. This study highlights the equivalent importance of all types of 
ASP programmes and they are successful in improving antimicrobial prescribing 
patterns.  
 
Whereas, Boyles, Whitelaw,  Bamford, Moodley, Bonorchis, Morris, Rawoot,  
Naicker, LusakiewiczI, Black, Stead, Lesosky,  Raubenheimer, Dlamini  and 
Mendelson  (2013:4)   found that the use of a 2-part intervention complicated 
inference about the specific effects of both the chart and the ward rounds (Boyles et 
al. 2013:7). Although most interventions individually show potential in reducing 
inappropriate prescribing, this study underscores the complexities brought by a multi-
component ASP. 
 
2.13 THEORETICAL FRAMEWORK 
Before discussing the methods used in this study the concepts theory and the 
framework needs to be clarified first to put the adopted framework into context. The 
theory consists of concepts and a set of propositions that explain or predict events or 
situations by illustrating the relationships between variables, as well as help to make 
research findings meaningful and interpretable (Polit & Beck 2010: 195-196). A 
framework is referred to as a collection of interrelated concepts that underpins a 
study (Polit and Beck 2010: 198) Therefore, theoretical framework serves as the 
structure and support for the rationale of the study as well as provide guidance on 
which to built and support a study (Grant & Osanloo 2014: 12 -13). 
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This study is guided by the RE‐AIM framework for evaluating the impact of health 
promotion program. This framework offers a comprehensive approach to considering 
reach, efficacy, adoption, implementation, and maintenance domains, which  offer a 
comprehensive approach to evaluating the impact of an intervention (Glasgow, 
Klesges, Dzewaltowski, Estabrooks & Vogt 2006:688). Each component of RE-AIM 
framework addresses a major research question that can guide program planning 
and evaluation (Ory, Altpeter, Belza, Helduser, Zhang & Smith 2015: 1). Five 
dimensions of RE-AIM framework to consider for program evaluation are shown in 
fig. 2.1. 
 
 
FIGURE 2.1 RE-AIM FRAMEWORK KEY COMPONENTS (Ory, Altpeter, Belza, 
Helduster, Zhang & Smith 2015:2).  
 
Reach, captures the percentage of people from a given population who participate in 
a program and describes their characteristics. Knowledge of the number of eligible 
participants taking part in the program as well as the number of drop-outs or attrition 
in the program, is important to help measure the success of recruitment, and 
retention of participants (Ory et al. 2015:2; Sweet, Ginis, Estabrooks & Latimer-
Cheung 2014: 74). 
Reach 
 
Effectiveness 
 
Adoption 
 
Implementation 
 
Maintenance 
 
RE- AIM 
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Effectiveness refers to the positive and negative outcomes of the program and 
provides the evidence of the success of the implemented program: whether it 
performs as expected, which ultimately revealing the program's value and return on 
investment (Ory et al. 2015:2). 
 
Adoption, is similar to Reach, (Glasgow, Vogt & Boles 1999: 1323) but is assessed at 
the level of the settings measuring organizational capacity and partnership support 
including factors such as cost, level of resources and expertise required, size of the 
adopting organization. It is important to know whether the program is sustainable and 
the facility has personnel and fiscal support to manage the program, and is located in 
areas where the target audience resides as well as whether there is the capacity to 
bring the program to scale (Ory et al. 2015:2).  
  
Implementation, is an indicator of the extent to which different components of an 
intervention are delivered as intended  and its cost (Glasgow, McKay, Piette, & 
Reynolds,  2001: 120),  it is important in  identifying areas of need for improvement in 
program delivery, assuring participant results can be attributed to the program and 
identify return on investment for stakeholders (Ory et al. 2015:2). 
 
Maintenance operates at both the individual and the system level. At the individual 
level, maintenance refers to how well behaviour change efforts hold up in the long 
term. At the organization level, it refers to the extent to which a treatment or practice 
becomes institutionalized as a routine part of usual care within an organization 
(Glasgow et al. 2001: 120; Sweet et al. 2014:74-78). 
 
2.14 THE RE-AIM FRAMEWORK FOR IMPACT EVALUATION  
Impact evaluation is defined as a systematic and empirical investigation of the 
impacts produced by an intervention (IE Working group 2012: 2). It assesses the 
changes in the well-being of individuals that can be attributed to a particular program 
or policy (Gertler et al. 2016: 4). In addition, AIPC (2003: 5) has suggested the 
inclusion of the process evaluation, which assesses the information on the process of 
delivering the program. This is important for measuring the activities and quality of 
the program or service and who it reaches (AIPC 2003: 5). This was further 
corroborated in the IDSA/SHEA guidelines that the implementation of an AMP should 
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include both process and outcome measures to measure the success and the impact 
on the antimicrobial use and resistance patterns (Dellit et al. 2007: 161). 
 
Gertler et al. (2016:4) point out that well-designed and well-implemented impact 
evaluation provides comprehensive evidence that can be used to inform policy 
decisions, shape public opinion, and improve program operations. The authors 
further state that impact evaluation results are particularly useful when the 
conclusions can be applied to a broader population of interest (Gertler et al. 2016: 
11). The RE-AIM framework adopted for this study is useful for assessing the 
implementation and performance of interventions in the real-world settings as well as  
their subsequent impacts at individual and organizational levels (NCCMT 2010:1). 
 
This framework covers the concepts which form the main basis of the entire research 
(fig 2.1), including:  Reach (proportion of the target population that participated), 
Efficiency of the program (success rate), Adoption (proportion of target settings 
involved), Implementation (extent to which the program was delivered as intended), 
and Maintenance (extent to which the program was sustained over time) (Glasgow et 
al. 1999: 1322). The application of RE-AIM framework has contributed to research on 
nutrition (Huye, Connell, Crook, Yadrick & Zoellner 2014: 34),  diabetes 
(Compernolle, De Cocker,  Lakerveld, Mackenbach,  Nijpels,  Oppert, Rutter, 
Teixeira,  Cardon & De Bourdeaudhuij 2014: 147), sexually transmitted infection 
(Jeong, Jo, Oh & Oh 2015:847) physical activity and nutrition curriculum (Dunton, 
Lagloire & Robertson 2009:229).  
 
2.15 CONCLUSION 
Over seven decades of successful antibiotic therapy, microbes have developed 
strategies to defend themselves from antimicrobials. The burden of resistance is 
persistently increasing. This afflict is further aggravated by risks factors including 
immuno-suppression, patients' frail condition, invasive medical devices, overuse, and 
misuse of antimicrobials in the ICU. Based upon the foundation of the emergence 
and spread of antimicrobial resistance established in this study, it is clear that unless 
an effective strategy is devised the scourge will continue to grow to enormous levels. 
Together, with the understanding of the factors promoting antimicrobial resistance 
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and having knowledge about the mechanism of bacterial resistance, antimicrobial 
interventions can help alleviate this scourge. 
 
A well-established programme of antimicrobial stewardship demonstrating positive 
results is evident around the world. Yet countries in the African continent still lack 
behind showing a steady growth in the implementation of the ASP. In particular, there 
is a lack of implementation and impact evaluation studies of the ASM programmes.   
The recommendations of the guidelines for the appropriate prescribing of 
antimicrobial (Delitt et al. 2007:159; NDoH 2017: 8), should lead to a well-structured 
and implemented programme with a strong underpinning for the eradication of 
antimicrobial resistance. 
 
However, despite all the best intention and efforts on the part of the healthcare 
professionals, the expected outcomes might not be achievable if the program is not 
regularly appraised. This shortfall may also have serious and detrimental effects from 
the perspective of disease management. Therefore, it is important to note that 
program evaluation is critical in determining the extent to which a program has 
achieved its intended outcomes and the processes undertaken to achieve these 
outcomes. Moreover, the availability of resources and the timing of decisions about 
the programme or policy under investigation must be taken into consideration 
(Rogers 2014: 2).  
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CHAPTER 3 
 
RESEARCH DESIGN AND METHODS 
3.1 INTRODUCTION 
In the subsequent chapter, the impact of ASP and its limitations were discussed and 
the need for constant evaluation of the programme was highlighted. Therefore, this 
chapter provides the specific methodological details of the research conducted. It 
details the approach used and conditions under which the various stages of 
investigations were carried out, acquisition of the permission to do research, and 
design of research instrument used to collect the primary data. It further indicates 
how issues of validity and reliability were addressed. Prior to conducting the study, 
an ethics clearance was obtained as shown in Annexure A. 
 
3.2 RESEARCH DESIGN 
 According to Polit & Beck (2010: 222) research design of a study provides the basic 
strategies that researchers adopt to answer research questions and test their 
hypotheses. It constitutes the blueprint for the collection, measurement, and analysis 
of data (Kothari 2004: 31). Furthermore, it provides an outline for conducting a study 
with effective management of threats to internal and external validity of the study 
(Burns & Grove 2003:195). In particular, Kothari (2004:33) pointed out that the best 
research design is the one which minimises bias and maximises the reliability of the 
data collected and analysed. 
 
3.2.1 Research design and strategy 
The purpose of this study was to assess whether the ASP is effective in limiting the 
spread of antimicrobial resistance. Therefore, a quasi-experimental descriptive 
quantitative study was undertaken. By definition, quasi-experiments lack random 
assignment to conditions by which treatment is assigned: control or experiment 
(Shadish, Cook & Campbell, 2002: 14). These designs aim to evaluate the impact of 
interventions and are frequently used when it is not logistically feasible or ethical to 
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conduct a randomized controlled trial of causal research design (Harris, Bradham, 
Baumgarten, Zuckerman, Fink & Perencevich, 2004:1586-1587). Quantitative 
method is a systematical process of gathering empirical evidence for a study using a 
formal instrument and analysed with a statistical procedure (Polit & Beck 2010: 17-
18). The researcher and research object are considered independent of each other, 
and the preferred methodological choice is one of experimentation and testing of a 
hypothesis (Guba & Lincoln 1994: 109). Furthermore, it has the capacity to 
generalize findings to individuals other than those who participated in the study (Polit 
& Beck  2010: 17). 
 
Seeing as quantitative research attempts to establish statistically significant 
relationships, this approach was followed in this study to answer the research 
questions restated below (Dawson 2002:15). 
  
1. Do hospitals have the capacity to appropriately prescribe antimicrobials? 
2. How appropriate are the antimicrobial prescribing procedures to patients 
suspected to have hospital-acquired infection 48-72h after admission? 
3. What is the incidence of different disease-causing bacteria and antimicrobial 
susceptibility patterns in patients in the intensive care unit (ICU)? 
4. How effective are current antimicrobial stewardship programmes in improving 
the quality of antimicrobial prescribing in the ICU? 
5. What strategies can be implemented to improve the effectiveness of 
antimicrobial stewardship programmes in reducing the spread of antimicrobial 
bacteria in patients admitted in the ICU? 
 
Furthermore, an analytical observational technique was utilised in this study to draw 
inferences from the data regarding existing relationship (Schoenbach 1999: 209). A 
prospective cohort approach characterised by the identification of study subjects at 
the starting point of the study and the assessment of their exposure to a risk factor 
was adopted (Euse, Zoccali, Jager & Dekker 2009: 214). Prospective studies can 
easily demonstrate that the exposure preceded the disease, thereby strongly 
suggesting causation (Theise 2014: 200).Furthermore, this approach involves 
broader inclusion criteria and fewer exclusion criteria, making the results more 
generalizable to clinical practice (Euse et al. 2009: 216-217). Conversely, the lack of 
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random assignment in this approach is daunting and makes it impossible to establish 
causal effects. Therefore, the outcomes observed may be attributable to other 
variables (confounders) and not to the intervention (Dimitrov & Rumrill, 2003: 160; 
Euse et al., 2009: 216: Harris, Bradham, Baumgarten, Zuckerman, Fink & 
Perencevich 2004:1588).  
 
A quasi-experimental study using a single group before-and-after intervention design 
was undertaken to measure the change resulting from the promotional intervention of 
appropriate antimicrobial prescribing in critically ill patients. By using quasi-
experiment, a causal relationship between an intervention and an outcome can be 
determined (Harris et al. 2004:1587). These designs are practical as they can be 
performed in real-life settings and can introduce some research control when full 
experimental rigor is not possible (Polit & Beck 2004: 186-187).  
 
3.3 RESEARCH METHODS 
3.3.1 Study setting 
A permission to conduct research was applied for at the healthcare institution using a 
letter shown in Annexure B. Both the Medical Advisory Committee (Annexure C) and 
the head of ICU (Annexure D) of Chris Hani Baragwanath Academic Hospital gave 
permission to conduct this study in the facility.  The study was conducted in the adult 
intensive care unit of an academic hospital situated in Gauteng province, South 
Africa.  This academic hospital provides highly specialised healthcare services, the 
site for research and serves as the specialist referral centre for regional hospitals and 
neighbouring provinces (GDoH 2016: 64).  
 
3.3.2 Study population  
Population refers to a group of individuals with the same characteristics to which the 
results of the study may be generalizable (Polit & Hungler 1999: 232). As such, the 
population for this study comprised all critically ill patients, ≥18 years, admitted to the 
ICU and prescribed antimicrobials at a public hospital in South Africa. For sampling 
purposes, this study framed all critically ill patients, 18 years and older, admitted to 
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the adult ICUs and prescribed antimicrobials at the Chris Hani Baragwanath 
Academic Hospital situated in Gauteng Province (South Africa).  
3.3.3 Sample and sampling 
According to WHO (2001: 71) sampling is a process of choosing a representative 
section of the population for observation and study to produce accurate 
generalizations about the larger group. Sampling involves two fundamental 
approaches that include non-probability sampling and probability sampling (Kothari 
2004: 58). Under non-probability sampling, the researchers purposively select a 
sample on the basis that it will be representative of the whole total population 
(Kothari 2004: 59). Whereas, in probability sampling, each unit in a population has a 
specifiable chance of being selected and it enables researchers to make accurate 
assumptions or generalizations from the sample to the population under 
investigation. Moreover, with this technique, the errors of estimation or the 
significance of results obtained from a random sample can be measured (Kothari 
2004: 60). 
 
A systematic random sample was drawn from a list of all tertiary and academic 
hospitals in Gauteng Province. Systematic sampling is a technique in which each unit 
in a population has a specifiable chance of being selected. This technique entails 
random selection of the first unit and then choosing the remaining units of the sample 
at fixed intervals. Furthermore, the systematic sample is spread more evenly over the 
entire population (Kothari, 2004:62). Hospitals were arranged in alphabetical order 
followed by a random selection of the initial study site. Consequently, two study sites 
were selected for this study. In addition to having an advantage of reducing sampling 
bias, this technique ensures that all members of the population have equal chances 
of being selected. 
 
3.3.4 Sample size and sample size calculation 
Sampling is the process of selecting a portion of the population to represent the 
entire population, such that the researcher can study the smaller group and produce 
accurate generalizations about the larger group (Kothari 2010: 307). For this study, 
two academic hospitals situated in Gauteng province, South Africa, which provides 
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services to a diverse population group, were targeted. The initial study site has 
approximately 3200 beds, with inpatient utilization rate of 77.7% and an average 
length of stay of 7.9 days (GDoH 2016: 64). The second study site was a tertiary 
healthcare facility with about 832 beds and approximately 53 beds in the ICU. This 
hospital has the inpatient bed utilisation rate of 78.9% and the average length of stay 
of 8.4 days (GDoH 2016: 62). 
 
Only a single targeted public hospital agreed to participate in this study. The optimum 
sample size is essential in any research to avoid having a confined sample that may 
result in under-powering the study and lead to failure to detect the difference in 
outcomes or having a large sample size that may result in wasted time and money 
(Pourhoseingholi, Vahedi & Rahimzadeh 2013:14). Accordingly, an adequate sample 
size to estimate the impact of the program with a good precision was determined. 
The researcher also attempted to reduce the selection bias and sampling error to 
ensure a large enough sample size by including all eligible patients admitted to the 
ICU.  
 
The following formula was used to estimate the  sample size  
 
N = (r+1) (Zα/2 + Z1-β)
2 σ2 
r (µ1 - µ2 )
2 
 
Assumptions 
Zα/2 =1, 96 for two-tailed test 0.5  
Z1-β = 0.84 for power 0.8  
r = n0/ n1 : ratio for sample size required for 2 groups, for a single group r=1 
σ : pooled standard deviation of 2 groups 
µ1 - µ2 : difference of means of 2 groups 
ES = µ1 - µ2 / σ : Effective size = 0.53 based on the data in the published study of 
Davey et al. (2013: 4).  
 
Assuming common variance of the two groups 
Since this is a single group pre-post study the number of participants was calculated 
as follows (Suresh & Chandrashekara 2012: 9): 
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N = 2(Zα/2 + Z1-β)
2 / ES2 
N = 2(Zα/2 + Z1-β)
2 / ES2  
N = 2(1.96 + 0.84)2 / (0.53)2 
N = 15.7 / 0.280  
N = 56 patients 
 
For the allowance of attrition and withdrawal of participants from the study the 
sample size was adjusted using the following formula: 
N1 = N / 1 – q, where q is the proportion of attrition 
 
Therefore, the sample size thus required was 56/ (1 - 0.1) =62 patience for 10% 
allowance of the withdrawn subjects and patients lost to follow-up (Habib, Johargy, 
Mahmood & Humma 2014: 26).  
 
3.3.5 Sample inclusion and exclusion criteria 
The medical charts of critically ill patients 18 years and above admitted or transferred 
to the ICU from other departments in the hospital or other healthcare institutions for 
more than 48 h, and prescribed antimicrobials within the period of admission were 
reviewed as part of the study. Patients of both gender and any race were included. 
Patients were excluded if they did not require admission to the ICU and if they were 
not prescribed antimicrobials during their stay in the ICU.  
 
The infection control specialist in the ICU was included in the study as an 
antimicrobial stewardship leader to provide information on the capacity of the facility 
to prescribe quality antimicrobials.  
 
3.3.6 Data collection method and technique 
Accurate data collection is essential to maintaining the integrity of research.  This can 
be achieved through the four core principles: the protection of the welfare and rights 
of research participants, and to reflect the basic ethical values of beneficence and 
maleficence, justice and respect for persons (NDoH, 2015:3; Owonikoko 2013: 242).  
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The welfare and rights of human subjects participating in a study can be protected by 
being informed about the nature of the research study, including any potential risk 
and benefits, also by signing a consent form before participating in the study (Bulmer 
2008: 63). Beneficence and maleficence demand that participants should not be 
harmed through the conduct of the study (Owonikoko 2013: 242). To accomplish this 
principle, research must be designed to minimize risk and participants must be made 
aware of the potential benefits and risks (ACFID 2017:4). While justice principle 
demands a fair distribution of and access to the benefits of participation in the 
research (ACFID 2017: 5; NDoH 2015: 5). 
3.3.6.1 Data collection instrument 
This study set out to collect information about the performance of implemented ASP 
in an academic hospital. The patients’ data were collected through the review of 
medical records using paper-based questionnaire. The questionnaire was developed 
based on the reviewed literature, existing surveys and published guides pertaining to 
the ASP (CDC 2014: 12; Dellit et al. 2007:159; PHE 2015: 12-17). The developed 
questionnaire consisted of three phases with a total of 57 items. The first phase 
included 19 items designed to collect information concerning the appropriateness of 
antimicrobials prescribed in the ICU and patients’ demographic characteristics. The 
second phase included 12 items concerning the outcome of the patients treated with 
antimicrobials. The third phase included 26 items about the capacity of the hospital to 
appropriately prescribe antimicrobials.  
 
Given that questionnaires can collect large amounts of information from a large 
number of people in an efficient and economical way, this method best suited the 
present study (Mathers, Fox & Hunn 2007: 6). Albeit, closed-ended questions limit 
the respondents to the options provided, the majority of the questions in the 
questionnaire were closed-ended questions with either ‘yes or no’ answer and 
choosing one alternative from three to more options (multiple choice) (Siniscalco & 
Auriat 2005: 24). Additionally, certain questions were provided with the option “please 
specify” so as not to limit participant’s responses to pre-defined answers. 
 
Using a standardized questionnaire makes the collected data comparable to the data 
set and reduces the chance of evaluator bias (Bird 2009: 1308). As the study was 
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carried out in the natural setting, administering the questionnaire did not interfere with 
the daily routines of the settings (Mathers, Fox & Hunn 2007: 6).  
 
In addition, as this study gathered sensitive patients' information; using 
questionnaires helped in maintaining such information anonymous and confidential 
(CDC 2008: 1). The use of close-ended questions restricts respondents to a fixed, 
manageable set of responses, which allows the inclusion of more variables. As such, 
the weakness of closed-ended questions is in providing insufficient information on 
context. Furthermore, due to the imprecise and unambiguous wording on the 
questionnaire, participants inaccurately interpret the questions thus establishing bias 
in responses (Siniscalco & Auriat 2005: 23- 24) 
 
3.3.6.2 Content validity of the instrument 
The questionnaire was not entirely a new creation, it was developed using the 
components of AMS that had been identified in ASP guides and from questions 
asked in published questionnaires and toolkits (see section 3.2.4.1). As noted by 
Chiwaridzo, Chikasha,  Naidoo, Dambi, Tadyanemhandu, Munambah and Chizanga 
(2017: 4) literature does not specify the number of content expects needed to 
validate a study, as such 5 ICU nurses were requested to participate in content 
validation of the tool.  
 
The initial questionnaire was distributed in July 2017 to 5 ICU nurses (experts) to test 
for the readability and clarity of the questions. Following the COnsensus–based 
Standards for the selection of health status Measurement INstrument (COSMIN) 
checklist with some modifications as depicted in Table. 3.1 (Mokkink, Terwee, 
Patrick, Alonso, Stratford, Knol, Bouter, & de Wet 2012: 30), the face and content 
validity of ASPAQ tool was assessed. The discussions with the experts highlighted 
three main issues which required attention before the commencement of the main 
study.  
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TABLE 3.1 FACE AND CONTENT VALIDITY CHECKLIST 
 
General requirements Yes No 
1. Are the words simple, direct and familiar?   
2. Are the questions clear and simple?   
3. Are there any questions with a double meaning?   
4. Are there any biased questions?   
5. Are there any leading questions?   
6. Are the questions sensible to all respondents?   
7. Can the questions be shortened without losing meaning?   
8. Are all questions relevant for measuring the impact of ASP on reducing the 
incidence of hospital-acquired antimicrobials? 
  
9. Are all the questions in phase 1 and phase 2 relevant for the study 
population, critically ill patients in the ICU? 
  
10. Are there any questions you wish to add to the questionnaire?   
 
The length of the questionnaire was the first issue identified, and the panel 
suggested that it needed to be shortened to encourage quick completion of the 
questionnaire thus reducing weariness of the data collector. The other concern was 
the repetition of questions which made the questions redundant and adding to the 
length of the questionnaire. Such questions were removed from the questionnaire. 
 
Among the checklist’s items the experts established, the experts could not reach a 
consensus on item 7 (table 3.1). The researchers decided not to shorten the 
questions. 
 
The participating nurses were given an information cover letter (Annexure E), 
consent form (Annexure F) the copy of the questionnaire and the checklist (Table 
3.1). The cover letter included the purpose and objective of the study, the reasons for 
selecting the nurses, the outline of the questionnaire and the content evaluation 
procedure. Each nurse was asked to read the questionnaires and fill the checklist as 
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well as comment on the relevance, ambiguity, and ease of comprehension of the 
items. The nurses were chosen because of their knowledge in the daily running of 
the ICU, and the use of antibiotics in the ICU. Responses to the questionnaire were 
considered and amendments were made. The questionnaires were revised until no 
further amendments could be made to the questionnaire.  
 
The final and adapted questionnaire was 8 pages long with 41 items (Annexure G). 
Phase 1 had 11 items, phase had 7 items and phase 3 contained 23 items. The 
researcher was trained by ICU nurses on reviewing patients' charts and extracting 
relevant information. For the ease of collecting data and not interfering with the daily 
running of the unit the data was collected during the visiting time and when doctors 
have completed their morning rounds. Data was collected on weekdays. Information 
on the capacity to prescribe appropriate antimicrobials was obtained from the head of 
the ICU department. An invitation letter, consent form and phase 3 of the 
questionnaire were given to the member of ASP team of the ICU for completion. 
 
3.3.6.3 Problems experienced during data collection 
No apparent problems were encountered during data collection, except that some 
patients had reservations for participating in the study because of fear of divulging 
their medical information to a stranger. When the consent form was explicitly 
explained to them they gave their consent. Additionally, it was difficult to avoid 
interfering with doctors’ rounds as there was no time set for such rounds. 
Microbiological results such as the susceptibility test results needed Doctors’ code to 
be accessed, making data collection difficult. 
 
3.3.7 Methods of data analysis 
The data from the questionnaire were statistically analyzed primarily focusing on the 
study questions specified in chapter 1. 
 
Research question 1: Do hospital have capacity to appropriately prescribe 
antimicrobials? 
 
In regard to assessing the capacity to prescribe prudent antimicrobials the core 
elements of hospital antibiotic stewardship program identified by the (CDC 2014: 4) 
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were used. The core elements of hospital antibiotic stewardship programs, include, 
Leadership commitment; accountability; drug expertise; action; tracking; reporting 
and education   (CDC 2014: 4). Therefore, for the purpose of this study, the capacity 
of the hospital to prescribe appropriate antimicrobials will be determined by 
assessing seven core elements of hospital antibiotic stewardship programs with a 
series of criteria as depicted in (Annexure I). Each core element was measured by 
calculating the score of the criteria of the above-mentioned core elements. Each 
criterion within a core element was scored as either Yes or No. To provide a 
comprehensive assessment, total scores of each category were added together and 
converted into percentages. The capacity of each core element can be characterised 
as deficient (0 – 25%), Low (26 – 50%), sufficient (51 – 75%) or satisfactory (76 – 
100%). 
 
For study questions 2 and 3 a data dictionary was created to organize data entry, as 
part of a validation plan and for statistical analysis (Elliott, Hynan, Reisch & Smith 
2006: 335). Patients’ primary diagnoses were grouped into major diagnostic 
categories (WHO 2016: 99-791). Five categories were appropriate for use in this 
study, these included the disease and disorder of the 1) respiratory system, 2) 
digestive system 3) circulatory system 4) Genitourinary system and 5) Injury, 
poisoning and other sequences of external causes. The data dictionary provided 
detailed information about the data, such as definitions of all data attributes, their 
meanings, and values (Annexure H). 
 
Research question 2: How appropriate are the antimicrobial prescribing 
procedures to patients suspected to have hospital-acquired infection 48- 72 h 
after admission? 
 
The method developed by Gyssens, Van den Broek, Kullberg, Hekster and Van der 
Meer (1992: 724) as cited by Baktygul, Marat, Ashirali, Harun-or-Rashid & Sakamoto 
(2011: 159) was followed to assess the appropriateness of antimicrobial prescriptions 
in the ICU. For appropriateness of the prescription the following parameters were 
assessed: correct dosage, interval, routes of administration and appropriate length of 
treatment.  
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Following the classification of prescriptions given by Baktygul et al. (2011: 159), 
prescriptions were considered therapeutic if (a) the medical record contained 
information that the antibiotic was prescribed for therapy, or (b) an infectious disease 
was diagnosed, or (c) clinical signs of an infection were present on the day that 
antibiotic therapy was initiated.  
 
Furthermore, the use of prophylactics were explained to elucidate the difference from 
antibiotic therapy and prophylaxis following the method of Baktygul et al. (2011: 159), 
wherein prophylactic is indicated if (a) the medical record stated that the antibiotic 
was prescribed for prophylaxis or (b) it was given for only one day relative to the 
timing of a surgical intervention (Baktygul et al. 2011: 159). The prescription of 
antimicrobials was judged according to local antimicrobial guidelines. 
 
Research question 3: What is the incidence of different disease-causing 
bacteria and antimicrobial susceptibility patterns in patients in the intensive 
care unit (ICU)? 
 
The incidence of different bacteria and their susceptibility to antimicrobials were 
assessed by determining the distribution of the bacterial isolate from microbiological 
samples amongst patients, the frequency of different bacteria isolated from patients 
admitted in the ICU, and the microorganisms’ susceptibility against antimicrobial 
treatment.  
 
All patients with positive microbiological cultures were considered for this section of 
the study. Infection rates per 100 patients were calculated by dividing the total 
number of patients with HAI by the number of participants (X100). The association 
between the HAI and potential risk factors was assessed using Chi-square test in 
univariate analysis (Shao, Ni, Goa, Wei, Zong, Meng, Yang & Liu 2016: 23644). 
 
The hypothesis regarding the association between potential risk factors and the 
development of HAI was tested: 
H0: There is no association between the potential risk factor and the incidence of  
HAI. 
H1: There is an association between the potential risk factor and the incidence of HAI. 
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If the calculated Chi-Square value is smaller than the critical Chi-square value (X2 < 
0.05) then the null hypothesis is not rejected. 
If the calculated Chi-Square value is equal or larger than the critical value (X2 ≥ 0.05) 
then the null hypothesis is rejected. 
If p ≤ 0.05, the association is statistically significant 
If p > 0.05, the association is not statistically significant 
 
Research question 4: How effective are current antimicrobial stewardship 
programmes in improving the quality of antimicrobial prescribing in the ICU?  
 
The RE-AIM framework has been developed to enhance the impact of health 
promotion programs by focusing on 5 dimensions including reach, efficacy, adoption, 
implementation and maintenance of these programs (Brunisholz, Kim Savitz, 
Hashibe, Gren, Hamilton, Huynh & Joy 2017: 2; Glasgow et al., 1999: 1322; Lee, 
Golaviz, Soltero, Chavez, Jauregue, Hernandez, Taylor & Estabrooks 2017:2). It 
provides a model to inform the design, implementation and evaluation of a health 
program (Lee et al, 2017: 2). Additionally, it can be used for evaluating the reach, 
impact and implementation of the program at individual level focusing on reach and 
effectiveness; organizational level focusing on adoption and implementation, and at 
both individual and organizational levels involving maintenance of the program 
(Jauregui, Pacheco,Soltero, O’Connor, Castro, Estabrooks, McNeil & Lee 2015: 
163). 
 
For this study, both individual and organization levels of the program were evaluated. 
This was achieved by using all 5 dimensions of the RE-AIM framework to assess the 
impact of the ASP in improving the quality of antimicrobial prescribing in the ICU. A 
detailed description of the RE-AIM dimensions and application in this study is given 
in (Table 3.2).  The impact of ASP was calculated by adding the scores on the five 
RE-AIM dimensions and dividing them by 5 (Compemolle, De Cocker, Lakerfeld, 
Mackenbach, Nijpels, Oppert, Rutter, Teixeira, Cardon, & De Bourdeaudhuij 
2014:151). 
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TABLE 3.2 OPERATIONALIZATION OF THE 5 RE-AIM DIMENSIONS FOR THE 
IMPACT OF ASP. 
 
RE-AIM DIMENSION DEFINITION GUIDING 
QUESTIONS 
EVALUATION 
CRITERION 
INDICATORS 
REACH Percent and 
characteristics of 
participating critically 
ill patients admitted to 
the ICU. 
Who amongst the 
critically ill adults ≥ 
18y admitted in the 
ICU of Gauteng public 
hospitals benefited 
from the program? 
The total number of 
eligible participants 
minus the number of 
declined patients. 
Demographic 
information. 
Gender.  
Level of education. 
Ethnicity. 
Marital status. 
Diagnosis. 
Percent of 
participants. 
EFFECTIVENESS A measure of health 
effects of 
antimicrobials 
prescribed for critically 
ill adults in the ICU. 
What proportion of 
critically ill adult 
patients developed 
adverse events or 
acquired 
antimicrobial-resistant 
infection? 
A measure of primary 
outcome. Positive 
outcomes minus 
negative outcome. 
Mortality  
Quality of care. 
Safety of care. 
Risk factors 
ADOPTION An organizational 
measure of the 
eligible hospitals and 
program delivery 
agents (ASP team 
members) 
 
How many hospitals 
are participating and 
how equipped are 
these settings?  
The proportion of 
participating settings 
including their 
capacity to prescribe 
quality antimicrobials. 
 
 
 
In-house 
microbiological 
laboratory. 
Human resources. 
Level of expertise of 
the team members. 
List of essential 
antimicrobials. 
Evidence –based 
local antimicrobial 
guidelines. 
 
IMPLEMENTATION An organizational 
measure of the extent 
to which the AS 
program is delivered 
as intended. 
 
 
What proportion of the 
procedures of 
prescribing 
antimicrobials in the 
ICU are followed? 
The number of 
activities completed 
for appropriate 
prescribing of 
antimicrobials. 
Microbiological tests. 
Antimicrobials 
indicators. 
Appropriateness of 
therapy. Review of 
therapy.Duration of 
therapy. 
 
Reach was calculated by counting the number of willing and participating patients 
and dividing this value by the total number of eligible recruited patients. Effectiveness 
was calculated by counting the number of patients who developed HAI, subtracting 
that number from the total and divided this value by the total number of participating 
patients.  
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The number of patients belonging to the race that were risk factors for the 
development of HAI was subtracted from the total number of participating patients 
and the difference divided by the total number of participants. The number of patients 
prescribed appropriate antimicrobials was divided by the total number of participating 
patients.   
 
Adoption was calculated as the number of the hospital which accepted the invitation 
to participate in the study divided by the total number of eligible hospitals recruited. 
The number of individuals who constituted multidisciplinary ASP team members was 
divided by the recommended number of ASP team members. Implementation was 
rated by assessing the steps taken to prescribe appropriate antimicrobials as 
specified in the guidelines (Wasserman, Boyles & Mendelson 2014: 6 – 10), then 
dividing that value by the total value of the steps required for prescribing appropriate 
antimicrobials. The maintenance domain was excluded because the duration for the 
collection of data was shorter than 6 months, the period required to measure the 
long-term effects of a program as well as, the program sustainability which is the 
extent at which the program is still ongoing ≥ 6 months after the study completion.  
 
Research question 5: What strategies can be implemented to improve the 
effectiveness of antimicrobial stewardship programmes in reducing the spread 
of antimicrobial bacteria in patients admitted in the ICU?  
  
As per the results obtained in question 1, the characteristic of each capacity area 
determined the strength and weaknesses of the organizational capacity and provided 
the information whether the capacity areas warranted any corrective measures. The 
factors that affected the organizations capacity were highlighted from the scores of 
the capacity areas to optimise the appropriate use of antimicrobial. Capacity areas 
with a diminished performance capacity were identified and a strategy was devised 
that focused specifically on improving the organizational performance on prescribing 
quality antimicrobial agents.  The following components of action plan were utilised 
(Catholic Relief Services 2011: 12) 
 The description of the capacity with a weakness. 
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 The improvement and capacity strengthening the effort 
 Steps necessary to improve the capacity. 
 
3.3.7.1 Cross-checking data for completeness 
Data errors can occur during data transfer and management processes leading to 
data loss, incomplete or inaccurate data (Amoakoh-Coleman, Kayode, Brown-
Davies, Agyepong, Grobbee, Klipstein-Grobusch & Ansah 2015:1-2). Such errors 
can be reduced and verified using logic checks: to determine the status of data that 
are not logically sound and can be performed by  range checks, detection of outliers 
and checking for relational conflicts; visual data verification which can be carried out  
by comparing the data from the database with the source data, while the double data 
entry method compares two databases are compared electronically to facilitate  the 
detection of data entry errors or a combination of  them (Fong 2001: 843).   
For this study, a double data entry technique was used to check for the data 
completeness. Data were entered twice and the two data sets were compared, 
differences were examined, noted and corrections made.  
3.3.7.2 Data coding 
The responses to most items related to the capacity of the institution to prescribe 
quality antimicrobials (phase 3 of the questionnaire), were NO / YES and were 
allocated the score of 1 and 0 respectively to facilitate data analysis and 
interpretation.  For item 1 all responses were allocated a score of 1. Items 2 and 12 
with responses Never, Seldom and Frequent were allocated scores 0, 1 and 2 
respectively. Item 6 responses, Own funding, and Sponsor were allocated scores of 
0 and 1 respectively. 
3.3.7.3 Data entry 
Data were entered into Microsoft Excel 2007 (Microsoft Corporation, Redmond, WA) 
and analyzed using SPSS version 24 for Windows (Amonk, NY: IBM Corporation, 
USA). 
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3.3.7.4 Analysing data  
The data extracted from patients’ charts were analyzed to summarize and describe it  
and to facilitate answers to the research questions through its examination and 
interpretation.  
 
3.3.7.4.1 Statistical methods used in data analysis 
Descriptive data were presented in frequencies and percentages with mean and 
standard deviation to summarize the data. Continuous variables were expressed as 
the mean and standard deviation. 
 
Multivariate logistic regression analysis was used to determine the relationship 
between the patient-specific factors and the occurrence of hospital-acquired 
infections (HAI). Standard methods were used to calculate 95% confidence intervals 
(CIs) for the proportion of patients who received antimicrobials in the ICU (Baktygul et 
al. 2011:160). The following variables were investigated as confounding factors (the 
variable that distorts the association between the exposure and the outcome) 
(Kamangar 2012: 308), for hospital-acquired infections: age, gender, and chronic 
disease, and these confounding factors were compared between patients. 
 
3.3.7.4.2 Presentation of results 
The results of the study were graphically presented to identify patterns and trends as 
well as relationships within the data. Categorical data were displayed using a bar 
chart, while histograms were used to display the distributional form of continuous 
data. In addition, the association between two continuous variables was visually 
examined by constructing scatter-plots.   
 
3.4 MEASURES TO ENSURE VALIDITY AND RELIABILITY 
Ensuring the integrity and quality of data collection is part of good data management 
(Peersman 2014:7). The two crucial aspects of ensuring quality in the evaluation of a 
measurement instrument are identified as validity and reliability (Tavakol & Dennick, 
2011: 53).  Furthermore, it is pointed out in the literature that an instrument cannot be 
valid unless it is reliable (Tavakol & Dennick 2011: 53), but an instrument can be 
reliable without being valid (Kimberlin & Winterstein 2008: 2278). 
 
 
 
56 
 
3.4.1 Validity  
The validity of an instrument has been generally described as the evaluation of  the 
degree to which the instrument measures what it is intended to measure (Alumran, 
Hou & Hurst 2012: 223; Kimberlin & Winterstein 2008: 2278; Moussaoui, Opmeer, 
Bossuyt Speelman, de Borgie & Prins 2004: 592). In addition, Cook and Beckman 
(2006: 8) describe validity as the degree of the trustworthy of the test results as 
interpreted for a specific purpose. Christensen, Johnson, and Turner, (2015:158) 
noted that the more evidence of validity is provided, the more trustworthy the 
interpretations based on the measurement scores will be. 
 
There are several ways to assess the validity of a test including face validity, content 
validity, construct validity and criterion validity (Bolarinwa 2015: 195). Content validity 
measures the adequacy with which the test items comprehensively and 
representatively sample the content areas to be measured (Anyanwu & Williams 
2015: 3). Criterion validity assesses whether scores of new instrument agree with an 
accepted measurement of the same theme. It may be divided into the concurrent 
validity and predictive validity depending on the condition of the state whether current 
or future (McDowell 2006: 31). Construct validity has been defined as the extent, to 
which an operationalization measures the construct it is supposed to measure 
(Pennings & Smidts 2000: 1338).  
 
For this study factor analysis was performed. This technique can be applied as an 
exploratory factor analysis (EFA), wherein the number of observed variables is 
reduced into a smaller number of construct variables by examining the co-variation 
among the observed variables (Schreiber, Stage, King, Nora & Barlow 2006: 323). In 
addition  the variables that are more important for measuring construct variables 
were established, thus organising those variables in a way reflecting the latent 
variable (Williams, Onsman & Brown 2010: 2). It can also be used as a confirmatory 
factor analysis (CFA) for confirming that the original variables reflect the latent 
variable as assumed, thus establishing validity evidence based on the internal 
structure of measuring instrument (Wetzel 2011: 31).  
 
In this study the exploratory factor analysis technique was undertaken to identify the 
variables that group together (Dhillon, Zaini, Quek, Singh, Kaur & Rusli 2014: 846). 
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Exploratory factor analysis was considered appropriately as there was no prior 
knowledge about the number of underlying factors that could be found to explain the 
data.  The data were screened for factorability using several criteria including sample 
size, participants to variable ratio, correlation matrix, multicollinearity and singularity, 
anti-image correlations, Kaiser–Myer–Olkin (KMO) measure of sample adequacy and 
Bartlett’s test of sphericity.  
 
First, the correlation matrix was analysed to verify the pattern of inter-correlations 
between the measured variables to justify factor analysis (Watkins 2018: 226). The 
Kaiser Meyer Olkin (KMO) and Bartlett’s sphericity test of sampling adequacy were 
used to determine the factorability of the matrix and data as a whole (Zulkepli, Sipani 
& Jibril 2017: 14). The recommended value of KMO> 5 (Field, 2000: 446), and the 
Bartlett’s sphericity test that should produce a statistically significant chi-square value 
(p< 0.05) to justify the application  of EFA (Pinto, RO, Pattussi, M P, do Prado 
Fontoura, L, PolettoI, S, Grapiglia, V L, Balbinot, A D, Teixeira, V A & Horta, R L. 
2016: 3).  
 
In order to determine the number of factors to retain for subsequent investigation, the 
Eigenvalues criterion >1 and the scree plot were considered (Watkins 2018: 230). 
The eigenvalue was assessed to determine the contribution of the factor to the 
model, with values <1 suggesting a low contribution to the model (Pedrosa, 
Rodrigues, Padilha, Gallani & Alexandre 2016: 652). In addition, the components of 
interest were rotated based on the eigenvalues over 1 criterion and the scree plot. An 
Oblimin (Promax) rotation was carried out to enhance interpretability of factor 
structure and to provide additional information on the correlation between factors 
(Wetzel 2011: 37).  
 
Subsequently, item communalities were determined to confirm whether all factors 
extracted from this analysis were reliable to be considered for further analysis 
(Zulkepli, Sipan  & Jibril, 2014: 14). Communality shows how much of the proportions 
of the variances for each variable are explained by the extracted components (Al-
Durgham &. Barghash 2015: 298). Item communalities of > 0.3 was considered an 
acceptable value (Mansor, Haque, Sheikh, Choon & Zin 2016: 359; Zulkepli, Sipan & 
Jibril 2014: 14). Higher communality values suggest a larger contribution of the 
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variance in the variables that has been accounted for by the extracted factors 
(Mansor, Haque, Sheikh, Choon & Zin 2016: 359).  
 
To ensure that each item corresponded to the construct’s underlying structure, a 
factorial load criteria equal to or greater than 0.4 was considered so that the item 
belonged to the construct (Pinto, Pattussi, do Prado Fontoura, PolettoI, Grapiglia, 
Balbinot, Teixeira & Horta 2016: 5).  
 
The validity of the tool is determined by the load value of each item, representing the 
correlation between the item and the related factor (Cecchetto & Pellanda 2014: 418; 
Reichenheim, Hokerberg & Maraes 2014:929). Items with the loading value of > 0.3 
are regarded as tolerable, whereas values ranging from 0.35 to >0.5 are regarded as 
fair, values between 0.5 and 7 as moderate and loading of 7 and above are good 
loadings (Reichenheim et al. 2014: 929 – 930).  
 
However, factor analysis could not be performed with the data collected from the 
ASP team member because of a very low sample size (single ASP member). Since 
the questionnaire was constructed to evaluate the impact of ASP on the antimicrobial 
prescribing, and on the premise that ASP aims to optimise patients' outcome while 
minimizing unintended consequences of antimicrobial use, Phase 1 and Phase 2 of 
the questionnaire were used. 
 
3.4.1.1 Internal validity 
Internal validity is defined as the degree to which observed changes in outcomes can 
be correctly inferred to be caused by an exposure or an intervention (Harris, 
McGregor, Perencevich, Furuno, Zhu, Peterson & Finkelstein 2006:18). It assesses 
whether the measures obtained from the research were actually quantifying what it 
was designed to measures (Bolarinwa 2015: 195).   
 
All patients' data were collected by the researcher personally to eliminate most 
threats, such as the inter-rater effects and testing effect to the internal validity of the 
scores. There was no unanticipated event that occurred during data collection. A 
standardized instrument was used to collect patients' data to reduce changes in the 
instrument measurement. 
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3.4.1.2 External validity 
External validity refers to the degree to which the results can be generalized to and 
across individuals, settings and times (Carlson & Morrison 2009: 81). Furthermore, 
internal validity is a prerequisite for external validity (Carlson & Morrison 2009:81). 
 
Although getting subjects to participate in a study that involves chart review can be 
difficult, the charts of all excluding three of the eligible patients who were approached 
to participate were reviewed. Three patients refused to take part in the study. To 
protect from sampling bias this study included critically ill adult patients of ≥ 18 yrs, of 
both sex, and any race, admitted to the ICU from other wards or transferred from 
nearby health care institutions, as well as prescribed antimicrobials.  
 
3.4.2 Reliability 
Reliability refers to the degree to which measures are free from error and it pertains 
to the consistency, or reproducibility of test score (Thanasegaran 2009:35). In 
accordance, the less consistent a given measurement is, the less useful it renders 
the data to be analyzed.  
 
There are several measures for evaluating the reliability of test scores: the measure 
of stability which involves the evaluation of the correlation of measures across time or 
evaluators, for example test-retest and inter-rater reliability; the measure of 
equivalence which involves the evaluation of a correlation between two sets of 
instruments such as split-half and parallel forms as well as internal consistency which 
measures the degree in which scores measure the same concept. It involves 
correlation among all items (Kimberlin & Winterstein 2008: 2277). 
 
3.4.2.1 Testing the reliability of the data collection instrument. 
The reliability of ASPAQ was assessed by means of the internal consistency using a 
variety of parameters (Thanasegaran 2009: 36); item-total correlation, inter-item 
correlations and Cronbach’s alpha (α). The internal consistency of the items was 
estimated by using Cronbach’s apha coefficient for the entire scale and the extracted 
factors. For the questionnaire to be considered reliable, the item total correlation 
should be >0. 50; the inter-item correlation should fall in the range 0.15 – 0.85 and 
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Cronbach’s alpha be > 0.6 (BrckaLorenz, Chiang, Nelson & Laird 2013: 1; Cecchetto 
& Pellada 2014: 418)  
 
3.5 ETHICAL CONSIDERATIONS  
3.5.1 Research ethics 
Research in the critical care environment is essential to inform best practice, but it is 
confronted with ethical challenges, such as the ability of a patient to make a rational 
informed decision, research related risk of harm, research related exploitation and 
coercion (Morrow 2015: 34). To ensure the maintenance of ethical integrity of this 
study the researcher considered several ethical principles as discussed in the 
following sections. 
 
Considering the autonomy principle (Morrow 2015:34; Norris, Jackson & Khoshnood 
2012: 4; Summers 2009:49), the researcher took special measure to ensure that 
participation in the study was voluntary. The researcher provided eligible participants 
with adequate information about the risk, benefits, duration, and the purpose of the 
study and the role of the participants. The eligible participants were informed of their 
rights to voluntarily participate or decline to participate or withdraw from participation 
at any time, thus allowing them to voluntarily choose to or not to participate.  
 
Informed consent is important in the research fraternity to inform potential 
participants, through documents and discussion, of the purpose, procedures, risks, 
potential benefits, and voluntary nature of the proposed research, and documenting 
the participant's agreement (WHO 2013:21). In order for a consent to be valid it must 
include; adequateness, voluntariness, and competence (EC 2010:37). Namely, the 
prospective participants must: have intact decision-making capacity; be legally 
competent; be fully informed; be able to communicate a decision; and offer the 
consent voluntarily, without any implicit or explicit coercion or undue influence (EC 
2010:37; Morrow 2015:34). Critically ill or injured patients may not be able to 
communicate fluently or may have limited understanding of the information provided 
to them or have sufficient decision-making ability, therefore in such situations a proxy 
consent; whereby a family member or guardian can sign on behalf of the participant, 
could be considered (Morrow 2015:34). 
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Confidentiality was also considered (Norris et al. 2012: 4). Each participant signed a 
questionnaire which was collected and stored. Different containers were used for 
both consent forms and the completed questionnaires, to ensure that no signed 
consent form could be linked to any specific questionnaire.  Furthermore, 
participants’ privacy (Norris et al. 2012: 4) was guaranteed by removing names and 
other identifying information from the data and any report of the study. To preserve 
the integrity and privacy of data, the collected data were also stored securely in a 
password protected computer.  
 
Considering beneficence (Norris et al. 2012:4), the results of the study will benefit 
patients in the future if the guidelines of appropriate antimicrobial prescribing are 
followed as promoted by the antimicrobial stewardship, subsequently reducing 
antimicrobial resistance bacteria. 
 
Another consideration of the ethics was the distribution justice (NDoH 2015:5). The 
study aimed to add to the knowledge on the appropriate antimicrobial prescribing in 
the ICU and especially of South African hospitals. The ICU patients were selected 
solely for the reason directly related to the problem being studied: quality of 
appropriate antimicrobial prescribing, rather than factors like easy availability and 
vulnerability of the patients. To ensure fair distribution of the benefits of research all 
races and gender were included to participate in the study.  
 
3.5.2 Participants consideration 
The ICU management and shift managers gave the researcher permission to collect 
patients' data before the commencement of the study. Informed consent was 
obtained from patients or relatives before commencing with the study. In addition, the 
Head of the ICU Department and ICU nurses gave informed consent before 
participating in the study. 
 
3.5.3 Researcher consideration  
The researcher collected data by reviewing patients’ charts in a way that did not 
harm anyone. The collected data were not manipulated or altered in any way that 
might impact or falsely influence the results. There is no conflicting interest that might 
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interfere with the ability to conduct the study objectively and /or compromise the 
integrity of the study results.  
 
3.5.4 Institutional consideration 
Ethical clearance of the study was obtained from The University of South Research 
ethics Committee-Department of Health Studies (Annexure A). 
Approval for the study was obtained from The Medical Advisory Committee of Chris 
Hani Baragwanath Academic Hospital in the Gauteng Province (Annexure B). 
Site permission to conduct the study was obtained from Chris Hani Baragwanath 
Academic Hospital Intensive Care Unit (Annexure C).  
 
3.6 CONCLUSION 
This chapter has outlined the processes used to collect information for solving the 
research problem specified in this study. The methodology, study design, sampling 
techniques and sample size were described. The inclusion criterion used for the 
selection of the participants, the data collection tools used, method of data collection 
and analysis, as well as the credibility of the data, were also undertaken. 
 
In the next chapter, the key findings of the study will be reported based on the 
methodology applied to gather the data. 
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CHAPTER 4  
 
RESULTS 
4.1 INTRODUCTION 
This chapter discuss the findings of the data analysis and interpretation with 
reference to different research questions of the study.  The purpose of this study was 
to evaluate the impact of antimicrobial stewardship program in limiting the spread of 
antimicrobial resistance in South African hospital, with the aim of identifying its 
deficiencies so as to act on them and improve their performance. The study site 
included in the study was selected from 8 academic hospitals in the Gauteng 
Province. The participating hospital had a total of 18 beds in the general ICU. 
Over the study period (1 July – 10 October 2017) a total of 65 patients who had been 
admitted for at least 48 h and prescribed antibiotics, were identified and recruited.  
However, 3 (4. 62%) of the 65 identified patients declined to participate in the study. 
Ultimately, data were collected from 62 (95. 38%) medical charts of patients admitted 
to the general ICU at Chris Hani Baragwanath Academic Hospital (CHBAH). Of the 
reviewed 62 charts, 3 (4. 84%) were missing data and deemed unusable. as such 
were excluded from data analysis 
This chapter starts with the statistical description of the data, showing the mean, 
standard deviation, variations, kurtosis and skewness of the data. Clinical and 
demographic characteristics of the study population including information on age, 
gender, race, level of education and admission condition are discussed next then 
followed by a detailed description of the results relating to the research questions. 
 
4.2 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
This set of data was intended to describe demographic variables of the sample to 
assess the representativeness of the participants and the variables’ influence on the 
outcome of the patients.     
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TABLE 4. 1 DEMOGRAPHIC AND CHARACTERISTICS OF THE SURVEYED PATIENTS 
(n = 59). 
Variables                                                                             Frequency  (%) 
n % 
GENDER                                  
Male                                                                                   
Female                                                                              
 
AGE (41.51± 16.63)                                                                                 
19 –38                                                                               
39 –58                                                                               
59 – 78                                                                                
79 –98                                                                                   
 
RACE 
Black                                                                                  
Coloured                                                                             
Whites                                                                                  
Indian                                                                                  
 
EDUCATION 
Primary                                                                                
High school                                                                       
FET/ College                                                                      
University                                                                             
 
MARITAL STATUS 
Single                                                                                  
Married                                                                             
Divorce                                                                                
Widowed                                                                            
 
DIAGNOSIS GROUPING 
Infectious diseases                                                          
Genitourinary system                                                     
Respiratory system                                                          
Digestive and liver                                                         
Trauma                                                                            
Circulatory system                                                           
Endocrine, nutritional and metabolic                          
 
SEVERITY OF ILLNESS 
Minor                                                                                
Moderate                                                                         
Major                                                                                
Catastrophic                                                                      
 
33 
26 
 
34 
16 
7 
2 
 
 
48 
3 
6 
2 
 
 
0 
32 
20 
7 
 
 
32 
23 
2 
2 
 
 
2 
4 
6 
11 
31 
2 
3 
 
 
13 
27 
18 
6 
 
 
55.93 
44.07 
 
 
57.63 
27.10 
11.86 
3.39 
 
 
81.36 
5.08 
10.17 
3.38 
 
 
0.00 
54.37 
33.90 
11.86 
 
 
54.37 
38.98 
3.38 
3.38 
 
 
3.39 
6.78 
10.16 
18. 64 
52. 54 
3. 39 
5. 08 
 
 
22. 03 
45. 76 
30. 51 
10. 17 
 
 
The demographic data involved information on age, sex, marital status, and ethnicity 
as well as the socio-economic status of study population including; educational level, 
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chronic disease and admission condition. Table 4.1 shows the demographic 
characteristics of the participants. The final number of patients’ charts reviewed 
comprised of 59 participants with 6 (10.17%) catastrophically ill, 18 (30.51 %) 
critically ill and 27 (45.76 %) moderately ill patients. The majority of participants were 
males 33 (55. 93%), and over half of the patients were between 19 – 38 yrs of age. 
This was a surprising finding since females tend to be sicker than males due to 
biological differences between males and females. The mean patient age was 41.51 
years and they ranged between 19 to 88 years of age.   
Of the 59 participants, Indian patients comprised of 2 (3.38 %) participants whereas 
blacks comprised the majority with 48 (81.36 %) of participants. Six (10.17 %) of the 
participants were white, followed by 3 (5.08 %) coloured participants. This finding 
was expected, considering that the hospital is situated in a black populated 
neighbourhood, albeit patients from other healthcare institutions are transferred to 
this hospital. 
 
 
 
Since people who are more educated tend to be more aware of health risks and 
ordinarily make healthier and positive choices, the highest qualified patients were 
expected to comprise the fewest of the patients admitted in the ICU. This study 
showed the majority (n= 32, 54.37%) of the participants admitted in the ICU reached 
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FIGURE 4. 1 THE FREQUENCY DISTRIBUTION OF DIAGNOSIS 
GROUPINGS FOR PATIENTS ADMITTED IN THE ICU.  
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high school level in education, followed by FET/College educated participant (n= 20, 
33.90%). Only 7 (11.86%) patients were highly qualified with university qualifications. 
Most participants were diagnosed with trauma (n=31, 52.54%) followed by digestive 
and liver diseases (n= 11, 18.64 %) and, disease of respiratory system (n= 6, 10.17 
%). The majority of male patients 19 (32.20%) were diagnosed with trauma, and 12 
(20.33 %) female patients were also diagnosed with trauma as shown in figure 4.1. 
Fewer patients 2 (3.39 %) were admitted with the diseases of the circulatory system 
comprising of 1 male and 1 female patients (Figure 4.1).  
4.3 STATISTICAL DESCRIPTION OF THE DATA 
This section discusses the distribution, central tendency and the dispersion of the 
data collected from medical records of patients admitted to the ICU. The descriptive 
statistics for each of the 13 ASPAQ items are presented in table 4.2. Item   6 
(severity of diseases) with, a scale of 1- 4, had the highest mean value of 2.32 (Table 
4.1).  
Subsequent high mean values were observed for clinical indications with a scale of 
1-3 and a mean value of 1.377, followed by length of treatment (1.607) in the scale of 
1-3, then susceptibility results (1.246) in the scale of 0 - 2. The lowest mean value 
was observed for the item chronic diseases on a scale of 0 - 1 and the mean value of 
0.361. 
The measure of the spread of data around the mean, standard deviation was 
assessed and the results are shown in table 4.2. For items in the scale of 1- 4, Item 6 
had the highest standard deviation of 0.96 indicative of a varied data scores. The 
item with the least varied data was found to be item 15 (Length of therapy) with a 
standard deviation of 0.70. For items in the scale, 0 – 1, item 8 (Ventilator) was found 
to have a low standard deviation at 0.28, followed by item 2 (Chronic diseases) and 
item 11 (Healthcare acquired events) both with a standard deviation of 0.48 indicative 
of less varied data scores. 
The results of the symmetric distribution of data were assessed by its skewness 
wherein, a perfectly normal distribution equal to zero (0) (Kim, 2013: 52). As seen in 
table 4.2, the following items: Severity of diseases, Combination antibiotics, 
microbiological results, Revision of therapy, and Patient’s outcome, had acceptable 
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skewness values for a normal distribution since their values were close to zero. Of 
the remaining items, 4 comprise negative skewness values indicating a departure 
from normality.  Five items comprise positively skewed data indicative of values 
departing further from normality. Overall, 8 of the 13 items tested for skewness were 
non-normally distributed. 
 
TABLE 4.2 DESCRIPTION OF THE EXTRACTED DATA OF ICU INPATIENTS (n = 
59). 
Variable Scale Mean StDev Variance Skewness Kurtosis 
Severity of 
disease 
1- 4 2,328 0,961 0,924 0,22 -0,85 
Chronic diseases 0- 1 0,3607 0,4842 0,2344 0,6 -1,7 
Ventilator 0- 1 0,918 0,2766 0,0765 -3,13 8,03 
Clinical indication 1- 3 1,377 0,5821 0,3388 1,29 0,73 
Combination 
antibiotics 
0- 1 0,3934 0,4926 0,2426 0,45 -1,86 
Microbiological 
specimen 
0- 1 0,7541 0,4342 0,1885 -1,21 -0,55 
Microbiological 
results 
0- 2 1,131 0,785 0,616 -0,24 -1,33 
Susceptibility 
results 
0- 2 1,246 0,869 0,755 -0,51 -1,5 
Revision of 
therapy 
0- 2 0,967 0,93 0,866 0,07 -1,88 
Length of 
treatment 
1- 3 1,6066 0,6899 0,476 0,7 -0,62 
Healthcare 
acquired events 
0- 1 0,3443 0,4791 0,2295 0,67 -1,6 
Length of  stay 0- 4 1,459 0,697 0,4858 1,52 2,11 
Patient’s outcome 0- 1 0,4098 0,4959 0,2459 0,38 -1,92 
 
The sharpness of the peak of the distribution of data was statistically measured by 
calculating the kurtosis value. The normality range for kurtosis is -3 to +3 (Ho & Yu 
2014:371). The item ventilator demonstrated a high kurtosis value of 8.03 indicative 
of a distinct peak near the mean (Table 4.2). The rest of the items were within the 
kurtotic range indicative of a normal peak of the distribution of test scores.   
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4.4 QUESTIONNAIRE EVALUATION  
According to William, Onsman and Brown (2010: 2) factor analysis is a multivariate 
statistical procedure involving two major classes of analytic approaches, the 
explorative factor analysis (EFA) that allows the researcher to explore the main 
dimensions to generate a theory or model from a relatively large set of latent 
constructs represented by a set of items, and confirmatory factor analysis (CFA) that 
allows the researcher to test a proposed theory or mode (William et al. 2012: 3). 
Seeing as the data collection tool was not entirely new and the hypothesis regarding 
the structural nature of the original factor was unknown, also it consisted of a lot of 
questions, some of which may measure different aspects of the same underlying 
variable, it was necessary to perform the EFA to uncover the underlying structure of 
the variable being measured and to analyse its internal reliability. 
 
4.4.1 Inter-correlations 
The first step in factor analysis entails the assessment of inter-correlations between 
the items studied, thus identifying the dimensionality of the correlation matrix by 
indicating variables that correlate highly with other variables (Field, 2000:424). The 
correlation results are shown in table 4.3. The largest correlation coefficient occurred 
between Item 7 (Microbiological results) and item 6 (Microbiological specimen) (r = 
0.84), as well as between item 8 (Susceptibility results) and item 6 Microbiological 
specimen(r = 0. 83).  
The following pairs of items had low correlations > 0.15: item 5 (Combination 
antibiotics) and item 2 (Chronic disease) (r= 0.09); Item 10 (Length of stay)  and item 
2 (Chronic disease) (r = 0.04); item 10 (Length of therapy) item 8 (Susceptibility 
results) (r = 0.09); item 11 (Healthcare acquired events) and item 2 (Chronic 
disease); item 11 (Healthcare acquired events) and item 8 (Susceptibility results) (r= 
0.08); item 13 (Patient’s outcome) and item 2 (Chronic disease) (r= 0.07); item 13 
(Patient’s outcome) and item 8 (Susceptibility results) (r= 0.07). 
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TABLE 4. 3 INTERCORRELATIONS AMONG THE STUDY VARIABLES (n = 59). 
 
 
Since inter-item correlation examines the extent to which items on a scale are 
assessing the same construct, the low correlations may be due to the items not 
assessing the same construct. The results showed that not all items in the 
questionnaire were well correlated with each other, and therefore the questionnaire 
was possibly multidimensional. Furthermore, the negative correlations between items 
may imply that items may be worded in an opposite direction. Overall, the ASPAQ 
tool showed acceptable levels of consistency.  
In the correlation matrix (table 4.3), 3 clusters of variables with high inter-correlations 
are bolded. These clusters could be suggestive of three possible factors. Item 6, 7,8 
and 9 seem to load on one factor; item 11, 12 and 13 seem to load on another factor; 
and items 9, 10 and 11 load on another factor. 
 
Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item  9 
Item 
10 
Item 
11 
Item 
12 
Item 
13 
Item 
1 1.00 
            
Item 
2 .246 1.000 
           
Item 
3 .446 .239 1.000 
          
Item  
4 .351 .212 .245 1.000 
         
Item 
5 .366 .093 .133 .242 1.000 
        
Item 
6 .480 .127 .325 .367 .377 1.000 
       
Item7 .560 .110 .256 .332 .363 .841 1.000 
      
Item 
8 .319 .193 .211 .440 .339 .828 .540 1.000 
     
Item 
9 .530 .228 .264 .233 .301 .573 .663 .445 1.000 
    
Item  
10 .207 .040 .312 .138 .102 .297 .232 .088 .264 1.00 
   
Item 
11 .378 .045 .120 .034 .164 .437 .811 .068 .492 .081 1.000 
  
Item 
12 .459 -.116 .316 .049 .194 .441 .547 .075 .429 .414 .506 1.000 . 
Item 
13 .366 .066 .081 .116 .387 .307 .514 .073 .344 .142 .493 .257 1.000 
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4.4.2 Bartlett’s test of sphericity 
The inter-correlations of the items were further checked by using Bartlett's test of 
spherity for testing the null hypothesis that the correlation matrix is an identity matrix. 
When the correlation matrix is an identity matrix, this will indicate that the variables 
are unrelated and therefore unsuitable for factor analysis. The Bartlett's test gave a 
significant result of Chi-square = 488.917, p = 0.000, therefore signifying that a 
correlation between the variables exist and the correlation matrix is not an identity. 
The null hypothesis was rejected. 
4.4.3 Sampling adequacy test  
The adequacy of the sample for factor analysis was checked by using the Kaiser 
Meyer Olkin measure of sampling adequacy (KMO test) which specify that the 
sample will be deemed adequate if the value of KMO > 5 (Field, 2000: 446).   
  
TABLE 4.4 KMO AND BARETT’S TEST RESULTS 
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .710 
Bartlett's Test of Sphericity 
 
 
 
Approx. Chi-Square 488.917 
df 78 
Sig. .000 
 
Factor analysis was considered appropriate for a further analysis of the data. Table 
4.4 showed a KMO value of 0.710, which indicates that the sample is adequate to 
continue with factor analysis. 
4.4.4 Total variance  
For this study, the important factors are defined as those factors with an eigenvalue 
(variance) greater than 1. The first four factors have eigenvalues greater than 1 and 
explain most (69.19 %) of the variability in the data (Table 4.5).  
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TABLE 4. 5 EIGENVALUES AND TOTAL VARIANCE  
Component Initial Eigenvalues  Extraction Sums of Squared Loadings Rotation Sums of Squared Loadings 
 Total % of 
Variance 
Cumulative % Total % of 
Variance 
Cumulative % Total % of 
Variance 
Cumulative % 
1 4.998 38.449 38.449 4.998 38.449 38.449 3.076 23.662 23.662 
2 1.648 12.674 51.123 1.648 12.674 51.123 2.647 20.362 44.024 
3 1.280 9.845 60.968 1.280 9.845 60.968 1.921 14.777 58.801 
4 1.069 8.221 69.189 1.069 8.221 69.189 1.350 10.388 69.189 
5 .919 7.066 76.256       
6 .713 5.481 81.737       
7 .667 5.133 86.870       
8 .533 4.102 90.972       
9 .441 3.389 94.360       
10 .373 2.870 97.230       
11 .282 2.168 99.399       
12 .060 .459 99.858       
13 .019 .142 100.000       
 
Among the 13 components, component 1 accounts for the largest amount of variance 
4. 998 (38.45 %) in the data, which means that out of the total variance, 38.45 % can 
be attributed to component 1. Component 2 is explained by 1.648 (12.67 %) of the 
amount of variability in the data. The third component (1.28) is explained by 9.85% 
and component 4 is explained by 1.069 (8.22 %) of the variability of the data. The 
remaining components, each explains less than 10 % of the variance of the data and 
may not be important enough to include in the further analysis. 
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FIGURE 4.2 SCREE PLOT OF THE EIGENVALUES AGAINST THE DIFFERENT 
COMPONENTS 
For visual determination of the number of factors to retain, the scree plot was used 
(Fig 4.2). The scree plot showed a distinct break between the steep slope of the large 
component and was the curve starts to flatten. The components with values above 
the point at which the curve flattens out, and had eigenvalues above 1 were retained. 
Furthermore, component 4 was excluded from the model because its eigenvalue 
barely exceeds 1 and explains less than 10 % of the total variance. Therefore, only 
three components were considered for this study. 
 
4.4.5 Factor extraction  
Communalities demonstrates how much of the variance in the variables have been 
accounted for by the extracted factors (Table 4.6).  Among the 13 variables, 
communalities ranged from high of 0.921 for the item Microbiological results to a low 
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of 0.356 for the item Combination antibiotics variables. It can be said that all 13 
variables, except for item Combination antibiotics had communality values above 0.5 
and therefore all variables were included in the 3 selected factors. But only some of 
the variables had high loads within each factor.  Overall 13 variables were reduced to 
3 factors that accounted for 58.80 % of covariance among the variables. 
Components were extracted using the principal component analysis method. Table 
4.7 shows the results of the extracted components after Promax with normalization 
rotation was performed on the data. The table shows the loadings of each variable 
onto each factor. Loadings close to – 1 or 1 indicate that the factor strongly 
influences the variable, whereas loadings close to 0 indicate that the variable is 
weakly influenced by the factor.   
TABLE 4.6 COMMUNALITIES VALUES BEFORE AND AFTER EXTRACTION 
Variable Initial Extraction 
Severity of the illness 1.000 .641 
Chronic disease 1.000 .711 
Ventilator 1.000 .664 
Clinical indicator 1.000 .500 
Combination antibiotics 1.000 .356 
Microbiological specimen 1.000 .908 
Microbiological results 1.000 .921 
Susceptibility results 1.000 .913 
Revision of therapy 1.000 .586 
Length of therapy 1.000 .614 
Healthcare acquired events 1.000 .785 
Length of stay 1.000 .765 
Patient’s outcome 1.000 .629 
 
All items had high loading values ≥ 5 with the exception of the item Combination 
antibiotics, this is indicative of the representativeness of the underlying factor. The 
communality value of the item Combination antibiotics was low indicating that the 
variable is an outlier. If an item is cross-loading (item loaded on two or more factors) 
it was placed in the factor with the highest factorial loading compared with the other 
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factors or to other factors due to theoretical reasoning. Four variables (Combination 
antibiotics, microbiological specimen, Length of stay, and Severity of illness) were 
found to have high factor loadings on different factors. 
The following variables: Healthcare acquired events (0.980), Microbiological results 
(0.864), Patient’s outcome (0.798), Revision of therapy (0.545) and Combination 
antibiotics (0.393) load primarily on factor 1. This factor explains the outcome of the 
patients with regards to developing hospital-acquired events, demonstrated in the 
microbiological test results and outcome of the patient. This factor has outcome 
measurements and is termed the Outcome factor. 
 
TABLE 4.7 LOADING OF VARIABLES TO CORRESPONDING FACTORS. 
 Component 
Item 1 2 3 
Healthcare acquired 
events 
0,980448   
Microbiological results 0,863751   
Patient’s outcome 0,798122   
Revision of therapy 0,544736   
Combinatio antibiotics 0,393051   
Susceptibility results  0,86431  
Clinical indicator  0,730628  
Chronic disease  0,546828  
Microbiological results  0,528479  
Length of therapy   0,801517 
Ventilator   0,776247 
Length of stay   0,554311 
Severity of illness   0,348267 
 
The following items; Susceptibility results (0.864), Clinical indicator (0.731), Chronic 
disease (0.547) and Microbiological specimen (0.528) load primarily on factor 2.  
Factor 2 describes the effects of antimicrobials prescribed on the pathogen isolated 
from the collected patients’ specimen, as well as the reasons for prescribing the 
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antimicrobials. This factor is therefore named the appropriate antimicrobial 
prescribing factor.  
Factor 3 had a strong correlation with items; Length of therapy (0.802), Ventilator 
(0.776), Length of stay (0.554) and Severity of illness (0.348). It describes the 
influence of length of antimicrobials treatments, the use of mechanical ventilation and 
the severity of illness on the patients stay in a hospital. Therefore, this factor is 
named the risk factor. 
This analysis revealed that the questionnaire was composed of three factors: 
patients' outcome, prudent antimicrobial prescribing and risk factors. The results 
show that the three factors are sub-components of ASPAQ. In addition, the 
intercorrelations among the factors were assessed (table 4.8). It can be seen that the 
factors 1 and factor 2 are correlated with r = 0.419, and factor 1 and factor 3 with r= 
0.440, Factor 3 and factor have a borderline correlation with r= 0.29. 
TABLE 4.8 COMPONENT CORRELATION MATRIX 
Component 1 2 3 
1 1,000 0,419 0,440 
2 0,419 1,000 0,294 
3 0,440 0,294 1,000 
 
The internal consistency of the entire scale and the factors extracted was estimated 
using Cronbach’s alpha coefficient (table 4.9). The reliability estimate for the entire 
scale was high (α = 0.83), signifying a high degree of homogeneity amongst the 13 
items of the scale. The values of alphas were adequate with α = 0.80 for factor 1, α = 
0.67 for Factor 2 and α = 0.74 for Factor 3, indicative of internal consistency within 
the items of each factor. To determine how each item individually contributes to the 
reliability of the entire scale, one item was deleted and the Cronbach’s alpha re-
estimated.  
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TABLE 4.9 THE ESTIMATED INTERNAL CONSISTENCY      
Item item -total 
correlation 
Item deleted α 
values 
Cronbach's 
alpha 
Factor 1   0.80 
Healthcare acquired 
events 
0.54 0.82  
Microbiological results 0.91 0.78  
Patient’s outcome 0.82 0.81  
Revision of therapy 0.78 0.80  
Combination antibiotics 0.70 0.82  
Factor 2   0.67 
Susceptibility results 0.46 0.82  
Clinical indicator 0.67 0.83  
Chronic disease 0.80 0.84  
Microbiological 
specimen 
0.89 0.84  
Factor 3   0.74 
Length of treatment 0.49 0.84  
Ventilator 0.76 0.83  
Length of stay 0.78 0.82  
Severity of illness 0.60 0.81  
Entire test  0.83 
 
From the results (Table 4.9) it can be seen that there was no difference between the 
alphas for item deleted and the alpha for the entire scale, indicating a positive 
contribution to the reliability of the scale. 
4. 5 THE CAPACITY TO PRESCRIBE ANTIMICROBIALS  
This section discusses the results of the capacity of the hospital to prescribe 
antimicrobials. The results of the capacity of the organisation to prescribe 
antimicrobials are presented in table 4.10. The total score of the capacity measure 
was found to be 69. 23 %, this is indicative of a sufficient capacity to prescribe quality 
antimicrobials. The deficiency of the capacity of the hospital to prescribe quality 
antimicrobials was observed for the core elements: leadership commitment (50.00 
%).  
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Since leadership commitment ensures dedicated human, financial and information 
technology resources, a lack of support of facility administration to sustain an ASP in 
this institution was observed (Table 4.10) Chris Hani Baragwanath Academic 
Hospital established its ASP in 2016. It consisted of team members such as infection 
prevention and protection specialist, microbiology laboratory manager, clinicians and 
a pharmacist. Currently, the ASP is led by a pharmacist.  This is expected because 
the ASP team should be led by a knowledgeable and respected leader with an 
extensive knowledge of antimicrobials and antimicrobial stewardship, who may be 
able to monitor antimicrobial use and make recommendations for treatment based on 
available guidelines.   
TABLE 4.10 CAPACITY MEASURES OF ANTIMICROBIAL STEWARDSHIP 
PROGRAM 
Key elements Yes No Total Percent (%) Characterized 
Leadership 1 1 2 50 Low 
Accountability 1 0 1 100 Satisfactory 
Drug expertise 5 2 7 71. 43 Sufficient 
Action 11 6 17 64.70  Sufficient 
Tracking 6 2 8 75.00 Sufficient 
Reporting 2 1 3 66.67 Sufficient 
Education 1 0 1 100 Satisfactory 
Total 27 12 39 69.23 Sufficient 
 
In this institution nurses were not included as the ASP team members, this was not 
expected as nurses are essential in monitoring and improving antimicrobial use 
through investigating changes in patients' condition, follow-up on microbiological 
results and adjusting antimicrobials accordingly. ASP members have other hospital 
duties and no dedicated time for ASP implementation, also the ASP had no formal 
funding and therefore depended on sponsors to support the ASP activities. 
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4.6 ANTIMICROBIALS PRESCRIBING 
4.6.1 Appropriateness of antimicrobial selection   
This section discusses the findings on the antimicrobial prescribing patterns in the 
ICU.  The use of antibiotic prophylaxis before surgery has been found to significantly 
decrease surgical site infection and postoperative infections (Lundine, Nelson, 
Buckley, Putnis & Duffy, (2010: 367- 368). Almost 68 % of the patients were 
prescribed surgical prophylaxis, 17 (28.81%) were prescribed medical prophylaxis 
and only 2 (3.39 %) were prescribed therapeutic antimicrobials (Table 4.11). First-
generation cephalosporin are the recommended first-line agents for most surgical 
procedures, targeting the most likely organism while avoiding broad-spectrum 
antimicrobial therapy that may lead to the development of antimicrobial resistance 
(Lundine et al.,2010: 368; Dellinger, Gross, Barrett, Krausse, Martone, McGowan, 
Sweet & Wenzel, 1994:423). 
 
 
In this study, the most common antimicrobials were augmentin which accounted for 
35.16% of the total number of prescribed antimicrobials. Imipenem comprising 16 
prescriptions was the second highest, followed by vancomycin 8 (8. 88%) then 7(7. 
69%) of tazocin. Whereas, generation 3 cephalosporin: Cefatoxime and Ceftazidime 
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FIGURE 4. 3 THE FREQUENCY DITRIBUTION OF ANTIMICROBIALS 
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and generation 4 cephalosporin: Cefipime, cephalosporins were prescribed the least 
for only 4 cases, during the study period (Figure 4.3).  
4. 6. 2 Antimicrobial spectrum 
The majority of patients 51 (88.14%)  were prescribed antimicrobials with a broad 
spectrum activity compared to 8 (11.86%) patients prescribed antimicrobials with a 
narrow spectrum (Table 4.6). The activity of the prescribed antimicrobials is shown in 
figure 4.2. The majority 70 (76.92%) of the prescribed antimicrobials were broad 
spectrum whereas, 21(23,08%) comprised of a narrow spectrum. According to 
Wasserman, Boyles and Mendelson, (2014:6) an appropriate empirical antibiotic can 
be selected by matching the narrowest spectrum antibiotic with the likely pathogen. 
Out of 59 patients, 38 (64.41%) were prescribed a single antimicrobial, 16 (27.12 %) 
patients were prescribed 2 antimicrobials, and 5 (8.47%) were prescribed more than 
2 antibiotics (Table 4.11).  
 
4. 6.3 Appropriateness of antimicrobial therapy 
During the follow-up of 59 participants, 44 (74.58 %) biological specimens were taken 
for culturing and a total of 23 (38.98%) biological samples were positive. Two 
patients were admitted because of the infections whereas, 21 developed hospital-
acquired infections and all were prescribed antimicrobials (Table 4.1). 
Of the 21 patients with HAI, 4 were treated with 3 or more antimicrobials, 7 were 
prescribed two antimicrobials and 10 were prescribed one antimicrobial as can be 
seen in table 4.12. In this study, the majority of prescribed antimicrobials were 
administered intravenously (IV) 57 (88.14%) and only 2 (3.39%) were administered 
orally (Table 4.11). This could be due to the severity of the condition of the patient 
and/or because the majority of patients were prescribed surgical prophylaxis. In 
addition, many patients in the ICU are unable to take anything by mouth due to 
intubation, scheduled medical procedure or an underlying condition. 
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TABLE 4.11 PATTERNS OF ANTIMICROBIAL PRESCRIBING IN THE ICU 
PROCESSES                                                                         NUMBER OF PATIENTS 
n % 
 
INDICATION OF TREATMENT                                                                  
Medical prophylaxis                                                                                  
Surgical prophylaxis                                                                                
Therapeutic                                                                                                
 
MICROBIOLOGICAL LABORATORY 
RESULTS                                  
Positive                                                                                                     
No growth                                                                                                
Not tested                                                                                                
 
SPECTRUM OF ANTIMICROBIAL                                                                                                            
 Broad                                                                                                      
 Narrow                                                                                                    
 
NUMBER OF  ANTIMICROBIALS                                                          
1                                                                                                               
2                                                                                                               
>2                                                                                                               
 
DURATION OF THE TREATMENT 
 (Mean ± Sd; 4.17 ± 1.84)                                                   
1 - 3 days                                                                                                 
4 - 6 days                                                                                                
7 - 9 days                                                                                                  
 
ADMINISTRATION OF THERAPY 
IV                                                                                                              
Oral                                                                                                              
 
16 
40 
3 
 
 
 
23 
21 
15
 
 
51
8
 
38
16 
5 
 
 
 
31
20
8
 
 
57
2 
 
 
27. 12 
67. 80 
5. 08 
 
 
 
38. 98 
35. 59 
25. 42 
 
88. 14 
11. 86 
 
 
64. 41 
27. 12 
8.47 
 
 
 
52. 54 
33. 90 
13. 56 
 
 
96. 61 
3. 39 
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Although, the use of a combination antimicrobial therapy is discouraged, in this study, 
it was found that the combination therapy was used for the synergistic and extension 
of activity of the antimicrobials and for the prevention of the development of 
resistance (Wasserman et al., 2014: 9) 
 
TABLE 4.12 NUMBER OF ANTIMICROBIALS PRESCRIBED FOR PATIENTS 
WITH HAI (n= 40). 
Number of antimicrobials Number of patients  
n % 
1 10 47.62 
2 7 33. 33 
≥ 3 4 19. 05 
 
 
The judgement of the appropriateness of antimicrobials per patient showed that 4 
(19.05 %) of the 21 patients with HAI were prescribed inappropriate antimicrobials. 
 
TABLE 4. 13 ASSESSMENT OF ANTIMICROBIAL THERAPY 
 
Antimicrobial 
selection 
 
Antimicrobial 
dosages 
 
Antimicrobial 
administration 
 
Duration of 
therapy 
 
Appropriate 
 
18 (92.11 %) 
 
20 (97.37 %) 
 
21 (100%) 
 
 
21 (100%) 
 
Inappropriate 
 
3 (7. 89 %) 
 
1 (2. 63 %) 
 
0 
 
 
0 
 
Total 21 21 21 
 
 
21 
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In 3 (14.29 %) patients, the choice of the agents were not according to the 
guidelines, whereas, the antimicrobial dosage prescribed for 1 (4.76 %) patient was 
not according to the guidelines and therefore considered inappropriate as shown in 
table 4.13. The route of administration and the duration of antimicrobials treatment 
were appropriate in all patients.  
 
4.7 INCIDENCE OF DIFFERENT BACTERIA IN THE ICU 
TABLE 4.14 FREQUENCIES AND SUSCEPTIBILITY OF BACTERIAL SPECIES 
ISOLATED FROM MICROBIOLOGICAL SAMPLES AMONGST ICU INPATIENTS 
(n= 27). 
Pathogen Resistant Sensitive Total 
n % n % n % 
A baumannii 4 14.81 - - 4 14.81 
C difficile - - 1 3.70 1 3.70 
Clostridium spp. - - 2 7.41 2 7.41 
Corynbacter 1 3.70 - - 1 3.70 
E coli 2 7.41 2 7.41 4 14.81 
E faecium 1 3.70 - - 1 3.70 
Enterobacteria spp. 2 7.41 - - 2 7.41 
H influenza 1 3.70 - - 1 3.70 
Klebsiela 1 3.70 - - 1 3.70 
S aureus 4 14.81 2 7.41 6 22.22 
S pneumoniae 2 7.41 1 3.70 3 11.11 
Salmonela spp. 1 3.70 - - 1 3.70 
 Total 19 70.37 8 29.63 27  
 
 This section dealt with the results of the assessment of the incidence of hospital 
acquires infections and the identification of the risk factors. Table 4.14 shows the 
frequencies of pathogens isolated from microbiological samples of ICU admitted 
patients.  
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TABLE 4.15 THE INCIDENCE RATES OF HAI AMONGST ICU INPATIENTS (n = 
42). 
Charecteristics   Negative n= 21 (50.00 %) Positive n= 21 (50.00 %)   Incident rate      (%)  
Gender 
   
Male 15 (35.71 %) 10 (23.81 %)            23.81 
Female 6 (14.28 %) 11 (26.19 %)            26.19 
Age 
   
19 - 38 12 (28.57 %) 13 (30.95 %)            30.95 
39 - 58 5 (11.90 %) 6 (14. 28 %)            14.28 
59 - 78 3 (7.14 %) 2 (4. 76 %)             4.76 
79 - 98 1 (2.38 %) 0              - 
Race                                                                                                                                   
Blacks                                 16 (38.09 %) 17 (40.48 %)            40.48 
Coloureds                           1 (2.38 %) 1 (2. 38 %)             2.38 
Indians                                2 (4. 76 %) 0               -  
Whites                                 2 (4. 76 %)   3 (7. 14 %)                                        7. 14  
Diagnosis groups                                                                                              
 
Circulatory system 2 (4.76 %) 0             - 
Digestive system 5 (11.90 %) 1 (2. 38 %)             2.38 
Endocrine, nutrition and 
metabolism                               0 3 (7.14 %)             7. 14 
Genitourinary system 0  2 (4.76 %)             4. 76 
Respiratory system 2 (4.76 %) 3 (7.14 %)             7. 14 
Trauma 12 (28.57%) 12 (28.57%)            28. 57 
SOI                                                     
Minor                    5 (11.90 %)                                                                  1 (2. 38 %)                        2. 38 
Moderate                  8 (19.04 %)                                 7 (16. 67 %)            16. 67 
Major                   7 (16. 67 %)                                 8 (19. 04 %)            19. 04 
Catastrophic                 1 (2.38 %)                                     5 (11. 90 %)            11. 90 
Chronic disease 
  
Present 8 (19.04 %) 8 (19.04 %)            19.04 
Absent 13 (30.95 %) 13 (30.95 %)            30. 95 
Mechanical ventilation  
  
Present 20 (47.61 %) 20 (47.61%)            47. 61 
Absent 1 (2.38 %) 1 (2.38 %)             2. 38 
     
Twenty seven pathogens were isolated from the 21 patients diagnosed with HAI. The 
most frequent bacterial species isolated was S aureus (n = 6; 22.22 %) followed by E 
coli (n = 4; 14.81 %) and A baumannii (n = 4; 14.81 %) followed by S pnuemoniae (n 
= 3, 11.11 %). Corynbacter, E faecium, H influenza, Klebsiela, C difficile and 
Salmonela species were the least frequently isolated pathogens, all had single (3.70 
%) isolates. From the 27 isolated pathogens, 19 (70.37 %) were resistant to the 
prescribed antimicrobials. All 4 (14.81 %)  A baumannii isolates were resistant, 4 
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(66.67 %) of the S aureus were also resistant and 50% of E coli isolates were 
resistant.  
Table 4.15 shows the results of the incidence of hospital-acquired infections. From a 
total of 42 patients tested for HAI, 21 (50.00 %) patients had positive microbiological 
samples. Of the total 59 participating patients 21 (35.59 %) developed HAI but from 
59 patients only 44 microbiological samples were tested. 
The positive microbiological samples were from 11 (25.00%) female patients and 10 
(27.27%) from male patients. Female patients had the highest incidence rate (26.19 
%) of hospital-acquired infection than male patients (23.81 %). Patients of the age 
group 19 – 38 years had the highest rate (30.95 %) of developing hospital-acquired 
infections during this study. Black patients had the highest incidence rate (40.48 %) 
compared to other races. This result was expected as most of the patients 48 (81.36 
%) were blacks (Refer to table 4.1). Patients admitted with trauma and those with 
major illnesses showed high incidence rates of 19.04 % and 28.57 % respectively. 
 
TABLE 4.16 THE ASSOCIATION BETWEEN POSSIBLE RISK FACTORS AND 
HIA (n = 42)  
Item Χ
2 
- value df Critical χ
2 
value 
p-value 
Age 1.34 3 7.82 0.72 
Gender 2.75 1 3.84 0.10 
Race 2.24 3 7.82 0.52 
Diagnosis groups 9.86 5 11.07 0.08 
Clinical indication 1.06 2 5.99 0.59 
Severity of illness 5.40 3 7.82 0.14 
 
The univariate analysis of risk factors for developing HAI showed that all risk factors 
studied (Age, gender, race, diagnostic groupings, clinical indications and severity of 
the illness) were not significantly associated with hospital-acquired infection p< 0.05 
(Table 4.16). The Chi-square critical values were found to be greater than the 
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calculated Chi-square implying that the null hypothesis that states that: there is no 
association between possible risks factors and the incidence of HAI in the ICU was 
accepted (Table 4.16). 
 
4.8 IMPACT OF ANTIMICROBIAL STEWARDSHIP PROGRAM 
This section deals with the evaluation of the effectiveness of the antimicrobial 
stewardship program with respect to improving the quality of antimicrobial 
prescribing. The impact of ASP was assessed through the identification of five core 
evaluation elements: reach, effectiveness, adoption, implementation, and 
maintenance. 
4.8.1 Reach dimension 
Regarding the demographics of the participants, the total of 65 participants was 
recruited for the study but 3 (4.62 %) declined and 3 (4.62 %) participants were 
missing data, such that only 59 (90.77 %) patients participated in the study (refer to 
table 4.1). The participants comprised 33 (55.93 %) male and 26 (44.07 %) female 
patients (Fig 4. 4). 
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FIGURE 4.4 DISTRIBUTION OF PATIENTS ACCORDING TO 
DIAGNOSIS GROUPS 
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Most participants 34 (57.63 %) were in the age group 19 - 38 years and those who 
were 59 or older accounted for a small proportion (13.55 %) of the participants. The 
participants' race was categorised as Black, White, Indian and Coloured, and the 
majority were Blacks (n = 8; 81. 36 %) followed by Whites (n = 6; 10.17 %). Indian 
patients accounted for a smaller proportion (3.38 %) of the participants. 
 
4.8.2 Effectiveness dimension 
Of the 59 participants, the majority (n = 27; 45.76 %) had moderate illnesses followed 
by 13 (22.03 %) with minor illnesses. Catastrophically ill participants accounted for a 
smaller proportion (n-6; 10. 10 %). Fifteen (25.42 %) patients were not tested for 
microbiological cultures, 23 (38.98 %) patients had positive microbiological cultures 
and 21(35.59 %) participants had negative microbiological cultures (Fig 4.5). Of the 
23 positive microbiological specimens, 2 (8. 70 %) were admitted for infectious 
diseases whereas, 21 (91.30 %) developed infections in the hospital (Fig 4.5). 
 
 
 
Regarding the safety of care, 21 (35. 59 %) participants developed hospital-acquired 
infections (Table 4.11). Eleven (18.64 %) of the HAI positive patients were females 
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FIGURE 4.5 MICROBIOLOGICAL TEST RESULTS OF PATIENTS 
ADMITTED TO THE ICU 
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whereas, 10 (16.95 %) were males. Among the studied races, 17 (28.81 %) Blacks, 
followed by 3 (5.08 %), then Coloured 1(1. 69 %) tested positive for HAI. Of the total 
59 participants, 12(20.33 %) diagnosed with trauma, 3 (5.08 %) diagnosed with the 
diseases of endocrine, nutrition and metabolism and 3 (5. 08 %) diagnosed with the 
diseases of the respiratory system tested positive for HAI. Eight (13.56 %) who had 
major illnesses, 7 (11.86 %) patients with moderate illnesses and 5 (8.47 %) patients 
with catastrophic illnesses all, tested positive for HAI. 
Regarding the quality of care, participants were prescribed antimicrobials for different 
reasons (Figure 4.6).  Sixteen (27. 12 %) participants were prescribed antimicrobials 
for medical prophylaxis, 40 (67.80 %) were prescribed antimicrobials for surgical 
prophylaxis and 3 (5.08 %) participants were prescribed antimicrobials for therapeutic 
reasons. Of the participants prescribed medical prophylaxis, 8 (50.00 %) participants 
tested positive for HAI whereas, 13 (32.50 %) patients prescribed surgical 
prophylaxis tested positive for HAI. In total, the number of patients tested positive for 
HAI were 21 (35. 59 %). The 14 (23.73 %) patients treated with surgical prophylaxis 
were not tested, suggesting that no signs of infection were observed and therefore, 
the preventive treatment was successful. 
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FIGURE 4.6 MICROBIOLOGICAL TEST RESULTS ACCORDING TO 
DIFFERENT ANTIMICROBIAL INDICATIONS 
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Refer to table 4.13, of the 21 HAI positive participants, 3 (14.29 %) were prescribed 
inappropriate antimicrobials due to the wrong selection of the antimicrobials. A single 
(4.76 %) patient was also prescribed inappropriate antimicrobial, but due to the 
wrong dosage. In total 4 (6.78 %) patients out of 59 participants were prescribed 
inappropriate antimicrobials. Seventeen (80.95 %) patients were prescribed 
appropriate antimicrobials. 
 
4.8.3 Adoption dimension 
The results for the adoption dimension are shown in table 4. From 8 academic 
hospitals situated in Gauteng Province, two healthcare institutions were recruited for 
the study. Of the 2 recruited hospital only one (50.00 %) participated. 
 
4.8.4 Implementation dimension 
Regarding the staff willing to implement the program, of 6 trained and educated 
multidisciplinary ASP members recommended, 5(83.33 %) antimicrobial stewardship 
members including infection prevention and protection physician; microbiological 
laboratory specialist (leader); clinicians with an interest in infection, pharmacist with 
expertise in infection were identified with the exception of nurses staff (16.67 %).  
Regarding the list of essential antimicrobials, both essential medicine list and 
evidence-based local antimicrobial guidelines were available (100%). The 
microbiological laboratory is situated in the enclosure of the healthcare facility for 
timely reporting of the results. Implementation dimension measures the extent to 
which different components of the program are delivered as intended which were 
evaluated using the principles for rational antibiotic prescribing (Wasserman et al. 
2014: 6-10). 
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TABLE 4. 17 PROCESSES OF QUALITY ANTIMICROBIAL PRESCRIBING. 
Process Performed 
 
Skipped 
Indication for antimicrobial use X  
Obtain cultures X  
Antimicrobial choice: 
Target the most likely pathogen X  
Assess the likelihood of resistance X  
Review contraindication (allergy)  X 
Select antimicrobial with adequate tissue penetration X  
Aim for a single antimicrobial with the desired spectrum X  
Appropriate antimicrobial dosage X  
Appropriate dose frequency X  
Appropriate route X  
Therapeutic drug monitoring  X 
The desired spectrum covered X  
De-escalation: 
Route  X 
Spectrum  X 
Total 10 (71.43 %) 4 (28.57 %) 
 
Refer to table 4.17, the majority 10 (71.43 %) of the steps for prescribing quality 
antimicrobials were delivered as intended with the exception of 4 (28.57 %). The 
results are surprising since prescribing an antimicrobial without testing for allergies 
can aggravate the condition of the patient and endanger the patient’s life. Since the 
the route and spectrum of the prescribed antimicrobial for patients in the ICU were 
not changed because the administration of an antimicrobial depends on the site and 
severity of the infection and is governed by the dosage  (Baggot,1998:179). Most 
57(96.61 %) patients were administered antimicrobials intravenously (IV) (Table 
4.11). 
Furthermore, Baggot (1998:178) noted that oral administration is used in the 
treatment of mild and moderate infections or when a prolonged duration of therapy is 
anticipated. Therefore,  the IV route of administration chosen can be due to the 
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condition of the patient or the severity of the infection and mostly the intended quick 
eradication of the infection. 
Table 4.18 shows the performance measures of ASP for each RE-AIM dimensions 
except the maintenance dimension. The maintenance dimension could not be 
considered for this study because the data collection only took 3 months whereas, 
the long-term effects of the program are meant to be measured after >6 months. For 
the reach dimension, a high-performance rate of 90.80 % was observed. 
 
TABLE 4. 18 IMPACT MEASURES OF RE-AIM DIMENSIONS 
RE-AIM dimension Measure Performance scores Performance rate 
Reach Number of participants. 
 
0.908 90.80 % 
 
 
 
90.80 % 
Effectiveness Patients without HAI. 
 
0.644 
 
64.4 % 
 
 
 
 
64.4 % 
Adoption Number of participating 
institutions. 
Number of ASP team 
members. 
 
In-house laboratory 
Antimicrobial guidelines and 
essential  list 
 
 
MEAN 
0.500 
 
 
0.833 
 
1 
 
1 
50. 00% 
 
 
83.3 % 
 
100 % 
 
100 % 
 
 
83.33 % 
Implementation Extent of the processes of 
quality antimicrobial 
prescribing 
 
 
0.714 71.43 % 
 
 
 
71.43 % 
Average   77.49 % 
 
 For effectiveness dimension, the program performed fairly with 64.40 % of patients 
not developing HAI, indicating a success rate of preventing the development of HAI. 
The total rate of effectiveness was fair at 64.40 %. The antimicrobial stewardship 
program in the studied facility was highly adopted at the adoption rate of 83.33 %, the 
facility had an in-house microbiological laboratory and the list of essential 
antimicrobials including the antimicrobial guidelines. In the hospital studied 71.43 % 
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of the steps recommended for prescribing quality and effective antimicrobials were 
successfully followed and therefore, the implementation rate of the ASP in the 
hospital was good enough.  
 
4.10 CONCLUSION 
This chapter discussed the findings of this study with reference to 5 research 
questions. Three latent variables that explained the correlation between the observed 
variables were identified using a principal component analysis and Promax with 
Kaiser Normalisation rotation. These factors correlated with each other. Alphas for 
the entire scale and Factors showed internal consistency within the items. 
The capacity of the participating hospital to prescribe quality antimicrobials was found 
sufficient in this study. The majority of patients admitted in the ICU were prescribed 
quality antimicrobials whereas; only 4 patients were prescribed inappropriate 
antimicrobials according to the guidelines. Forty-two bacterial species were isolated 
from biological sampled obtained from patients admitted in the ICU. Both male and 
female patients were equally infected but had different frequencies for different 
pathogens. The incidence of HAI in the ICU was moderate and more frequent for the 
age group 19 – 38 years. In addition, black patients and patients with major illnesses 
were frequently infected in the ICU. All possible risk factor for the development of HAI 
and assessed in this study were not risk factors 
Although, the effectiveness of the ASP was average, the overall impact of ASP to 
prescribe quality antimicrobials was high. The leadership support for ASP’s effort of 
promoting prudent prescribing of antimicrobials was low. It was identified as the 
weakness of the capacity performance of the hospital and a number of strategies 
were recommended to strengthen and improve the weakness. 
In the next chapter, the implications of the findings for the participating hospital, the 
impact of ASP on the development of hospital-acquired infection and the evaluation 
of the programs impact using RE-AIM framework will be discussed. The limitations of 
this study will also be discussed and recommendations made.  
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CHAPTER 5 
 
SUMMARY AND DISCUSSION 
5.1 INTRODUCTION 
This chapter provides a summary of the study, including the purpose of the study and 
the discussion of the main findings. A detailed summary of the study, including 
literature review and methodology as well as the findings of the study will be 
discussion herein. 
5.2 SUMMARY OF THE STUDY  
The current study aimed at assessing the effectiveness of antimicrobial stewardship 
program in limiting the spread of antimicrobial resistance in the hospital’s ICU. It also 
aimed at identifying the deficiencies in the program’s performance and proposing 
strategies for strengthening these deficiencies. 
The threat posed by antimicrobial resistance has become a global issue, particularly 
in the ICU due to the increasing rates of inappropriate antimicrobial prescribing 
associated with greater morbidity and mortality (Llor & Bjerrum, 2014: 229; Kollef & 
Micek 2012: 179).  Thirty to 60% of antimicrobials prescribed in the ICU are either 
unnecessary, inappropriate or suboptimal (Luyt, Brechot, Trouillet & Chastre 2014: 
480). The development of resistance can delay the prescribing of quality 
antimicrobial treatment for the infection, thus aggravating the condition of the patient 
and leading to the extension of the hospital stay (Brink et al. 2006: 153). 
Consequently, a well structured hospital-based antimicrobial stewardship may afford 
the best care of patients with infection and prevent the development of resistant 
bacteria (Leuthner & Doern 2013: 3919). A multifaceted approach: antimicrobial 
stewardship program, aimed at increasing clinical outcomes, minimize adverse 
effects of antimicrobial use and reduce healthcare costs by improving antimicrobial 
use was introduced (Dellit et al. 2007: 159). This approach has been shown to impact 
the emergence of antimicrobial resistant bacteria by optimising the treatment of 
infections and reducing adverse events associated with antibiotic use (Davey et al. 
2013: 15).  
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The evidence of high rates of antimicrobial resistance from published literature has 
highlighted the importance of investigating the effectiveness of antimicrobial 
stewardship program implemented in the South African hospital. Therefore, this study 
focused on evaluating the efficacy of ASP that has been implemented and is in 
operation in the Chris Hani Baragwanath Academic Hospital in the Gauteng 
Province. 
5.3 STUDY DESIGN AND SETTING 
A quantitative, single group before- and –after quasi-experimental design was 
conducted to evaluate the impact of ASP on reducing the development of 
antimicrobial resistant in the ICU by improving the quality of the prescribed 
antimicrobials    (Kothari 2004:41). This was the appropriate method to use because 
the data collected was in numerical form and was analysed using a statistical 
procedures, also, as the study used critically ill patients, it was not logistically feasible 
or ethical to conduct a randomized controlled trial of causal research design and thus 
no group was allocated as a control (Harris, Bradham, Baumgarten, Zuckerman, Fink 
& Perencevich 2004:1586-1587). The study was conducted in the intensive care unit 
and as such, by using this method the existing setting was not disrupted. The study 
was conducted at the Chris Hani Baragwanath Academic Hospital in South Africa, 
Gauteng Province.  
 
The study population included all critically ill patients, 18 years and older, admitted to 
the ICU during the period of data collection. Patients also had to be admitted in the 
ICU for 48h or more with no signs of bacterial colonisation and prescribed 
antimicrobials, to be included. Sixty-five patients were approach for participation in 
the study, of which 3 denied to participate and another 3 had incomplete information 
extracted from their records. The total number of patients who participated in this 
study was 59. 
A structured questionnaire was used to collect information from the patients’ medical 
records. All the data were de-identified and participants were given a study number. 
Extracted data was entered into the SPSS computer program and analysed.    
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5.4 SUMMARY OF THE RESULTS 
5.4.1 Validation of the measuring instrument 
This study has validated a vaguely new antimicrobial stewardship program 
assessment questionnaire. Factor analysis technique through principal component 
analysis and Promax rotation was used. Three factors were highlighted and 
explained 58.8 % of the measurement variance. Factor 1, the outcome factor, 
grouped items that measure the clinical outcomes related to antimicrobial use and 
the common adverse effects thereof. This factor explained 38.45 % of the 
measurement variance.  Factor 2, appropriate antimicrobial prescribing factor, 
grouped items that measure the quality of antimicrobial prescribing through the 
assessment of the selection of the ideal antimicrobial drug regimen, dose, duration 
and the route of administration. This factor explained 12.67% proportion. Factor 3, 
risk factors, explained 9.84 % proportion of the measurement variance. This factor 
grouped items that are related to the appropriateness and duration of treatment, the 
severity of the illness and also the length of stay that may have an impact on the 
development of antimicrobial resistance. 
Each item of the ASPAQ tool demonstrated high loading values ( ≥ 0.5) indicative of 
a valid measurement tool. In addition, the Cronbach's alpha for the entire scale was 
high (α = 0.83), indicating a strong relationship between the concepts represented by 
each factor. For the assessment of the strength of factors underlying the dataset the 
Cronbach's alphas of Factor 1 (outcome factor) α = 0.80 and Factor 3 (α = 0.74) 
demonstrated strong factors underlying the dataset, whereas the strength of Factor 2 
(α = 0.67) was adequate.  The correlations between the entire scale and the item 
score were moderate to high: alpha ranged from 0.46 to 0.91. In addition, all items 
contributed positively to the reliability of the total scale except the item microbial test 
results (α = 0.78) which resulted in a low α- value after deletion compared to the 
entire scale (α = 0.83). After deletion of the remaining items, no changes were 
observed. The evaluated questionnaire was considered reliable. 
 5.4.2 Research question 1 
Does the hospital have the capacity to appropriately prescribe antimicrobial? 
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The capacity of the hospital to prescribe quality antimicrobials was assessed by 
identifying the core elements of hospital antibiotic stewardship program available in 
the hospital. The findings of this question revealed that leadership support was 
lacking in the hospital. Leadership commitment ensures dedicated human, financial 
and information technology resources (CDC 2014: 4). Although Abbo, Smith, 
Pereyra, Wyckoff, and Hooton (2012: 376) encourages the inclusion of nurses in the 
antimicrobial stewardship program to improve the effective use of antimicrobials, in 
this study, it was found that nurses were not represented in the ASP team of the 
studied institution. Edwards, Drumright Kieman, and Homes (2011: 6) indicated that 
nurses are best positioned to monitor and audit prescriptions but their role in ASPs is 
often overlooked. 
Furthermore, ASP team members in this institution have other hospital duties and 
therefore could not dedicate their time entirely to the ASP but incorporate their ASP 
work into existing duties. The ASP team need to be allocated more time to contribute 
to the running of the antimicrobial stewardship program. 
The ASP had no formal funding such that the institution depended on sponsors to 
support the ASP activities, with the hope that in the long run, the ASP may become 
self-sufficient by preventing expenditures on unnecessary antibiotics and prevention 
of the development of resistant pathogens. 
5.4.3 Research question 2 
How appropriate are the antimicrobial prescribing procedures to patients suspected 
to have hospital-acquired infection 48 –72 h after admission? 
The findings of this study revealed that less than 20 % of patients who developed 
hospital-acquired infections were inappropriately prescribed antimicrobials. Contrary 
to the findings of this study, the study by Baktygul et al. (2011: 165) found that 73.3% 
of patients were prescribed inappropriate antimicrobial therapy. This was also evident 
in a study by Adorka, Mitonga, Lubbe, Serfontein and Allen (2014:356). 
According to Willemsen, der Kooij, van Benthem, Wille and Kluytmans (2010: 6) 
judging the appropriateness of the antimicrobial therapy is not easy and requires 
extensive training. In addition, insufficient patient information complicates the judging 
of the appropriateness of antimicrobial therapies (Willemsen et al. 2010: 6). In this 
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study, all of the prescribed antimicrobials were assessed for appropriateness, but the 
results may be an underestimation of the potential inappropriate prescribing of 
antimicrobials. Therefore, validation of the results by expects may probably adjust the 
findings downwards. 
5.4.4 Research question 3 
What is the incidence of different disease-causing bacteria and antimicrobial 
susceptibility patterns in patients in the ICU? 
The results showed a high incidence rate of HAI (50%) that is slightly above the rate 
reported for Sub-Saharan Africa hospital-acquired infection which ranged from 2 – 
49% (Mbim, Mboto & Agbo 2016: 3). Furthermore, the high HAI rate in this study was 
corroborated by the EPIC II study, which reported the rate of all infections as 51%  
(Vincent, Rello, Marshall, Silva, Anzueto, Martin, Moreno, Lipman, Gomersall, Sakr & 
Reinhart 2009: 2327). Yesilbag, Karadeniz, Basaran and Kaya (2015: 236) reported 
the rate of nosocomial infection as 65 %, higher compared to the infection rate found 
in this institution.   According to Khan, Baig and Mehboob (2017: 478), an increase in 
these infections may lead to an extended stay in the hospital, increased morbidity, 
increased antimicrobial resistance and increased mortality rate. 
The frequently isolated bacteria in this study included S aureus,  E coli,  A baumannii 
and S pnuemoniae, which are considered the main pathogens associated with 
hospital-acquired infections, apart from S pnuemoniae (Lisboa & Nages 2011: 120). 
These pathogens are referred to by the acronym ESKAPE, they account for more 
than 80 % of infectious episodes in the ICU and involves both gram-negative and 
gram-positive bacterial species, which are characterized by increasing levels of 
antimicrobial resistance (Santajit & Indrawattana 2016: 1; Zilahi, Artigas & Martin-
Loeches 2016: 97). These infections are the most common complications affecting 
hospitalized patients (Mishra, Panarjee & Gosain 2014: 39). In their study, Yesisbag 
et al. (2015: 236) found that K pneumonia, P aeruginosa, Acinetobacter spp. and E 
coli were the most common pathogens, which was contrary to the findings of this 
study. In addition, the frequency of S aureus infections was low (4%) compared to 
the 14.81 % frequency found in this study. The growing numbers of ESKAPE 
pathogens place a significant burden on healthcare systems (Santajit & Indrawattana 
2016: 1). 
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The high incidence rates observed in this study indicate that the antimicrobial 
stewardship program implemented in this facility was not effective in improving the 
safety and care of the patients, one of the program's main objectives. To minimize 
the incidence and adverse outcomes of these infections, appropriate resources and 
activities to protect patients, healthcare workers and visitors from infections are 
essential, and these should be accomplished in the most cost-effective manner 
(Misra et al. 2014: 38). 
Certain factors can affect the development of hospital-acquired infections: these 
include the underlying disease process as well as the severity of the disease (Mishra 
et al. 2014: 39); invasive devices such as mechanical ventilators and urinary 
catheter; surgical interventions applied, which may be an entrance for the causative 
microorganisms  (Yesilbag et al. 2015:237). Furthermore, Weinstein (1998: 417) 
stated that nosocomial infections typically affect patients, who are 
immunocompromised because of age, underlying diseases, or medical or surgical 
treatment.  
 
 The univariate analysis revealed that age, gender, use of mechanical ventilation, the 
severity of illness and diagnostic groupings were not significantly associated with the 
development of HAI in this study. Contrary to the study by Yesilbag et al. (2015: 237) 
that revealed that the use of mechanical ventilation, hemodialysis, central vascular 
line, urinary catheter, nasogastric catheter were significantly associated with an 
incidence of HAI. Their findings further showed no significant correlation between 
age and the development of HAI, which was in line with the findings of this study 
(Yesilbag et al. 2015:237). This finding was also corroborated by the study of Mihaly, 
Orsolya, Monica, Anna, Hajna, Maria and Judit (2016: 307) which found no 
significant differences between infected and non-infected patients regarding age and 
gender.  
In this study, factors such as old age, underlying diseases, the severity of the illness 
and undergoing surgical procedures did not significantly increase the chances of 
more patient developing HAI, moreover, there are contradictions observed in 
published data as discussed above. 
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5.4.5 Research question 4 
How effective are current antimicrobial stewardship programmes in improving the 
quality of antimicrobial prescribing in the ICU? 
In order to address this research question, the RE-AIM framework was adapted 
(Glasgow et al. 1999:1322). This framework focuses on five most important 
dimensions (Reach, Effectiveness, Adoption, Implementation and Maintenance) for 
evaluating the potential public health impact of programs intended for wide-scale 
implementation and dissemination (Compernolle, De Cocker, Lakeveld, 
Mackenbach,Nijpels, Oppert, Rutter, Teixeira, Cardon & Bourdeaudhuij 2014: 149). 
The RE-AIM framework has been widely used in international studies (Baba, Oliviera, 
Silva, Vieira, Cerri, Florindo & Gomes 2017: 709; Compernello et al. 2014:147; 
Farris, Will, Khavjou & Finkelstein 2007: 641; Jaurequi, Pacheco, Soltero, O'Connor, 
Castro, Estabrooks, McNeil & Lee 2015:162; King et al., 2010: 2076; Sweet et al. 
2014: 74). Thus far this is the first study to evaluate the impact of health promotion 
program using the RE-AIM framework in the ICU.  
The RE-AIM evaluation revealed that the program reached approximately 90 % 
eligible critically ill adult patients admitted in the ICU. This was calculated as the 
percentage of the number of participants divided by the number of eligible and invited 
people (Compernolle et al. 2014:49). Considering study group differences, reach was 
substantially greater for the Black patients than other race groups. According to Soto, 
Martin and Gong (2013: 3183) men and African Americans have a higher incidence 
of getting critically ill and admitted to the ICU. Whereas, the general household 
survey conducted by Statistics South Africa (Lehohla 2013:77) found that most 
people from white population group were reported ill or injured before the survey than 
people from black African and Coloured population groups. However, most Blacks 
and Coloureds use public health facilities whereas; most of the Whites and Indians 
population groups use private health facilities (Lehohla 2013: 17). Accordingly, small 
numbers of Whites and Indian are observed in public hospitals, such as the one 
studied herein. 
Regarding the age difference, most patients reached were younger than 65 years 
compared to the elderly patient group, this was a surprise finding. Solis-Vernadez, 
Vilades-Reyes, Garza-Gonzalez, Guojordo- Alvares, Chavez- Moreno and Comacho- 
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Ortiz (2016: 32620) noted that the global aged population has been increasing 
resulting in the increase of admission of elderly patients in the ICU. Ozdermin and 
Dizbay (2015: 39) clarified that the need for the elderly to be admitted in the ICU is 
due to changes in the immunity, organ and tissue dysfunctions and underlying 
chronic disease in the elderly age group.  
The program was adopted by an approximately half of the invited hospitals that was 
equipped with essential medicine list and the antimicrobial guidelines as well as the 
in-house laboratory. Promoting the rational use of medicine requires effective policies 
(Ofori-Asenso 2016:1) such as the standard treatment guidelines and essential 
medicine policies advocated by the World Health Organization (WHO 2002: 2). 
Evidence-based clinical guidelines are critical to promoting rational use of medicine 
(WHO 2002:3). Essential medicines have been described as those medicines that 
satisfy the priority health care needs of the population (WHO 2002: 3). The WHO 
(2002:3) suggested that the essential medicines should always be available in 
adequate amounts, appropriate dosage forms, with assured quality and adequate 
information for both the community and individual. Moreover, the essential medicine 
list should be based upon clinical guidelines (WHO 2002: 3). During the study period, 
both the clinical guidelines and essential medicine list were available. 
In addition, more than 80 % of healthcare givers (ASP team members) agreed to 
participate in the program.  The results further revealed that ASP achieved its goal of 
reducing the spread of antimicrobial resistance with approximately 65 % of patients in 
the ICU not developing HAI. Approximately 71 % of the activities for quality 
antimicrobial prescribing were delivered as intended.  
5.5 CONCLUSION 
In general, these findings indicate that the ASP has the potential for adequate to high 
public health impact. Furthermore, this study has demonstrated how RE-AIM 
evaluation model can be used to assess the impact of ASP in reducing the spread of 
antimicrobial resistance. 
This study demonstrates that with a little support and promotion of the appropriate 
use of antimicrobials a significant reduction in the development of adverse 
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antimicrobial effects and the preventing the spread of antimicrobial resistance can be 
achieved. 
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CHAPTER 6 
 
STRATEGIES FOR IMPROVING ASP PERFORMANCE 
6.1 INTRODUCTION 
This study examined the effectiveness of the ASP implemented in the hospital, to 
prescribe appropriate antimicrobials thus limiting the spread of antimicrobial-resistant 
bacteria. This chapter deals with the aspects of the ASP that were identified as 
weaknesses in the AMS program, to inform decisions on whether to expand, modify, 
or eliminate that particular aspect of the program. In addition, this chapter discusses 
the strategies suggested to optimise the performance of the AMS program. 
6.2 ANTIMICROBIAL PRESCRIBING CAPACITY  
The results of this study revealed that leadership commitment is lacking for an 
antimicrobial stewardship program to be successful. The leadership commitment 
element was found to be low (50.00 %) in capacity performance (Table 4.10).  
Hospital leadership support is essential to the success of ASP by ensuring the 
program has sufficient budget, technology, time management and resources (NQF 
2016: 6; Pollack & Srinivasan 2014: 97). In this study, it was found that ASP 
members have other hospital duties and could not dedicate time for ASP activities.  
Although, ASPs are often self-sufficient through savings in both antibiotic 
expenditures and indirect cost, financial support enhances the success of the 
program (Pollack & Srinivasan 2014: 97- 98). In the studied facility no formal funding 
was available for running the program thus the program depended on sponsorships 
for sustenance. 
Action plans to improve antimicrobial prescribing include convincing the hospital 
leadership to support the program by showing them the program’s evidence of cost 
saving through quality care and improved patient safety due to quality antimicrobial 
prescribing.  Communicating and regularly updating the leadership on the ASP 
outcome may secure leadership support and improve the program’s success rate. In 
addition,   the leadership should be convinced to ensure adequate staffing for ASP 
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activities in order to provide sufficient time to contribute to stewardship activities 
including education and training (NQF 2016: 6 - 7). 
Furthermore, ASP activities should be integrated into quality improvement and/or 
patient safety initiatives and to ensure that the ASP team member's knowledge is 
regularly updated in measuring and improving antibiotic use. Leadership support 
should be prioritised through the accessibility and employment of qualified staff, as 
well as funding for information technology and policies should be availed to providers 
to perform their ASP duties to their best abilities (NQF 2016: 6). 
6.3 CONCLUSION 
Although the study showed that the performance of the ASP implemented in this 
facility was sufficient, there are strategies which can be used to optimise the 
program. This chapter demonstrated that regular evaluation of the health program is 
a necessity for identifying the weakness and positives so as to upscale it. 
For the studied facility it was found that the ASP has no management support. There 
is no financial and personnel support to sustain the program and most of the 
healthcare workers are discouraged to participate in the program, subsequently 
leading to the poor performance of the program. 
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CHAPTER 7 
 
RECOMMENDATIONS, LIMITATIONS, AND CONCLUSION 
7.1 INTRODUCTION 
This chapter discusses the recommendations, limitations of the study and 
suggestions for future research. The spread of antimicrobial resistance is a major 
public health problem that influences patients' outcome and long stay in healthcare 
settings. Inappropriate prescribing of antimicrobials is implicated as the critical cause 
of this afflicts in healthcare settings, which subsequently resulted in the birth of 
antimicrobial stewardship programs. The ASP's aims included the promotion of 
appropriate antimicrobial use with the purpose of improving patients' safety, 
healthcare cost and the reduction of antimicrobial resistance. Such programs are 
rarely evaluated to improve their performance. 
This study demonstrates that the RE-AIM framework can be used to 
comprehensively evaluate the impact of ASP implemented in the hospital. The 
evaluation of reach, effectiveness, adoption, and implementation of ASP showed an 
adequate impact of the program on reducing antimicrobial resistance. For a 
comprehensive evaluation, it is recommended that all 5 RE-AIM dimensions be 
assessed; conversely, in this study the maintenance dimension was not included due 
to the short duration of the study. Therefore, a longer duration with a follow-up of 
more than six months is recommended. 
Regarding the capacity of the hospital to prescribe quality antimicrobials, the facility 
leadership support was lacking. The leadership support is critical to the success of 
ASP and thus it is recommended that the hospital leadership should be persuaded to 
be more concerned about the importance of ASP. 
7.2 CONTRIBUTION OF THE STUDY 
Promoting appropriate use of antimicrobials in the healthcare setting will reduce 
unnecessary prescribing of antimicrobials and therefore, limiting the spread of 
antimicrobial resistance. A major contribution of this study pertains to the RE-AIM 
framework; to our knowledge this study is the first to assess the impact of a health 
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promotion program in the ICU in South Africa. Moreover, the results emphasize the 
beneficial effects of the program for the public health. The results of the study 
highlight the importance of knowing what is available or not available, with respect to 
the core elements of the program, to improve the success rate of the program. 
7.3 LIMITATIONS OF THE STUDY 
This study had several limitations: 
Collection of the information of adult patients only makes the results of the study not 
generalizable to paediatric patients. The small number of participating hospital may 
not allow the generalization of the results to other hospital settings. 
Microbiological data were not readily available for the study because bar-coded 
results were used in this facility, to report data. 
The data collection period was not long enough to monitor the long-term outcome of 
the patients and determine the program's effectiveness. A longer study duration 
might have demonstrated more meaningful results by showing maintenance of the 
patients' improvement or re-admission to the hospital and identify the causal factors 
thereof. Moreover, it is difficult to measure ASP effectiveness on the reduction of 
resistance because such reductions may take years to be observed (Lai, Shi, Chen & 
Wang 2016: 80). 
The participation of single public hospital for this study restricted the study from 
obtaining a comprehensive picture of the impact of the ASP in South African 
hospitals. 
Another possible limitation to this study could be the sample size.  Inadequate 
sample size has limitations that can compromise the conclusions drawn from the 
study and prevent the findings from being generalized (Faber and Fonseca 2014: 28; 
Patra 2012: 5).   In order to minimize insufficient data collection, the chance of 
rejecting null hypothesis when it is true (Type 1 error) as well as the probability of 
committing type 2 error (failure to reject the hyphothesis when it is falls), some 
authors have recommended calculation of sample size calculation before conducting 
any study (Habib, Johargy Mahmood and Humma 2014:24; Patra 2012: 5). In this 
study the researcher calculated the sample size prior to the commencement of the 
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study, taking into consideration all key concepts in sample size calculation such as, 
the Type 1 and 2 errors, significance level, statistical power and the effect size 
(Habib et al. 2014:24).  Sathian, Sreedharan, Baboo, Sharan, Abhilash and Rajesh 
(2010:4) suggest that the significant level and power must be fixed before sample 
determination so as to ensure the reliability of the results. For this study, the 
significance level was set at 5% (p = 0.05)  to  have a 95% confidence that the 
study’s conclusions are accurate, and the statistical power was set at 80 %, an ideal 
statistical power, to recognize a likelihood of 1 in 5 of detecting a difference between 
groups if it exist (Habib et al. 2014: 24, 25).  
Accordingly all precautions to have an appropriate sample size for this observational 
study were taken and an adequate sample was recruited.  
7.4 RECOMMENDATIONS FOR FUTURE RESEARCH 
Due to the limitations of this study, future research should consider including both 
public and private hospitals and broaden the scope to include different types of 
intensive care units and patients. It is further recommended that the study duration is 
increased giving allowance to follow-up studies. For a more thorough impact 
evaluation, the measure of cost-effectiveness (the worth of the program) is also 
recommended to assess if the benefits outweigh the cost of the program. 
7.5 CONCLUDING REMARKS 
This study intended to assess the performance of the ASP implemented in the ICU of 
an academic hospital, to encourage and facilitate the promotion of appropriate 
antimicrobial use. The implemented ASP was found to be sufficient to promote 
appropriate use of antimicrobials and further suggest that not only should the ASP 
guidelines be adhered to, but to constantly evaluate the ASP’s impact on the 
reduction of antimicrobial use, improving patient outcomes, reducing adverse events 
and reducing antimicrobial resistance. 
In addition, this study revealed a lack of leadership support of the ASP in the 
institution which raises concern about the preparedness of the institution’s executives 
to improve the success rate and sustainability of the program. For the ASP to be 
successful, it requires the commitment of leadership with a guarantee of dedicated 
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human, financial and information technology. The lack of leadership support may 
contribute to the collapse of the ASP. 
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I proposed is part of the requirements for the D Litt et Phil study   with the University 
of South Africa. My supervisor is Dr S Sibanda.   The title of my study is: The impact 
of stewardship of antimicrobial use in limiting the spread of antimicrobial resistance in 
South Africa. The purpose of this project is to assess the effectiveness of the 
implemented antimicrobial stewardship programs and identify their deficiencies, to 
act on them and improve on the program’s impact. 
 
Identifying the deficiencies of the antimicrobial stewardship program implemented in 
South African hospitals, will aid in optimising the promotion of appropriate use of 
antibiotics subsequently preventing and controlling unnecessary prescribing and 
misuse of antibiotics. The study will contribute substantially to strengthening infection 
control practices, as well as, reducing hospital acquired infections. Critically ill 
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patients 18 years and above, admitted in the intensive care unit and developed signs 
and symptoms of bacterial infection after 48 - 72 hours of admission.  
  
Data will be collected using structured and standardized Questionnaires. The daily 
routine will not be disturbed, and patients will not be interfered with. I will keep all the 
data I collect completely confidential, and I will not use any patient’s names in any research 
reports. Any information that I present will not be linked to any personal information that could 
be used to identify individual students. I am confident that I have taken the necessary steps to 
ensure that my research will be conducted in ways that meet ethical standards. 
Attached to this letter is the copy of my proposal, research ethics approval letter, data 
collection forms and consent forms. Should you require any further information, please do 
not hesitate to contact me (E-mail:  53739027@mylife.unisa.ac.za, Cell number: 0731097498) 
or my supervisor (E-mail : sibans1@unisa.ac.za, Tel: +27 12 429 6003). 
Yours Faithful 
 
Mr B E Nkosi 
Cell number: 0731097498  
Email: 53739027@mylife.unisa.ac.za 
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ANNEXURE C: APPROVAL LETTER MEDICAL ADVISORY COMMITTEE 
 
 
 
 
 
 
142 
 
ANNEXURE D:  APPROVAL LETTER FROM CHBAH’S ICU 
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ANNEXURE  E: LETTER FOR REQUEST THE PARTICIPATION OF ASP TEAM 
MEMBERS IN THE STUDY 
    377 Nkuna  Street 
        Zone 5 Meadowlands 
    1852 
 
Chris Hani Baragwanath Academic Hospital 
Department of ICU 
03- 09- 2017 
 
Dear Sir/ Madam 
 
RE:  Participation in antimicrobial stewardship assessment study. 
 
My name is Bongani Nkosi and I am currently registered with UNISA for a PhD.  I am 
doing research on the effectiveness of microbial stewardship programmes that aims 
to reduce inappropriate use of antimicrobials, while improving patients’ outcome and 
preventing the spread of antimicrobial resistance. Attached is an antimicrobial 
stewardship programme questionnaire.  
You were approached because your participation in this study will assist in 
determining the effectiveness of antimicrobial stewardship programme in promoting 
the prudent use of antimicrobials in hospitals. The questionnaire intends to collect 
information on the capacity of the hospital to prescribe antimicrobials. Information on 
the availability of financial, personnel and structural support for prescribing quality 
antimicrobials will be collected. Furthermore, this study is for the fulfilment of the 
requirements for the doctoral degree in the subject Health Studies at UNISA. 
Hope my request will receive favourable response 
Yours Sincerely 
Bongani Nkosi 
E- mail : 53739027@mylife.unisa.com 
Cell: 073 109 7498 
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ANNEXURE  F:  CONSENT FORM FOR REVIEWING PATIENTS’ MEDICAL 
RECORDS. 
INFORMED CONSENT FORM FOR REVIEWING PATIENTS’ MEDICAL RECORDS 
AND USE IN A RESEARCH STUDY 
PROJECT TITLE 
Impact of antimicrobial stewardship in limiting the spread of antimicrobial resistance 
in South Africa  
Principal Investigator: Mr Bongani Nkosi  
Contact: Cell number:  0731097498; email: 53739027@mylife.unisa.ac.za 
Supervisor:  Dr Sibanda; (012) 4296003; email: sibans1@unisa.ac.za  
What you should know about this research study: 
 We give you this consent so that you may read about the purpose, 
risks, and benefits of this research study. 
 The main goal of research studies is to gain knowledge that may help 
future patients. 
 We cannot promise that this research will benefit you.  
 You have the right to refuse to take part or agree to take part now and 
change your mind later. 
 Whatever you decide, it will not affect your regular care. 
 Please review this consent form carefully.  Ask any questions before 
you decide. 
 Your participation is voluntary. 
 
PURPOSE 
This study aims to comprehensively assess the effectiveness of antimicrobial 
stewardship program in promoting the judicious prescribing and use of antimicrobials 
in South African hospitals, to identify its deficiencies. Subsequently, the effect of the 
program on limiting the spread of antimicrobial resistant bacteria will be measured. 
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PROCEDURES AND DURATION 
Information about the appropriateness of antimicrobial prescribing will be collected 
using a structured questionnaire and reviewing of patients’ medical record. The 
process of data collection will consist of 2 phases: A baseline phase will entail the 
extraction of information from medical records of patients who have developed signs 
and symptoms of infection within 48h of admission to the ICU. There will be no 
interference with daily routine practice. The information collected will include: 
patients’ demographics and clinical information. Additionally, a questionnaire on the 
capacity of the hospital to prescribe judicious antimicrobials will be completed. The 
second phase will take place after 4 days of the empirical antibiotic therapy, and it 
will involve the extraction of   microbiological test results, review of the empirical 
antimicrobial therapy and patients’ outcome, without disturbing the daily routine 
practice.   
RISKS AND DISCOMFORTS 
This is a non-intrusive study and there will be no interference with the daily routine 
practice of the hospital. There is no foreseeable risk of harm or discomfort to 
participants.   
CONFIDENTIALITY 
To secure the confidentiality of the participants, data from individual participant will 
be collected and anonymised by aggregating the individual information according to 
specific characteristic. Therefore, participant’s identification will be concealed.  
ADDITIONAL COSTS 
No additional costs will be incurred by your participation.  
VOLUNTARY PARTICIPATION 
Participation in this study is voluntary therefore you are free to choose either to 
participate or not to participate.  If you decide not to participate in this study, your 
decision will not affect your future relations with the hospital, its personnel, and 
associated hospitals. At any given time, you are free to withdraw your consent and to 
discontinue participation at any time without penalty. 
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OFFER TO ANSWER QUESTIONS 
Before you sign this form, please ask any questions on any aspect of this study that 
is unclear to you.  You may take as much time as necessary to think it over. 
AUTHORIZATION 
You are deciding whether to participate or not to participate in this study.  Your 
signature indicates that you have read and understood the information provided 
above, have had all your questions answered, and have decided to participate. 
Research Title: Impact of antimicrobial stewardship in limiting the spread of 
antimicrobial resistance in South Africa  
    
Name and signature of Research Participant                   Date 
 _______________________________   ________________________________________  
Signature of Researcher                       Date 
  
YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM TO KEEP 
If you have any questions concerning this study or consent form beyond those 
answered by the investigator, including questions about the research, your rights as 
a research participant or research-related injuries; or if you feel that you have been 
treated unfairly and would like to talk to someone other than a member of the 
research team, please feel free to contact the UNISA Higher Degrees Ethics 
Committee. 
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ANNEXURE G: FINAL QUESTIONNAIRE FOR DATA EXTRATION 
 
ANTIMICROBIAL STEWARDSHIP IMPACT ASSESSMENT QUESTIONNAIRE   
Introduction 
Antimicrobial stewardship programmes aim to reduce inappropriate use of 
antimicrobials, while improving patients’ outcome and preventing the spread of 
antimicrobial resistance.  
PHASE 1  
APPROPRIATENESS OF ANTIMICROBIAL PRESCRIBING  
 
Name of Facility:                         Name of data collector:    
Ward:      Date of data collection:  
  
Patient’s code:              
 
 DERMOGRAPHICAL DATA 
 
1. How old is the patient?  Specify the age   
2. Gender (Check X only one box) 
Female      Male   
3. Ethnic origin (Check X only one box)  
Black  White  Indian  Coloured  Other (Specify)  
4. Highest qualification (Check X only one box) 
     Primary  High School  FET/College   University   
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5. Marital status (Check X only one box) 
    Single   Married   Divorced     Widowed  
 
 HEALTH RELATED INFORMATION 
 
6. Does the patient suffer from any chronic disease? (Check X only one 
box) 
No     Yes  
If yes, please specify       
   
7. What was the initial diagnosis upon admission?   
  
8. Does the patient require mechanical ventilation? (Check X only one box) 
No      Yes   
9. What is the clinical indication for the initial prescription of antibiotics? 
 Medical prophylaxis  Surgical prophylaxis   Therapeutic  
10. Is a combination of antimicrobials prescribed to the patient during ICU 
stay?  
No      Yes    
Specify the following: 
Number of antimicrobials    
Name     
Dosage    
Mode of administration     
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Spectrum     
11.   Is the microbiological specimen obtained?  (Check X only one box) 
No      Yes   
If yes, please tick the relevant source 
Sputum   Urine  Swabs   Blood   Fluids  
 Other   
PHASE 2 
REVIEW OF THE ANTIMICROBIAL THERAPY  
 
12. What are the results of microbiological test? (Check X only one box) 
Positive      Negative   
If yes specify the bacteria      
13. Is the microbe susceptible to the antimicrobial treatment? (Check X only 
one box)  
No      Yes   
14. Is the prescribed antimicrobial treatment reviewed? (Check X only one 
box) 
No      Yes   
If yes check X the relevant 
           Therapy stopped        
  The route changed        
Dosage altered          
The spectrum altered      
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15. How long has the patient been on prescribed antimicrobial treatment? 
Specify number of days_______________ 
16.  Are there any hospital acquires events observed? (Check X only one 
box) 
No        Yes   
(If yes specify) ___________________ 
17.  What is the patient’s outcome? (Check X only one box) 
Still hospitalised        Discharged          Died  
18.  How long is the patient’s stay in the ICU? 
Specify in days    
 
Thank you for participating 
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PHASE 3  
ANTIMICROBIAL PRESCRIBING CAPACITY  
Phase 3, is to be completed by the member of the ASP team or the Head nurse.  It 
intends to collect information on the availability of financial, personnel and structural 
support as well as prescribing guidelines for quality antimicrobials.   
 
Name of the Facility    Name of data collector:  
  
Data collection date:   HOD/ Team member    
 
1. Which of the following personnel are involved in improving the quality of 
antimicrobial prescribing in your facility? (Check X all that is relevant) 
Infection prevention and protection   
Microbiology laboratory                    
Clinicians                     
Nurses         
Other please specify_____________________ 
2. How often does your ASP team meet? (Check X only one box) 
Never     Seldom   Frequent  
3. Does your facility provide IT support to facilitate day to day monitoring 
prescription, antimicrobial use and data reporting? (Check X only one 
box) 
Yes     No  
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4. Which antimicrobial stewardship strategy is used in your facility for 
promoting the improvement of the quality of antimicrobials prescribed? 
(Check X only one box) 
Prospective audit with direct intervention and feedback    
Formulary restriction and preauthorisation requirement    
Other be specify     
5. Who is responsible for programme outcome of stewardship activities in 
your facility? (Check X only one box) 
Physician  Pharmacist   Physician and pharmacists  
6. How does your facility financially support the antimicrobial stewardship 
activities? (Check X only one box) 
Own funding     Sponsor   
7. Does your facility provide education to clinicians and any other relevant 
personnel on improving the quality of antimicrobial prescribing? (Check 
X only one box) 
Yes     No  
8. Does your facility have an essential medicine list authorized for 
acquisition of medicines by hospital? (Check X only one box) 
Yes     No   
9.  Is a set of essential antimicrobials always available in your facility? 
(Check X only one box) 
Yes     No  
10.  Is the essential medicine list in your institution regularly revised? (Check 
X only one box) 
Yes     No   
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11. Does your facility have evidence-based local antimicrobial guidelines for 
the diagnosis and treatment of common infections? (Check X only one 
box) 
Yes       No  
12.  How often does your facility audit antimicrobial guidelines? (Check X 
only one box) 
Never    Seldom   Frequent   
13.  Is the prescribing behaviour within your facility audited? (Check X only 
one box) 
Yes     No    
14.  Does your facility identify and address non-compliance to local 
antimicrobial prescribing guidelines? (Check X only one box) 
Yes     No  
15.  Is regular feedback provided to prescribing physician? (Check X only 
one box) 
Yes     No  
16.  Does your facility provide regular surveillance and reporting of 
inappropriate prescribing and resistance patterns? (Check X only one 
box) 
Yes     No  
17.  Does your facility track and report antibiotic use? (Check X only one 
box) 
Yes     No  
   If yes, how is antibiotic use monitored? (Check X only one box) 
By number of days of therapy (DOT)?   
         By number of grams of antibiotics used (Defined Daily Dose: DDD)?  
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   By direct expenditure for antibiotics over time (purchasing costs)?  
    
       Other specify    
18. Does your facility have an in-house microbiology laboratory? (Check X 
only one box) 
Yes                    No  
19.  Does the in-house laboratory routinely perform antimicrobial 
susceptibility tests? (Check X only one box) 
Yes            No     
  
20.  Is an antibiogram regularly distributed in your facility? (Check X only 
one box) 
Yes            No  
21. Does your facility track rates of Clostridium difficile? (Check X only one 
box) 
Yes           No  
22.  Has the quality of antimicrobial prescribing improved since the 
implementation of the antimicrobial stewardship program? (Check X only 
one box) 
Yes             No  
23.  Does your facility have a follow-up system to enhance long-term 
improvements? (Check X only one box) 
Yes             No     
 
 
Thank you for participating 
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ANNEXURE H: DATA DICTIONARY FOR THE DESCRIPTION OF STUDY 
VARIABLES FOR ANALYSIS 
Variable name Role Label Units Type Values Codes/range 
Identification Predictor Patient’s ID Numerical Continuous 1-62 
 
 
 
Age Confounder Age at admission 
date 
Years Continuous 19 – 38 = 1 
39 – 58 = 2 
59 – 78 = 3 
79 – 98 = 4 
Sex Confounder Gender of the 
patients 
Text Categorical Male= 1 
Female= 2 
 
Race Confounder Classification of 
patients according 
to racial groups. 
Text Categorical Black = 1 
White = 2 
Coloured = 3 
Indian = 4 
Marital status Confounder Marital status of 
the participants 
Text Categorical Single = 1 
Married = 2 
Divorced = 3 
Widowed = 4 
 
Level of 
education 
Confounder The highest level 
of education 
acquired 
Text Categorical None = 0 
High school = 1 
College/FET = 2 
University = 3 
Chronic 
diseases 
Confounder The presence or 
absence of 
chronic diseases 
Numerical Binary Yes = 1 
No = 0 
 
Ventilation Confounder The presence or 
absence of 
mechanical 
ventilation. 
Numerical Binary Yes = 1 
No = 0 
 
Diagnosis 
groupings 
Predictor Diagnosis 
grouping upon 
admission 
Text Classification of the 
illness 
Infectious disease  
Genitourinary system  
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Digestive system. 
Respiratory system. 
Circulatory system. 
Endocrine and 
nutrition  
Injury, poisoning =7  
Initial diagnosis Predictor Initial diagnosis 
upon admission  
Text  Diagnosed illness Illness 
Secondary 
diagnosis 
Predictor Compounding 
diagnosis 
Text Secondary illness Illness 
Severity of 
illness index 
Predictor The severity of the 
illness 
Numerical Discrete Minor = 1 
Moderate = 2 
Major = 3 
Catastrophic = 4 
Clinical indicator Predictor Clinical indications 
for antimicrobial 
prescribing. 
Numerical Binary  Surgical prophylaxis= 
1 
Medical prophylaxis = 
2 
Therapeutic = 3 
Combination 
antimicrobials 
Predictor Is a combination 
of antimicrobials 
prescribed to the 
patient? 
Numerical Binary Yes =1 
No = 0 
Antimicrobials Predictor The type of 
prescribed 
antimicrobials  
Text Antimicrobials  Antimicrobial type 
Antimicrobial 
spectrum 
Predictor The range of the 
empirical 
prescribed 
antimicrobials. 
Numerical Binary Narrow =1 
Broad = 2 
Microbiological 
test 
Outcome Test for Microbial 
growth and their 
susceptibility to 
antimicrobials   
Numerical Binary Yes = 1 
No = 0 
Microbiological 
results 
Outcome Microbiological 
test results 
Numerical Binary Positive = 2 
Negative = 1 
Not tested = 0 
Microbes Outcome The identified 
growing microbe 
Numerical Discrete Not tested = 0 No 
growth= 1 
Bacterial name= 2 
Susceptibility 
results 
Outcome The effectiveness 
of antimicrobial 
treatment  
Numerical Discrete Not tested = 0 
Resistant = 1 
Sensitive = 2 
 
Treatment Predictor The number of 
treatment 
Numerical  Discrete 1-4 
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prescribed 
Adminitration Predictor The mode of 
administering 
antimicrobials 
Numerical Binary IV = 1 
Oral =0 
Dosage Predictor The dosage 
prescribed for the 
indication 
Numerical Discrete 500 mg - 2g 
Length of 
treatment 
Predictor Length of 
treatment 
Numerical Continuous 1 – 3 days = 1 
4 – 6 days = 2 
7 -  9 days = 3 
 
Treatment review Predictor Altering of the 
treatment 
numerical Discrete Stopped = 0 
Changed = 1 
Not tempered with = 2 
 
 
Healthcare 
acquired events 
Outcome ICU acquired 
events  
Numerical Binary Yes = 1 
No = 0 
Length of stay Outcome Length of stay in 
the ICU 
Numeric Categorical 4 – 7 days= 1 
8 – 11 days = 2 
12 –15 days = 3  
16 – 19 days = 4 
Patient outcome Outcome Status of the 
patient  
Numerical Discrete Discharged= 0 
Still admitted = 1 
Dead = 2 
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ANNEXURE I: CHECKLIST FOR THE CORE ELEMENTS OF THE HOSPITAL 
ANTIBIOTIC STEWARDSHIP PROGRAM. 
Key element Questions No Yes 
Leadership 
support 
Does your facility have a formal, written statement of 
support from leadership that supports antibiotic 
stewardship? 
  
Does your facility receive any budgeted financial support 
for antibiotic stewardship activities? 
  
Accountability Is there a physician leader responsible for program 
outcomes of antibiotic stewardship activities at your 
facility? 
  
Drug expertise Is there a pharmacist leader responsible for working to 
improve antibiotic use at your facility? 
  
Does any of the staff below work with the stewardship 
leaders to improve antibiotic use? 
  
Clinicians   
 Infection prevention and epidemiology   
Quality assurance   
Microbiology (Laboratory)   
Information technology   
Nursing   
Actions to support optimal antibiotic use 
Policies Does your facility have a policy that requires prescribers 
to document in the medical record during order entry, a 
dose, duration and indication for all antibiotic 
prescriptions? 
  
Does your facility have facility-treatment 
recommendation, based on national guidelines and 
susceptibility, to assist with antibiotic selection for 
common clinical conditions? 
  
Specific 
interventions 
Are the following actions to improve antibiotic prescribing 
conducted in your facility? 
  
Broad intervention Is there a formal procedure for all clinicians to review the 
appropriateness of all antibiotics 48 h after the initial 
orders? 
  
Do specific antibiotic agents need to be approved by a 
physician or pharmacist prior to dispensing (pre-
authorisation) in your facility? 
  
Does a physician or pharmacist review courses of 
therapy for specific antibiotic agents (prospective audit 
and feed-back) at your facility? 
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Pharmacy-driven 
intervention 
Are the following actions implemented in your facility?   
 Automated changes from intravenous to oral antibiotic 
therapy in appropriate situations?  
  
Dose adjustment in case of organ dysfunction?   
Dose optimisation to optimise the treatment of organisms 
with reduced susceptibility? 
  
Automatic alerts in situations where therapy might be 
unnecessarily duplicative?   
  
Time- sensitive automatic stop orders for specified 
antibiotic prescriptions? 
  
Diagnosis and 
infection specific 
intervention 
Does your facility have specific intervention in place to 
ensure optimal use of antibiotics to treat the following 
common infections? 
  
Community acquired pneumonia   
Urinary tract infection   
Skin and soft tissue infection   
Surgical prophylaxis   
Empirical treatment of MRSA   
Non- C difficile infection (CDI) antibiotics in new cases of 
CDI 
  
Culture proven invasive (e.g. blood stream) infections   
Tracking: 
monitoring 
antibiotic 
prescribing  
Does your stewardship program monitor adherence to a 
documentation policy (dose, duration and indication) 
  
Does your stewardship program monitor adherence to 
facility specific treatment recommendations?  
  
Does your stewardship program monitor compliance with 
one or more of the specific interventions in place? 
  
Does your facility track rates of C difficile infection?   
Does your facility produce an antibiogram?   
Does your facility monitor antibiotic use by one of the 
following? 
  
By counts of antibiotics administered to patients per day 
(Days of therapy; DOT)? 
  
By number of grams of antibiotics used (Defined daily 
dose; DDD)? 
  
By direct expenditures for antibiotics (purchasing costs)?   
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Reporting 
information  
Does your stewardship program share facility specific 
reports on antibiotic use with prescribers? 
  
Has a current antibiogram been distributed to prescribers 
in your facility? 
  
Do prescribers ever receive direct, personalised 
communication about how they can improve their 
antibiotic prescription? 
  
Education Does your stewardship program provide education to 
clinicians and other relevant staff on improving antibiotic 
prescribing? 
  
Total     
 
 
 
 
 
 
 
 
 
 
 
 
